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ABSTRACT 
Will Our Final Years Be Golden?  Mortality by Alzheimer’s Disease in the United States. 
(May 2006) 
Mary Ann Davis, B.A., Lamar University; M.S.S.W., 
The University of Texas at Arlington 
Chair of Advisory Committee:  Dr. Dudley L. Poston, Jr. 
 
Alzheimer’s disease (AD) is the fifth leading cause of death among the elderly. 
This study uses National Center for Health Statistics (NCHS) Multiple Cause of Death 
data for the United States for the years 1998 to 2002, examining the 9.5 million death 
records of all decedents of age 60 and over, and determines their incidence of AD.  Seven 
independent variables are used: age, sex, race, ethnicity, marital status, education level 
and whether or not they lived in a metropolitan area.  This study uses logistic regression, 
modeling five nested models, to determine the likelihood of mortality by AD and the 
direction of the relationship between AD and each of the variables. A Bayesian analysis, 
used to determine the best fit model, found that the full model was the best fit.  
The major findings of the study are that the incidence of AD increases 
significantly with increasing age in decedents aged 60-90. However, this peaks for 
decedents aged 85-89.  Those who survive past age 90 begin to have a lesser likelihood 
of mortality by AD. With the exceptions of marital status and education, the hypotheses 
were supported. Females are more likely to die of AD than males. NonHispanic Whites 
are more likely to die of AD than Hispanics and NonHispanic Blacks.  There is an 
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increased risk of dying in a nursing home if one dies of AD. Future research as outlined 
above is needed to learn further about this fifth leading cause of mortality of those over 
age 60.  
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CHAPTER I 
INTRODUCTION 
Background 
This dissertation explores one of the devastating outcomes for the elderly, the 
mortality caused by Alzheimer’s disease and dementia (AD). Chapter I introduces the 
research question regarding the extent of mortality, and morbidity, by AD among elderly 
decedents, over sixty years of age. Three theoretical perspectives of mortality; a 
rectangularization of mortality, Epidemiological Transition theory and the perspective 
that life span is indefinite provide the foundation for data analysis of morbidity and 
mortality in the elderly in the United States. Second, is a description of Alzheimer’s 
disease and dementia, a group of chronic and degenerative diseases increasing in the 
elderly population. Third, is a description of the population in the United States showing 
current projections for the aging population through 2050. These projections are 
compared to those of other countries to show such trends in an aging population are 
global. Next is the research question exploring the extent of mortality by AD in the over 
sixty population as well as the rationale for presenting morbidity data to provide a clearer 
picture of AD. The chapter concludes with a brief outline of the remainder of the 
dissertation. 
The title of this dissertation questions the quality of life among the elderly.  The 
popular picture of the elderly, as depicted by Shakespeare in As You Like It, is of a  
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demented person who is mindless, forgetful and childlike requiring total care, much like 
the person who is diagnosed with Alzheimer’s or dementia:  
 The last scene of all, 
 That ends this strange eventful history, 
 Is second childishness and mere oblivion, 
Sans teeth, sans eyes, sans taste, sans everything.  
(http://www.tech.mit.edu/Shakespeare). 
 
Senility and dementia are now seen as a disease instead of the natural aging 
process. A critical issue is how widespread is AD in the elderly population?  Dalsania 
(2004) notes that recent studies have shown that at age sixty, one percent of the 
population is found to have dementia however by age eighty-five it is estimated that 
50percent-80 percent of the population will develop dementia. Since modern man has a 
longer life span than at any other time in history, we can investigate the mortality and 
morbidity of the elderly and answer questions of what is normal aging and whether with 
increased longevity there will be increased disability.   
We are facing global issues of an aging population. Later this chapter describes 
global demographics. Projections of the aging population estimate that by 2050 between 
20 to 33 percent of the population will be over age 60.  Realistically, although research is 
making progress in treatment and cure of specific chronic and degenerative diseases that 
affect the elderly, one cannot expect that life of the elderly will be without morbidity. 
Accordingly this study has selected one of the chronic and degenerative disease groups, 
Alzheimer’s disease and dementia, to explore the extent of mortality and morbidity.  
 Alzheimer’s disease and dementia (AD) was selected for three reasons. First, AD 
has become the eighth leading cause of mortality in the elderly, over 65 population in the 
United States (Hoyert, 1996). Projections of morbidity from AD are even greater with 
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Dalsania (2004) projecting that by age eighty-five 30 to 50 percent of the population will 
develop dementia. Brookmeyer and colleagues (1998) estimated that 4.5 million in the 
U.S. have AD. Even though AD ranks fifth in incidence they noted that AD ranks third in 
expense due to the length of  length of morbidity ranging from 5 to 20 years along with 
the broad range of services required by those with AD, usually culminating in Nursing 
home care (Brookmeyer et al.,1998.) Third, is the question of whether there are social 
demographic issues that influence mortality by AD.  Many demographers (Rogers et 
al.1987, Rogers et al. 1996, Rogers et al. 2000, Rogers et al. 2005 and Schoenborn, 1986) 
have addressed the effects of social demographic factors such as education, income, 
ethnicity, social class, medical care access on mortality. This study will address those 
social demographic variables which influence biological disease processes.  
A brief presentation of three theoretical explanations of mortality sets the stage 
 for an understanding of mortality issues:  Epidemiological Transition theory, a 
rectangularization of mortality, and the perspective that life span is indefinite. 
Epidemiological Transition Theory 
The first theoretical explanation for mortality is Epidemiological Transition 
theory.  This theory was postulated by Omran (1971), consisting of three stages. The first 
was the Age of Pestilence and Famine the primary causes of mortality were influenza, 
pneumonia, smallpox, tuberculosis and other related diseases with high infant and 
childhood mortality and a life expectancy averaging between 20 and 40 years. In 
developed countries this stage persisted until around 1875. The second stage is the Age of 
Receding Pandemics.  During this stage there is a decline in mortality due to improved 
sanitation, increases in standards of living and public health, resulting in a steady increase 
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in life expectancy to between 30 and 50 years. According to Rogers and Hackenberg 
(1987) the stage of receding pandemics was approximately 1875 to 1930. During the 
third stage mortality declined due to medical advances in the prevention and treatment of 
infectious diseases. The remaining causes of mortality are the chronic degenerative 
diseases, heart disease, cancer and stroke. During this recent stage the life expectancy at 
birth has risen rapidly so that fertility has been the primary factor in population growth as 
life expectancy exceeds 70 years (Omran 1971). Olshanksky and Ault (1986) report 
about three fourths of deaths in the advanced years are the result of degenerative diseases.  
Rogers and Hackenberg (1987) added a fourth ‘hybristic stage’ where mortality is heavily 
influenced by individual behavior or life style choices, and deaths are due to social 
pathologies such as accidents, alcoholism, suicide and homicide as well as life style 
issues such as smoking and diet. This dissertation later focuses on two social variables, 
educational level and marital status. 
Caldwell (2001) compares the mortality transition of Epidemiological and 
Demographic Transition theories.  The Demographic Transition Theory predominates in 
explaining population changes in fertility related to modernity. Prior to modernity, there 
is a high mortality stage which he labels as pretransitonal.  Second, is the early 
transitional stage with a decline in mortality due to a combination of hygiene and public 
health lowering mortality caused by infectious diseases. These declines in mortality 
began with the youngest, both infants and children, so that in the 185 years between 1780 
and 1965 both male and female life expectancies doubled. Third, is the late transitional 
stage in which mortality is caused primarily by degenerative diseases. In Australia, 
Canada and Sweden the decline in mortality was attributed to a decline in death from 
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heart disease; in France and Japan the greatest declines were attributed to a decline in 
strokes. In the fourth stage, mortality is further reduced because of the delay or reductions 
in mortality from degenerative causes (Caldwell 2001). 
Rectangularization of Mortality 
 The second theoretical explanation for mortality is the rectangularization of the 
mortality curve that occurred with modern health practices.   As early as 1825 Benjamin 
Gompertz developed a mathematical formula depicting mortality by age (Rogers et al. 
2005), claiming a law of mortality which was depicted as a slope with rates of mortality 
increasing with age.  However, in modern times deaths have been compressed into the 
oldest old ages. This causes a narrow age range of death appearing not as a gentle slope 
but as a rectangle.  Demographers (Carnes and Olshansky 1993, Olshansky 2003, 
Olshansky and Carnes 1994, Olshansky et al. 2001, Olshansky et al. 1990, Olshansky et 
al. 2004) have argued, that we can anticipate a life expectancy of around age 85 or 90 due 
to senescence, a biological limit to life span. They further argue that even if there are 
medical advances to increase longevity those who survive due to a cure or treatment of 
one specific disease will be frail, evidencing morbidity of other disease processes 
(Olshansky et al. 1990). 
  Although there have been dramatic increases in life expectancy over the last 
century these have primarily been changes in mortality risks in infancy, childhood and 
early adult life. Since these young have already had their life span increased we cannot 
anticipate such dramatic changes in the future. Unless there is a change in fundamental 
aging, with increased vulnerability to all common causes of death, life span will not be 
increased by more than 15 years even if all aging-related causes of death, such as cancer 
  
6 
and heart diseases, are eliminated (Olshansky et al. 2001). Olshansky and colleagues 
(2004) posit that our search for the magic anti-aging pill leaves us open to “snake oil 
salesmen” and engaging in risky behavior such as starvation diets. Although starvation 
diets increase longevity in laboratory studies of other species, they do not readily transfer 
to humans.   
There are no life-style changes, surgical procedures, vitamins, antioxidants, 
hormones, or techniques of genetic engineering available today with the capacity 
to repeat the gains in life expectancy that were achieved during the 20th century.  
If there is going to be another quantum leap in life expectancy at birth (20 to 30 
years or more), these large gains will have to come from adding decades of life to 
the lives of people who reach the ages of 70 and older.  Modifying endogenous 
biological processes to achieve this goal, although theoretically possible, will be 
much harder than reducing children’s death rates from infectious and parasitic 
diseases. (Olshansky et al. 2001). 
 
  Thus, from the perspective of the rectangularization of mortality, one would 
expect that in the 80’s mortality will continue to increase. Specifically, mortality from 
AD would continue with the age eighty plus decedents having increasing mortality from 
AD.  Because the theoretical assumption that with senescence there is increased mortality 
from a combination of causes, an increase would be especially evident if the dependent 
variable of AD is expanded from the underlying cause of mortality to include all who 
have AD as one of the twenty conditions of mortality.  
Life Span Is Indefinite 
The third theoretical perspective that life span is indefinite is a challenge to both 
Gompertz’s “law of mortality”, which depicts an acceleration of mortality with increasing 
age, and the rectangularization of mortality. The perspective that life span is indefinite 
argues that a definite life span is a faulty theoretical concept as it is based on the life span 
of a single human.  The longest known life span is 122 years and five months 
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authenticated as the age of Frenchwoman Jeanne Calment who died in 1997 (McFalls 
2003). This record could be broken by one person who lives to 122 and six months.  
Thus, since a single human who lives longer than Jeanne Calment can change the life 
span, we cannot define the life span of humans.  
Vaupel (2001) notes that prior to the 19th Century only a scattered few individuals 
survived past 100.  There were countries with over one million in population with no 
documented centurions (and no supercenturions, aged 110 and over). However, as we 
entered this century, there were over 100,000 documented centurions.  Beginning with 
the first documented supercenturion, Katherine Plunket, who died at age 111 in 1932 in 
Northern Ireland; we now have begun to document supercenturions. With the 
supercenturions we question the validity of their age, requiring collaborative 
documentation prior to accepting claims of age (Vaupel 2001, Vaupel et al. 1998).  
Ahlburg and Vaupel (1990) argue that our projections for life expectancy are 
based on conservative forecasting. They argue that mortality rates have declined at a rate 
of 1 percent to 2 percent per year in developed countries, especially the mortality rates of 
the age 65 + population. They assume that if this mortality decrease continues at a 2 
percent progression, in 2080 we could expect a life expectancy of 100 years for females 
and 96 for males (Ahlburg and Vaupel 1990).  
If life expectancy was approaching a biological limit one would assume that the 
mortality rates of the oldest old would tend to be higher in countries with higher rates of 
the oldest old. However Vaupel (1997) found that countries with the oldest old, France, 
Japan and Sweden, show a slowing of the mortality rates in the oldest old.  Vaupel, 
Director of the Max Planck Institute for Demographic Research, argues that life 
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expectancy has been rising at a regular linear pace over the last 160 years. For example 
whereas Swedish women held the record in 1840 with a life expectancy of 45 years and 
in 2000 Japanese women held the record for  life expectancy at 85 years (Horiuchi  and 
Wilmoth (1998). This increase occurred at a steady rate of almost three months per year.  
Demographers (Vaupel et al. 1998; Horiuchi  and Wilmoth 1998) found that mortality in 
the elderly goes through three stages; namely a deceleration of mortality after age 80, a 
mortality plateau between ages 80 to 105 and an actual decline in mortality in the highest 
ages, over 110. Manton and colleagues (1991) argue that even with the interdependence 
of diseases as we progress in treating specific diseases such as AD, we are altering 
sensence.  
Since longevity factors are biological issues which should be available for cross 
species analysis, Vaupel and Carey agreed to collaborate on a large scale life table of the 
Mediterranean fruit fly. The human aging population is difficult to analyze in a laboratory 
setting due to ethical issues of experimentation involving subjects in starvation and 
deprivation environments as well as there being only a small number of supercenturions 
available for analysis. The Mediterranean fruit fly project, based in Tapachula, Mexico, 
allowed for a database of over 5.6 million subjects under controlled situations. They were 
able to expose flies to multiple conditions not possible with human subjects. Using such a 
large number of subjects Carey found subjects who survived to the oldest old age. The 
analysis of the indeterminacy of life span research documented, under optimal laboratory 
conditions, that longevity can be over three times the expected life span of the given 
species (Carey 2003).   
  
9 
This dissertation will only use five years of data.  Thus it is beyond the scope of 
this project to address the theoretical perspective that life span is indeterminate. However, 
if life span is indeterminate, mortality from the chronic and degenerative disease of AD 
should follow the mortality curve of decreasing mortality from AD in the over 80 
population. By combining five years of mortality data from the National Center for 
Health Statistics this study will have a large number of decedents over age 80, 90 and 100 
so to be able to analyze the mortality in the oldest old. 
Alzheimer’s Disease 
Mortality from chronic and degenerative diseases includes Alzheimer’s disease 
and dementia as one of the leading causes of mortality in decedents over sixty. 
Historically, physicians used the terms senile dementia and senility to describe age 
related cognitive deterioration. Holstein (2000) notes prior to the mid 70’s most 
physicians considered AD to be rare preferring to use a mixture of diagnoses such as 
senile dementia, senility, senile psychosis or organic brain syndrome. Part of the 
reluctance to recognize that AD was a distinct disease is that it was commonly assumed 
that normal aging was a degenerative process so that loss of memory, decreased cognitive 
functioning, inattention, and lack of concentration leading to the stage of “second 
childhood” was but a normal part of aging.  
In the past century Alzheimer’s disease has been diagnosed as a disease, 
following its identification by Dr. Alois Alzheimer in a female patient in 1906 (Holstein 
2000). As the diagnostic labeling on death certificates has become more standardized 
with each improvement in diagnostic nomenclature the percentage of the elderly 
diagnosed with Alzheimer’s has increased so that mortality by AD became one of the ten 
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top causes of death for the over 65 age decedent ( Hoyert 1996).  AD, a degenerative 
neurological disease, is classified by the International Classification of Diseases, ICD, 9 
and ICD 10 as a mental and behavioral disorder.  
Alzheimer's disease is a progressive, degenerative disorder that attacks the brain's 
nerve cells, or neurons, resulting in loss of memory, thinking and language skills, 
and behavioral changes. These neurons, which produce the brain chemical, or 
neurotransmitter, acetylcholine, break connections with other nerve cells and 
ultimately die. For example, short-term memory fails when Alzheimer's disease 
first destroys nerve cells in the hippocampus, and language skills and judgment 
decline when neurons die in the cerebral cortex. Two types of abnormal lesions 
clog the brains of individuals with Alzheimer's disease: Beta-amyloid plaques—
sticky clumps of protein fragments and cellular material that form outside and 
around neurons; and neurofibrillary tangles—insoluble twisted fibers composed 
largely of the protein tau that build up inside nerve cells. Although these 
structures are hallmarks of the disease, scientists are unclear whether they cause it 
or a byproduct of it. (http://alzfdn.org/alzheimers/index.shtml) 
 
AD causes a slow neurological and physiological degeneration. The cognitive 
degeneration includes memory loss, deterioration in language, comprehension, 
calculation, learning, and mental functions. The American Psychiatric Association (APA) 
in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 
(1994) defines the clinical syndrome of AD. Although the diagnostic nomenclature of the 
ICD has changed through editions, the disease Alzheimer’s is essentially the same 
disease as was identified by Dr. Alois Alzheimer in 1906 through an autopsy of a female 
patient showing the plaques and tangles that today characterize the disease (Holstein, 
2000).  
The APA DSM-IV notes that AD has two critical aspects; cognitive functioning 
and the impact of cognitive functioning on daily living activities. First, AD involves 
cognitive functioning which includes at least two or more of the following domains. The 
first and most common domain is memory, defined as the ability to learn, retain and 
  
11 
retrieve information. Second is language, both receptive language, encoding information, 
and expressive language, the ability to communicate verbally or by gestures with others.  
Third is visual-spatial ability; the ability to judge distance and orientation.  Wandering 
and getting lost or losing items are primary symptoms of an impaired visual spatial 
ability. Fourth is the executive function that involves planning, organizing sequencing 
and abstracting. Next is the impact of cognitive functioning on daily living activities such 
as dressing, eating, toileting, grooming and walking. The cognitively impaired person is 
no longer able to be independent in daily living activities requiring increasing caretaking 
as the disease progresses. Finally, there are changes in personality and behavior which 
may include moodiness, affect lability, aggression, wandering and sleep disruption (APA 
DSM-IV 1994).  
A difficulty in diagnosing AD is due to its insidious, slow progression. With 
normal aging memory is maintained, with a slight delay in recall of newly learned 
material (Dalsania 2004). Mild cognitive impairment, with isolated amnesia or memory 
impairment while maintaining all other domains, may accompany a number of illnesses, 
and improve as the illness is treated. For example depression may cause mild cognitive 
impairment which will improve with treatment of the depression with medication. 
However with AD there is a progression from the cognitive functioning of normal aging, 
to mild cognitive impairment, to dementia, to death.  The progression is variable but 
seems to be a stepwise progression at a rate of losing 10 to 15 percent of functioning per 
year. Although there is no cure for AD there are medications that, if taken early may slow 
the progression (Dalsania 2004). 
  
12 
Initially a diagnosis of AD was only confirmed after death by autopsy of the 
brain, as an autopsied brain revealed the characteristic neurological tangles and plaque 
and significant atrophy of AD. Hoyert (1996) notes that research in the 1970’s indicated 
that 60 to70 percent of the suspected cases were confirmed through autopsy and that in 
the 1990’s more than 90 percent of suspected cases were confirmed by autopsy.  Current 
diagnostic techniques, including neurological testing and scans allow diagnosis in the 
living.  For example a magnetic resonance imaging (MRI) clearly reveals AD without 
autopsy. Figure A.1 in the Appendix is a MRI which shows the atrophy and loss of brain 
mass in the progression of the disease (http://www.mayoclinic.com).  
 AD is the most frequent cause of dementia.  Dementia is also associated with 
cerebrovascular disease, the second most common cause of dementia; moreover one- 
third of stroke patients develop dementia. Other causes of dementia include normal 
pressure hydrocephalus, affecting about 10 percent of adults over age 60; alcohol related 
dementia/ Korsakoff’s syndrome; Parkinson’s disease, dementia with Lewy bodies and 
frontal temporal dementia. Infections may also cause dementias such as AIDS, viral 
encephalitis, spirochetal disease, Lyme disease, chronic bacterial meningitis and 
Creutzfeld’Jacob’s disease (CJD) (APA-DSM-IV 1994, Dalsania 2004, Hoyert 1996,).  
Other dementias will be included in this study because they are also progressive 
neurological dementias with a similar impact. 
One of the critical issues about AD is its increasing effect in an elderly 
population.  Dalsania (2004) notes that recent studies have shown that at age sixty, one 
percent of the population is found to have dementia, however, by age eighty-five it is 
estimated that 50 percent to 80 percent of the population will develop dementia. Modern 
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man has a longer life span than any age making possible a demographic analysis of 
mortality and morbidity of a late onset disease such as Alzheimer’s.   This raises the 
question of how many elderly will be diagnosed with Alzheimer’s and dementia at death 
as well as what will be the morbidity of the elderly. Also addressed is the theoretical 
question of whether, as demographers (Manton and Gu 2001 and Uhlenberg 1992) have 
posited, with increased longevity there will be increased disability.  
Population Projections through 2050 
 According to the US Census Bureau, International Population Reports, in 2004, 
life expectancy at birth in the World was 65 for males and 69 for females. In more 
developed countries it was 72 and 80, and in less developed countries, 63 and 67. The 
highest life expectations at birth were in Japan, 78 for males and 85 for females; the 
lowest were in Sierra Leone, 34 for males, 36 for females. In 2002 globally there were 
440 million persons over age 65 which is 7 percent of the total population. The over 65 
population is projected to double by 2020 and almost triple by 2050 with 17 percent of 
the world’s population projected to be over age 65. This segment is projected to grow 
faster than any other age segment due to increased longevity and decreased fertility (US 
Census Bureau 2004). The United Nations (UN) projections are based on the population 
that is over 60 and show even more dramatic increases in the elderly.  The UN projects 
that by 2050 there will be nearly two billion over age sixty, or 22 percent of the 
population.  The UN reports global aging trends of median age increasing from 23.5 
years in 1950, to 26.4 in 1999 with a projection of 37.8 in 2050. Further the UN projects 
that nearly one person in three will be over age 60 in 2050 
(http://www.un.org/esa/population/publications/sixbillion/sixbilpart1).  
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In 2001 life expectancy in the U.S. was 77 years, ranking 20th in the world.  In the 
U. S. during the last century, life expectancy at birth has increased from 47 in the 1900’s 
to 67 in 2000 (McFalls: 2003). This increase coupled with lower fertility is creating an 
aging population. Descriptive data in Appendix A, Table A.1 from the  U.S. Bureau of 
the Census International Data Base, (IDB) indicate that 3.3 percent of the US population 
was 80+ in 2000, 4.5 percent are projected to be 80+ in 2025 and 8 percent are projected 
to be 80+ in 2050..  The IDB Population Pyramid summary for the U.S. in Appendix A, 
Figure A.2 depicts the current population and trends with the aging of the baby boomers, 
lower fertility rates and the aging of the population. The numbers for the IDB Pyramids 
over age 60 are included in Appendix A, Table A.1. Note the projection in 2050 is that 
the median age is 39.1 and approximately 10 percent of the females are over age 80. 
Appendix A, Table A.2 illustrates the U.S. Bureau of the Census IDB projected 
dependency ratios for the U. S. in 2000 to be 18.75 percent over 65, with projections for 
2025 of 29.33 percent over 65 and 2050 with 34.57 percent over 65. 
As mentioned earlier Ahlburg and Vaupel (1990) argue that our projections for 
life expectancy are based on conservative forecasting. They argue that the U. S. Census 
bureau’s projection of a life expectancy of 91 for females and 85 for males in 2080 is 
low.  Since mortality rates have declined at a rate of 1 percent to 2 percent per year in 
developed if one assumes this progress continues through 2080 one could expect a life 
expectancy of 100 years for females and 96 for males (Ahlburg and Vaupel 1990).  
The Extent of Mortality by AD 
This dissertation will address one aspect of increasing disability in the elderly 
population, specifically mortality and the related morbidity caused by AD. Hoyert (1996) 
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posited that AD as a cause of mortality has increased significantly from 1979 to 1991.  
“Between 1979 and 1991 the age-adjusted death rate for Alzheimer’s disease increased 
twelvefold from 2.5 to 29.3 per 100,000 population age 65 and over” (Hoyert 1996). This 
pattern is probably due to better diagnosis of AD and better medical certification than to 
an actual increase in disease (Hoyert 1996).  AD has become the eighth leading cause of 
mortality in the over 65 population. 
It must be noted that there is a suspected underreporting of AD as a cause of 
mortality on death certificates, data which will be used in this dissertation. Burns and 
colleagues (1990) report that in 30 percent of the cases studied there was no mention of 
dementia on the death certificate recommending that a higher autopsy rate would increase 
the accuracy of reporting of AD on death certificates. Hoyert (1996) argues that neither 
AD nor other dementias are mentioned on a quarter to one third of the death certificates 
of diagnosed persons.  Hoyert notes that AD is underreported on death certificates for a 
number of reasons: first AD may be present but not diagnosed; second, AD may be 
diagnosed but not be considered to have caused the death; third the person with AD  may 
only be recognized when the disease is in its final stages; fourth, the individual with AD 
in the final stages is susceptible to other chronic conditions and infectious conditions 
which are more easily reported by medical personnel as conditions contributing to death 
(Hoyert 1996).  
 Hebert, Scherr, Bienias, Bennett and Evans (2003) studied the incidence of AD 
using three adjacent neighborhoods in Chicago. Seventy-nine percent of the residents 
participated. AD incidence was measured among 3838 persons. Of these, 835 met the 
criteria established by the National Institute of Neurological and Communicative 
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Disorders and Stroke. This study estimated 4.5 million in the U. S. with AD; 0.3 million 
or 7 percent  were between ages 65 and 74; 2.4 million or 53 percent  were between ages 
75 and 84; and 1.8 million or 40 percent  were 85 years of age or older. They estimated 
that in 2010 there will be 5.1 million persons with AD and by 2050 there will be between 
1.3 million and 16.0 millions with AD due to the rapid growth in these oldest age groups 
(Hebert, et. al, 2003:1119) 
 Although mortality data does have limitations as were mentioned earlier, with 
an underreporting of mortality by AD recognized by Hoyert (1996), the data are the 
documented causes of mortality.  Refer to Appendix A, Figure A.3 for an initial analysis 
of the National Center for Health Statistics (NCHS) Multiple cause of Death files in 
2001(Davis et al. 2004). Refer to Appendix A, Figure A.3 for the percentages of 
mortality by AD by age over 60 years. The incidence of AD increases from .71 percent 
for male decedents and .04 percent for females decedents in their 60’s to 2.3 percent for 
male decedents and 2.78 percent for female decedents in the 70’s.  Decedents in the 80’s 
continued to have increased mortality from AD; the 4.48 percent of male and 5.52 
percent of female decedents in their 80’s died of AD.  The growth in mortality by AD 
slows in the 90’s and 100’s to 4.61 percent for males and 5.86 percent for females in the 
90’s and 3.21 percent for the males and 4.07 percent for females in the 100’s.  This 
increase in AD as a cause of mortality is clarified by Figures 4 and 5 which depict the top 
causes of mortality in decedents two age groups, age 60’s and age 80’s respectively. 
Appendix A, Figure A.4 shows that at for decedents aged 60’s AD is the twelfth leading 
cause of mortality. Appendix A, Figure A.5 shows that in decedents aged 80’s the 
percentage has increased so that AD is the fifth leading cause of mortality. 
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Uhlenberg (1992) notes that unless there is significant progress in research, the 
increased numbers of the oldest-old will lead to increased numbers of elderly with 
disabilities requiring long-term care.  The implications of mortality from late onset 
degenerative diseases must be considered in conjunction with the age structure of the 
population as decreases in fertility rates, and increases in life expectancy during the last 
century have profound implications for the population. Therefore, this topic is a 
particularly timely one in that the large cohort of “baby boomers” is reaching the age at 
risk for dementia.  This creates the need for a demographic analysis to prepare for the 
significant financial impact of morbidity by AD in this cohort. 
 There is a gap in research pertaining to the incidence of AD in the oldest old, 
those over 90. This dissertation will use mortality data to address this gap by combining 
five years of data to have sufficient numbers of those who die after age 90 and after age 
100, addressing whether the increase in AD that begins in the 60’s continues in the oldest 
old or whether there is a critical period of AD incidence.  
Overview of Research 
Following this introductory chapter, Chapter II reviews the relevant literature on 
mortality by Alzheimer’s Disease and describe current demographic research regarding 
mortality issues related to chronic and degenerative diseases affecting the elderly. 
Chapter III will discuss the data and methods of analysis.   The data are Multiple Cause 
of Mortality data for the years 1998 to 2002 from the National Center for Health 
Statistics, NCHS. Descriptive analysis is used first to study variables affecting the aged 
decedents including the main causes of mortality by age. Descriptive analysis also depicts 
mortality differences by sex, ethnicity, marital status, education level, metropolitan status 
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and place of death.  Next the logistic regression depicts the odds of dying of Alzheimer’s 
disease versus other causes of mortality using the independent variables.  Chapter IV 
provides the results of the analysis of the NCHS death certificate data. Chapter V 
summarizes the main findings of the dissertation, presents implications for policy 
development and suggestions for future research.   
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CHAPTER II  
LITERATURE REVIEW 
This chapter reviews relevant literature on mortality by Alzheimer’s disease, 
describing current demographic research regarding mortality issues related to chronic and 
degenerative diseases affecting the elderly. The AD literature is organized into categories 
related to the variables to be addressed in this dissertation: theoretical literature about life 
expectancy and life span; literature regarding the demographic variables of age, sex, 
marital status, race and ethnicity, education level; and general morbidity. A bibliographic 
review was undertaken using such internet web searches of JSTOR, Science Direct, 
Popline, Cambridge Scientific Abstracts, and Sociological Collection.  A brief synthesis 
of the literature for each variable will follow, which will be used in chapter three to 
support the research hypotheses. 
Theoretical Literature about Life Expectancy and Life Span 
Epidemiological Transition theory, espoused by Omran (1971) posits three main 
stages: the Age of Pestilence and Famine, the Age of Receding Pandemics and the Age of 
Chronic and Degenerative Diseases.  According to Rogers and Hackenberg (1987) the 
United States is in a fourth ‘hybristic stage’ with mortality heavily influenced by 
individual behavior or life style choices. In this stage most deaths are due to social 
pathologies such as accidents, alcoholism, suicide and homicide, as well as life style 
issues such as smoking and diet.   
The bulk of literature pertaining to the incidence of AD appears to substantiate 
Epidemiological Transition Theory, with increases in AD related to the increases in 
numbers in the aging population.  The difficulty in obtaining valid statistics globally not 
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withstanding, Wilmo and colleagues (2003), used worldwide United Nations data, based 
on the medium fertility variant, to project the population of the world. They calculated 
the number of cases with dementia as multiplications of the age and class-specific 
dementia:“1% in age group 60-64 years, 1.5% in 65-69 years, 3% in 70-74 years, 6% in 
75-79 years, 13% in 80-84 years 34% in 90-94% and 45% in ≥95 years (Wilmo 2003, 
64).”  Because of global aging, they estimated the number of demented people will 
increase from 25.5 million in 2000, to 63 million in 2030, and to 114 million by 2050. 
Although there were some international conflicting reports of AD incidence (e.g. China 
and Nigeria reporting a lower portion of dementia than in Europe and North America), 
other studies show global prelevance similar to the Western rates with AD increasing as 
the population ages (Wilmo 2003).  
The trend of increasing AD has been supported by research. The Center for 
Disease Control (CDC) estimated that in the United States the incidence of AD doubles 
every 5 years after age 65 with approximately 10 percent of adults ≥ 65 years, and 47 
percent of adults ≥85 diagnosed with AD (CDC: 2003, 104). As the population aged and 
the techniques for the diagnosis of AD were refined, the death rate from AD increased 
from 0.4 per 100,000 in 1979 to 4.2 per 100,000 in 1987 (CDC: 1990,1).  Sahyoun and 
colleagues (2001), examining death certificates beginning in 1933, noted an increase in 
mortality by AD as the population aged. AD was ranked among the top 10 leading causes 
of death in 1994.  Hoyert (1996) also found an increase from 857 AD deaths in 1979 to 
14,112 AD deaths in 1991.  She explained the increase in AD caused mortality as being 
due to multiple factors including an increase in the population at risk for AD, 
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improvement in the diagnosis of AD, and an increase in medical personnel reporting AD 
and other dementias on death certificates.   
Other researchers (Antuono and Beyer 1999, Dalsania 2004, Gambassi  and 
colleagues 1999, Giovanni and colleagues 1999, Hoyert 1996, Nocera and colleagues 
2003, Pollen 2000) have shown support for the positive associate between AD and age. 
Dalsania’s percentages were lower than those of the CDC. He found that at age 60 one 
percent of the population has dementia. However, by age 85 an estimated 30 to 50 
percent of the population has dementia (Dalsania 2004). Gambassi  and colleagues (1999) 
agree that about 50 percent at age 85+ have AD. Giovanni and colleagues (1999) suggest 
a prelevance of AD in about 50 percent of the over 85 population in the US, estimating 
nearly 4 million people to have a diagnosis of AD, which would make it the fourth 
leading cause of death in the elderly. 
 Nocera and colleagues (2003) have shown that the rate of AD increases with age 
with an occurrence of 9 to 10 percent at age 65+ and 30-50 percent at age 85+. The 
incidence rates used to describe newly diagnosed cases were 0.5 percent at age 65 and 8 
percent at age 85. Pollen (2000) extended the incidence of AD to the lower age of the 
50’s, by noting that the risk of AD doubles every five years between ages 50 to 80. 
Hoyert (1996) noted that National Center for Health Statistics mortality data from 1979-
1991  showed that rates for the 85+ age group were 19.3 times those for the 65-75 age 
groups. 
Other studies have focused on projections from specific neighborhoods. Hebert 
and colleagues (2003) studied the incidence of AD in three neighborhoods in Chicago, 
with a seventy-nine percent participation rate. Of the 3,838 persons in the study, 835 met 
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the criteria for AD established by the National Institute of Neurological and 
Communicative Disorders and Stroke. From this study, they estimated that of the 4.5 
million persons in the U. S. diagnosed with AD, 0.3 million or 7 percent were between 
ages 65 and 74; 2.4 million or 53 percent were between ages 75 and 84; and 1.8 million 
or 40 percent were 85 years of age or older. They estimated that in 2010 there will be 5.1 
million persons with AD and by 2050 there will be between 1.3 million and 16.0 millions 
due to the rapid growth in these oldest age groups (Hebert, et. al, 2003:1119) 
Comorbidity of AD with other chronic and degenerative diseases also effects 
mortality. With the aging of the world’s population, 80 percent of those aged 65 and over 
will have one chronic condition, and 50 percent will have at least two chronic conditions 
(CDC 2003). Hoyert (1996) argued that the comorbidity of AD with other chronic 
conditions has lead to the underreporting of AD on death certificates. Even if AD was 
diagnosed and may have contributed to death, the physicians were accustomed to 
reporting one cause of death, the overt reason for the death, rather than the contributing 
chronic conditions.  
Ganguli and colleagues (2005) compared death certificate conditions with 
diagnostics to confirm suspected underreporting of AD on the death certificates.  They 
found only 12.3 percent of those diagnosed with AD had it reported as a condition of 
death. The extensive comorbidity might be a cause of this underreporting. They also 
found that cancer deaths were underreported in those with AD which might reflect either 
that AD or cancer were competing risks or that there is a lower detection of cancer in 
those with AD (Ganguli et al. 2005). 
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 Mortality in the hybristic stage of the Epidemiological Transition theory tends to 
be heavily influenced by individual behavior or life style choices (Rogers and 
Hackenberg 1987). This hybristic stage is supported in the Cache County Study (Miech 
and colleagues 2002 and Tschanz and colleagues 2004). Cache County, Utah was 
selected for study because it has an elderly population with the highest life expectancy in 
the United States. Over 90% of the population belongs to the Church of Jesus Christ of 
Latter-day Saints, a church which prohibits such life style choices known to increase risk 
factors for heart disease and cancer, as smoking and drinking alcoholic beverages. These 
beliefs also endorse life style choices, such as stable marital unions and close knit 
families, which also support longevity.   
Tschanz and colleagues (2004) monitored deaths in Cache County, Utah, using 
vital statistic records and newspaper obituaries of 355 individuals with dementia and 
4,328 with no dementia. They were screened using psychological, medical and 
neurological exams, and an informant interview.  As was hypothesized they had lower 
incidences of AD than would be estimated by national age projections suggesting that life 
style indeed influences AD (Miech and colleagues 2002 and Tschanz and colleagues 
2004).  
The research of Antuono and Beyer (1999) also supports the hybristic stage; Their 
data suggested that only 5 percent of AD may be genetically determined while the 
remaining 95 percent may be attributed to personal choice risk factors such as education, 
nutrition and incidence of vascular disease which is itself alterable by healthy life 
choices.  
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 The second theoretical perspective is the rectangularization of mortality.  Some 
demographers (Carnes and Olshansky 1993, Olshansky 2003, Olshansky and Carnes 
1994, Olshansky et al. 2001, Olshansky et al. 1990, Olshansky et al. 2004) have posited 
the existance of senescence, that is a biological limit to life span, namely a life 
expectancy of around age 85 or 90. They argue medical advances to increase longevity 
will leave frail survivors susceptible to morbidity of other disease processes (Olshansky 
et al. 1990). 
Wilmoth and Horiuchi (1999) have described the rectangularization of mortality 
as a compression of mortality at older ages so that the survival begins to appear more 
rectangular suggesting there is a distinct upper limit to human life expectancy.  Even 
though life expectancy has increased from the 30’s in historical times, to the upper 70’s 
in modern times, patterns of mortality reduction appear to be slowing.  Wilmoth and 
Horiuchi (1999) agree with Epidemiological theory that initially the greatest decreases in 
mortality were aged infancy to five years.  Once a population reaches age 70 and above 
mortality decline tends to slow.  
   Research by Brookmeyer and colleagues (2002) and Ganguli and colleagues 
(2005), would seem to support the rectangularization of mortality theory. Ganguli and 
colleagues (2005), in a fifteen year epidemiological study which included 1000 person-
years, found that  the age of onset and the duration of survival differed by age. Elderly 
persons, over age 85, who were diagnosed with AD, survived for fewer years than those 
who were diagnosed prior to age 75.  
Brookmeyer and colleagues (2002) also found that length of survival after 
diagnosis depends on the age at onset, or original diagnosis, which would support a 
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rectangularization theory. If AD is diagnosed in the 60’s or 70’s the average length of 
survival is 7 to 10 years.  However, if diagnosed in the 90’s, the average length of 
survival is 3 years or less. Brookmeyer and colleagues (2002) have noted that if 
prevention strategies or treatments could allay symptoms even for five years, the current 
goal of research, there could be significant reduction in morbidity by AD.   
Another theoretical perspective is that the life span is indefinite. Demographers 
(Vaupel et al. 1998; Horiuchi  and Wilmoth 1998) supporting this perspective have  
posited that mortality in the elderly goes through three stages; a deceleration of mortality 
after age 80, a mortality plateau between ages 80-105, and an actual decline in mortality 
in the highest ages, over 110.  This theory does not refute Epidemiological Transition 
theory; it merely suggests that the life span in the modern societies is indeterminate.  
 Several research findings support the theory that the life span of the oldest old is 
increasing, pointing to the fact that those who survive the risks of mortality at earlier ages 
have an expanded life (Gatz et al. 2000).  Miech and colleagues (2002) support the theory 
that life span is indefinite in that the pattern of mortality by AD, along with other chronic 
and degenerative diseases, declines in extreme old age. For both sexes the incidence of 
AD was lowest in the oldest old.   They studied 185 individuals with dementia among 
3,308 participants. They found that the incidence of AD increased until age 85 to 90 but 
appeared to decline after age 93 for men and age 97 for women. Miech and colleagues 
(2002) concluded that the incidence of AD increased with age but peaked and declined 
among the extremely old, those over 100.  
Brookmeyer and colleagues (1998) studied the incidence of AD using age-
specific incidence rates from epidemiological studies in Boston, Framingham, Rochester 
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and Baltimore. They agree that the incidence of AD grows exponentially with a doubling 
time of 4.9 years. However, they question whether this growth continues to the oldest old 
where rates appear to plateau and then decline. They noted that there are limited data 
regarding the incidence of AD beyond age 95 other than estimates based on 
extrapolations from current models.  Data from Brookmeyer and colleagues (2002) also 
support this theory, suggesting a decline of AD in the oldest old.  
Gambassi and colleagues (1999) support the argument that AD does not have a 
linear relationship with age, agreeing that there is a decrease in AD in the oldest old. 
They found that autopsies of those who die of AD at advanced ages show fewer senile 
plaques and neurofibrillary tangles, the key autopsy diagnostics for AD.   
Gatz and colleagues (2000) found that rates of AD tend to increase exponentially 
with age with approximately 0.5 cases per 100 being in age group 60-65, which increases 
to 123 cases per 100 in the age group 80-85. They speculated a plateau after age 90-94 
years of age (Gatz et al. 2000). 
Perhaps this argument has been most clearly stated by Ritchie and Kildea (1995) 
who argue that although the onset of AD is age related, in that it occurs within a specific 
age range, it is not caused by the aging process. Due to limited numbers of the ≥80, they 
did a meta analysis of data from 12 studies. They found that the rate of increase in AD 
begins in the 60’s and continues to a point when it begins to decline in age range 80-84 
and then levels off at around age 95.  They noted that, to date, single studies have not 
included sufficient numbers of the ≥80 population to address this population (Ritchie and 
Kildea 1995).  Other researchers (Gao et al. 1998, Hofman et al. 1991) also attempted to 
address the gap of research in the oldest old through meta analyses however the numbers 
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of those over 95 were limited.  These studies would indicate a gap in the literature on the 
incidence of AD in the oldest old.  
Literature Concerning the Relationship of Sex and AD 
Incidence data of AD by sex include sex differences in both morbidity and 
mortality.  All agree that AD occurs in both sexes and is age related.  Thus the question is 
whether the incidence of AD is higher in females owing to more females surviving to 
older ages. Demographers (Christensen and colleagues 2001 and Carey 2003) have 
addressed the greater survival of females across species due to multiple causations, 
including the advantage of the X chromosome. Briefly, males have two chromosomes, X 
and Y, and females have two X chromosomes. Males must have both X and Y 
chromosomes. However, if one of the female X chromosomes is deficient the other X 
chromosome can be used, maximizing the possibility of having healthier genetics. 
Among mammals the life span record holder is most often a female.   
 Bonsignore and colleagues (2002) noted that epidemiological surveys on the sex 
differential have been inconsistent although the trend was for higher mortality by AD in 
females.  This higher incidence was partially explained by three factors. First, females 
have greater longevity and were thus more likely to contract an age related disease. 
Second, females have lower education than age-matched male, and education level was a 
risk associated with AD. Third, depression was also indicated as an AD risk factor and 
females had a higher incidence of this psychological disorder.  They sampled 1,628 
patients including those affected with AD or depression and matched control subjects. 
Fifty-one percent were females and had a mean education level of 9.3 years. They found 
that males and females showed the same risk of AD and suggested that in order to study 
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the sexual incidence of AD subjects should be matched in number, age and educational 
level (Bonsignore et al. 2002).  
Heun and Kockler (2002) studied 146 patients with AD, 168 patients with major 
depression, 136 age –matched subjects from the general population and 718 first degree 
relatives. They found most of the cognitive impairment of AD was from preexisting 
gender differences in specific cognitive impairment. For example there were gender 
differences in visual spatial tests with women typically scoring lower, and women had 
lower education levels than males. Although women had better verbal skills than men, 
they did not find differences in the language decline by sex. 
 Larson and colleagues (2004) in an observational study  from 1987-1996, studied 
AD following initial diagnosis in a base population of 23,000 persons aged 60+ in 
Seattle, Washington, of whom 521 were diagnosed with AD. This sample was obtained 
from the clients of a health maintenance organization.  They were persons who had 
access to health services which may have biased the sample by excluding those with 
lower socioeconomic conditions.  They found that men had poorer survival in all age 
groups surviving only 4.2 years following diagnosis, whereas women survived 5.7 years. 
The sex gap did vary by age with a median life expectancy of 4.4 additional years for a 
70 year man with AD compared to 8.0 years for a woman. However, overall, men with 
AD had half the life expectancy of women with AD. 
Ganguli and colleagues (2005), in a fifteen year epidemiological study which 
included 1,000 person-years, found that the age of onset and the duration of survival 
differed by sex. The mean age of AD for males was 80.1 years with duration of 6.3 years.  
In women the mean age of onset of AD was 80.3 with duration until death of 5.8 years.  
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Hoyert (1996) found that although initially it appears that more females than 
males die of AD, the age adjusted death rates for males were greater than those for 
females. Hoyert (1996) noted that female rates increased almost every year from 1979 to 
1991 while for men increases appear to have stopped around 1987 (Hoyert, 1996). 
Katzman and Bick (2000) also noted that although initially AD was seen as a female 
disease, their research did not find this pattern.  
Dodge and colleagues (2003) studied a population sample of 1,201 individuals, in 
the Monongahela Valley of  Pennsylvania. At age 70 and every 2 years thereafter they  
compared those with AD to those without. They found that a diagnosis of AD shortened 
life expectancy in both males and females. Although women with AD lived longer than 
men with AD they spent more years than males with increased disability.  Both sexes also 
had an average of 6 to7 more activities of daily living (ADL) impairments than those who 
were nondemented. Although women had a greater comorbidity, as well as a more rapid 
progression of AD, they still lived longer than men (Dodge et al. 2003).   
There is a popular view that hormone replacement therapy (HRT) protects post 
menopausal women from AD.  However, this has not been confirmed by epidemiological 
research. Helmer and colleagues (2000) studied 3,675 participants in a French cohort, 
aged 65+ from 1988-1998. Two hundred and eighty-one were actively diagnosed with 
AD, with a mean age of onset of 82.3 years.  Although the onset of dementia was difficult 
to pinpoint, their results showed that women with AD had longer survival than men. The 
effect of sex decreased with age, with greater differences in sex at age 75 than at age 85 
and above.  Helmer and colleagues (2000) found that few women in their study had taken 
HRT so this could not explain the longer survival of women with AD.  
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Zandi and colleagues (2002) also using the Cache County Study tested whether 
the use of hormone replacement therapy (HRT) would decrease the risk of AD. They had 
small numbers of HRT users in the study so their findings were inconclusive. However 
HRT only appeared to be beneficial if taken over 10 years (Zandi et al.2002).   
Antuono and Beyer (1999) agree that the epidemiological studies on HRT were 
inconclusive. HRT studies to date have not addressed the coexistence of other 
predisposing factors such as education, access to health care, and lower cerebrovascular 
health risk factors.   
Miech and colleagues (2002) in “The Cache County Study” found that the 
incidence of AD tended to decline in the early 90’s for men and in the later 90’s for 
women. The incidence of AD in women was much higher than in men after age 85.  
Tschanz and colleagues (2004) in “The Cache County Study” found male sex and older 
age were associated with a shorter length of survival following diagnosis with AD; 
however the interactions of sex with dementia and other risk factors were not significant. 
Barnes and colleagues (2005) studied the clinical manifestations of AD in males 
and females using a population of 1000 Catholic nuns, priests and brother in a 
longitudinal Religious Orders study, obtaining annual clinical evaluations and autopsies 
at death. Of the original 1,000 subjects, 196 had died and 181 had undergone brain 
autopsy. They found that if they controlled for age and education level, sex was not 
related to the odds of AD. However, they did find stronger clinical manifestations of AD 
in women. Barnes and colleagues speculated that females might lack some protective 
factor, such as estrogen receptors, which might increase their vulnerability to AD (Barnes 
et al. 2005). 
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Lapane and colleagues (2001) studied 2,838 males and 6, 385 females ≤65 who 
were newly admitted to nursing homes in five U. S. States with a diagnosis of probable 
AD. They found that men were more likely to die of AD, though women with AD 
showed more severe impairment and an accelerated rate of decline (Lapane et al. 2001). 
They found that women with AD have a better prognosis than men, when age, race and 
severity of dementia were controlled.  
Literature Concerning the Relationship of Education Level and AD 
Most studies support the assertion that higher education levels were either 
protective against AD or delay the onset of symptoms.   Those studies that do not find 
educational level to be significant were those with a homogenous population where 
education level does not vary.   
Mortality research in general noted that there is a tendency for those with higher 
education to have increased health and longer life span. Many demographers (Crimmins 
and Saito 2001, Rogers, Hummer, Nam and Peters 1996 and Stern et al. 1994) have noted 
that mortality in general was higher among those with low levels of education, low 
incomes and unemployment.  Since education level was attained at a young age there 
were lifelong effects from educational status. Those with higher education were more 
likely to have better access to a healthier lifestyle and to live longer. They found that 
persons with lower education have shorter lives, and that racial differences in total life 
expectancy were greatest with lowest levels of education. Black males with low 
education have a 19.9 year lower life expectancy than high educated whites (Crimmins 
2001:1634) When one looks at mortality by social class, Katzman and Bick (2000) have 
shown that education appears to protect one from AD.  
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Antuono and Beyer (1999) found that low educational achievement in early life is 
a risk factor related to the development of AD in later life.  Of the 600 nuns in the United 
States Nun Study, the 14 nuns who developed AD had low education levels. Their 
autobiographies, written prior to the onset of AD, showed low linguistic ability and poor 
cognitive functioning.  Antuono and Beyer questioned whether higher education may 
identify those with greater cognitive reserves who will be less likely to develop AD.  
Another speculation is that those with higher education may have greater longevity with 
less disability from the AD. 
  Bennett (2004) presented a preliminary report of a longitudinal Religious Orders 
Study of 950 nuns, brothers, and priests. The participants underwent detailed annual tests 
of a variety of memory and cognitive skills and at death also donated their brains for 
autopsy. Initial autopsy of 130 decedents showed that although both groups had the same 
number of plaques, those with higher education showed relatively less mental decline. He 
postulated that mentally challenging activities often provide a reserve that protects 
against mental decline.  
Freeman and Martin (1999), using the 1983 and 1993 panels of the Survey of 
Income and Program Participation, found that improvements in education and adaptive 
functioning of the aged tend to increase together. The pathways from increased education 
begin in early life with increases in income, as well as fewer environmental stressors and 
lower risk factors due to access to health care and preventative health care. Persons who 
were not high school graduates had twice the risk of functional limitations in later life. 
They postulated that increases in education level may continue, however, possibly not as 
dramatically as in recent decades (Freeman and Martin 1999).   
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Scarmeas and colleagues (2001) and Stern and Colleagues (1994) were associated 
with the Taub Institute for Research in Alzheimer’s disease and the Aging Brain. They 
studied 1,772 individuals age 65+, followed longitudinally for 7 years.  They found those 
with higher education education appeared to have a reserve protecting against AD.  Since 
leisure activities were related to education and occupation, they expanded education to 
include leisure recreation and social activities. They found that those with high leisure 
activities whether they were physical, social or intellectual, had the lowest relative risk of 
AD, suggesting that increasing leisure activities might reduce the risk of AD.  
Heininger (2000) agreed that most studies suggest that lack of education or a 
lifelong history of lower cognitive activity is related indirectly to the incidence of AD. 
The “use it or lose it” advantage of the higher educated posited that having a lifelong 
pattern of cognitive activity built a brain reserve that protected against AD. There also 
may be a diagnostic bias in that psychological tests favor those with higher education.   
He suggested that there may be a bias in the person with low education may have low 
cognitive functioning so that AD can be detected sooner.  However, his overall findings 
were that the effect of education was low and that education level was not significantly 
associated with survival.  
Tschanz and colleagues (2004) in “The Cache County Study” found that years of 
education was not significant in mortality risk.  However the population studied was a 
homogeneous, white and of similar education and religion. Over 82 percent of the 
participants in the Cache county study had ≥ 12 years of education.  
Gatz (2000) studied 129 pairs of Swedish twins in which one twin in each pair 
had dementia. He compared these twins with 249 other twins with dementia and 498 
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healthy twins. Gatz found low education positively related to AD. Of the twins with AD, 
90.4 percent fit the criteria for low education.  However, education was not significant 
when compared with their healthy twin, suggesting that genetics, not education, had the 
protective affect.   
 Wolfson, and colleagues (2001) studied factors of survival following the onset of 
dementia.  They found that education level was not associated with length of survival. 
However, the Canadian population was homogenous and only had two categories of 
education, below 8 years and above 8 years.   
Literature Concerning the Relationship of Marital Status and AD 
Demographic studies support a negative relationship between marital status and 
AD.  However, most studies do not include the oldest old.  Fratiglioni and colleagues 
(2004 ) have postulated three hypotheses to explain the negative relationship between 
marital status and AD. The first is the cognitive reserve hypothesis.  This would posit that 
marriage selects those who have greater capital such as more education and better health; 
therefore the married would be less likely to develop AD.  Second, is the vascular 
hypothesis.  Dementia is related to cognitive decline following vascular incidents. The 
married have better health, better diets and were more likely to have a healthier lifestyle 
and thus be less likely to suffer from vascular dementia.  Third, is the stress hypothesis. 
Those who were married have a support system which minimizes stress as well as 
offering more coping alternatives. They found that those who were married were more 
likely to have an active and socially integrated lifestyle in later life which protects against 
dementia and AD.  
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Many demographers  (Goldman 2001 Rogers 2000) agreed that the underlying 
processes involved in marriage lead to the healthiest individuals getting married, and that 
these processes continue so that age graded effects of marriage continue with age.  The 
married usually were physically healthier, more attractive and even taller (taller persons 
were more likely to be upwardly mobile) than those who were single and never married. 
Married people also have higher quality occupations, working in less dangerous jobs for 
fewer hours, with more health insurance benefits.  Those who were married have higher 
education levels. Moreover these factors occur at a younger age so the married have 
lifelong advantages over those who were single and never married. Married people were 
less likely to smoke, use drugs, drink, and were less likely to be mentally ill.  In old age 
when there is the increased likelihood of chronic diseases, those who have the social 
support of marriage were more likely to receive care in their own homes, and if 
hospitalized more likely to return to their own homes following treatment. The difference 
in life expectancy appears to be growing so that in Japan, one of the countries with the 
highest life expectancy, married people have a 15 year life-expectancy advantage over 
the single (Goldman 2001).     
Antuono and Beyer (1999) have also noticed that nutrition is related to AD.  The 
married were more likely to have a healthy diet, which is related to the onset of AD from 
cardiovascular disease.  
Fratiglioni and colleagues (2000) in the Swedish Kingsholmen Project studied 
1,203 people who lived in their own homes in Sweden, 176 patients who were diagnosed 
with AD.  They found compared with married people, single people and those living 
alone had a greater risk of developing AD. They found that satisfaction in contacts with 
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children, friends, and relatives was more important than the frequency of contact. 
However, being single carried the highest risk, with no difference between widowed or 
divorced people living alone and widowed or divorced people living with others.  
Bassuk and Glass (1999) followed 2,812 elderly <65 for 12 years and found that 
those with increased social ties, including presence of a spouse, monthly contact with at 
least three relatives or close friends and yearly contact with at least 10 relatives or close 
friends were less likely to experience cognitive decline. Persons who had no social ties 
were twice as likely to experience cognitive decline as persons who had 5 or 6 social ties. 
Seeman and Crimmins (2001) have noted the relationship between social ties and social 
engagement with dementia and cognitive impairment.  Their results showed that higher 
levels of social support, such as the emotional support of marriage were more strongly 
related to improved functioning in the early stages of cognitive decline than in the later 
stages. 
Berkman (2000) has noted that even cross species studies show the benefits of 
family living in maintaining cognitive functioning. Goldman (2001) has shown that 
monkeys and baboons with higher social advantages, associated with marriage in 
humans, were less likely to have cardiovascular disease and atherosclerosis and have a 
better immune system.  
 Other studies involving marital status were qualitative in nature involving the 
spouse as caretaker and the relationship of nursing home admission to disability 
(Corcoran, 2004; Dobalian et al., 2003; Elman and Uhlengerg, 1995; Meuser, 2004; 
Rogers, et al., 2000; and Uhlenberg, 1992). Elderly females who live alone present the 
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greatest health risks; however these studies do not address marital status as a specific risk 
factor in AD.  
Literature Concerning the Relationship of Metropolitan Status and AD 
 There were few studies exploring metropolitan and urban versus rural incidence 
of AD. Dobalian and Radcliff (2003) analyzed the 1996 Nursing Home Component of 
AHRQ's Medical Expenditure Panel Survey. They compared the diagnoses of 5,899 
residents residing  in 815 rural and urban nursing home homes and found no difference in 
a diagnosis of AD between rural and urban homes.  
Other studies pertained to services access. There was less accessibility to services 
and more limited medical, social and caretaker services available in rural areas. 
Geronimus and colleagues (2001) found that rural dwellers lived longer than urban 
dwellers and the more affluent urban dwellers lived longer than those in high poverty. 
Poverty, race and environment had multiple interactions on mortality.  
Financial considerations also varied with persons in rural areas of the United 
States more apt to seek expensive nursing home care as the only available service option 
thereby making AD in rural areas more expensive. Another aspect of rural urban 
differences was that if persons with AD in rural areas wander, they faced greater 
environmental dangers than those who wander in an urban setting where their aberrant 
behavior is more likely to be spotted.   
Literature Concerning the Relationship of Ethnicity and AD 
The literature about the relationship between race and ethnicity and AD is 
inconclusive.    First, as was mentioned in Chapter I, race and ethnicity involve multiple 
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risk factors including but not limited to socio-economic level, early life exposure to heath 
care services, education level, as well as exposure to environmental hazards.  
Second, racial demographics were a factor in the increased diagnosis of AD 
which was aging related.  According to the Kochanek and colleagues (2004) at the Center 
for Disease Control (CDC) the black/white age disparity has been decreasing since 1989.  
They project that the racial differences in AD will change as the number of blacks begins 
to reach the age at risk, over age 65. Although in 2002 the age adjusted death rate for 
mortality by AD was 0.7 black to white and 0.5 Hispanic to Non Hispanic white, there 
was a 5.8% increase in mortality by AD from 2001 to 2002, and 2.4% of mortality was 
caused by AD in 2002.   The comorbidity of both blacks and Hispanics with 
hypertension, strokes and diabetes, which contributes to vascular dementia, places them 
at an increased risk of AD as the population ages (Kochanek et al. 2004).  
 Demographers (Crimmins and Saito 2001, Geronimus et al. 2001, Rogers et al. 
1999 and Rogers et al. 2000) have also noted that differences in mortality by race may 
actually be due to differences in socio-economic level, education level, marital status, 
hazardous employment and access to health insurance. Geronimus and colleagues found 
that even economically advantaged blacks have greater mortality than whites of the same 
economic level. This was likely related to the high incidence of stress related diseases, 
including heart disease, high blood pressure and strokes among middle-class blacks 
compared to whites. Myers and colleagues (1989) argued that these stress related diseases 
were responses to racial oppression.  
Ethnicity poses similar ambiguities in that ethnic groups often show more within 
group than between group differences with the majority population.  Some demographers 
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(Berkman, et. al. 1989, Geronimus et al. 2001 and Manton and Gu (2001) have concluded 
that the differences in black and white mortality related to health status were largely the 
result of socio-economic variables. Although disability from chronic and degenerative 
diseases declined from 1982 to 1999, chronic disability in blacks did not follow this same 
straight line decrease. Chronic disability increased in black Americans from 1982-1989 
though it began to decline from 1989-1994 with a larger decline from 1994-1999.  This 
decrease appeared to follow the same pattern as the increase in education level (Manton 
and Gu 2001). 
A third factor was the black/white mortality crossover which has been researched 
for the past twenty years. Many researchers (Berkman et al. 1989, Coale and Kisker 
1986, Johnson 2000, Lynch and colleagues 2003, Nam 1995 and Preston 1996) have 
addressed the mortality crossover. Although this research has been questioned, due to 
possible age under reporting, there was a consistent pattern of mortality crossover in the 
oldest old. Lynch (2003) found that the age of crossover has increased from age 79 years 
in 1970 to 87 years in 1992. Coale and Kisker (1986) credit the crossover to the early 
mortality of the frail so that only robust persons survive.  
Research about the impact of race and ethnicity were at times contradictory. First 
were the studies which have showed no difference in mortality by AD between blacks 
and whites.   Green and colleagues (2001) compared the risk of an AD diagnosis among 
relatives of whites and African Americans who have a genetic tag of an AD. They 
followed for 10 years, between 1991 and 2001, 17,639 first-degree biological relatives 
and 2,474 spouses of 2,339 whites diagnosed with AD probands, and 2,281 first-degree 
biological relatives and 257 spouses of 255 African American diagnosed with AD 
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probands. They found that if one controlled for sex, first degree relatives of whites and 
African Americans, with the genetic tag of AD probands, had the same risk of AD (Green 
et al. 2002).  
Gambassi and colleagues (1999) found that in spite of increased socioeconomic 
risk factors, minority groups had a reduced risk of AD mortality compared to non 
Hispanic whites. Gambassi and colleagues conducted a longitudinal study of all 
Medicare/Medicaid residents in nursing homes in five U.S. states. This population 
included 9,264 patients age 65+ with AD. They found that other racial or ethnic groups, 
including African-Americans, had a lower risk of mortality than whites, independent of 
the severity of the dementia (Gambassi et al. 1999, 62). They also found that the age at 
onset of AD was difficult to obtain because nearly 80 percent of AD diagnoses were 
made by lay evaluators.  Although confirmed by hospital discharge record 
documentation, there were inconsistencies.  
 Other studies showed a lower rate of AD in blacks compared to whites.  The 
CDC has noted that from 1979-1987, although the AD mortality rates for blacks and 
whites both increased by age, the rates for whites was higher than for blacks in all age 
ranges (CDC: 1990,1). The CDC has also reported that in California in 1985-1987 of 
those diagnosed with AD 77.2 percent were white, 9.1 percent were black, and 2.1 
percent were Hispanic (CDC: 1990). 
Gambassi and colleagues (1999) used a SAGE database of all nursing home 
residents from 1992-1995 in five U. S. states. This study included 9,264 patients aged 
65+ followed for a median of 23 months, with about 70 percent female and 91 percent 
white. They found that blacks had a reduced risk of mortality compared to whites, even 
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after adjustment for age, sex and level of impairment.  The factors most associated with 
increased risk of mortality were male sex, age and white race (Gambassi et al. 1999). 
There was also the question of whether the black incidence of AD was 
environmental or genetic.  Hendrie and associates (2001)compared American and African 
black populations in the Indianapolis-Ibadan Dementia Project, a longitudinal study with 
a baseline survey in  1992-1993 along with follow-up waves, in 1994-1995  and in 1997-
1998. The African residents sampled were 2,459 Yoruba residents of Ibadan, Nigeria, 
without dementia. The African American residents initially sampled were 2,147 residents 
of Indianapolis, Indiana, without dementia (all aged 65 years or older). They found that 
the age-standardized rates of AD were significantly lower among the Yoruba, indicating 
that factors other than race were influencing AD rates (Hendrie et al. 2001). 
Heininger (2000) also addresses the issue of genetic predisposition or 
environmental causes of racial differences in AD by comparing the low incidence of AD 
among East Africans with African Americans.  Although these were racially similar 
populations, the different environments revealed different levels of AD. He suggests that 
the Western lifestyle of limited physical exercise and high cholesterol diet set the stage 
for AD. He noted also that the genetic factors cannot be overlooked. There was a higher 
incidence of AD in European or American immigrants than in African or Asian 
immigrants (Heininger 2000).  
Saenz and Morales (2005) have suggested that ethnicity has more pronounced 
effects than race in its comparison with the dominant group as ethnic groups have racial 
and cultural distinctions as well as economic disadvantages.  Although they acknowledge 
that both race and ethnicity were socially constructed, they make distinctions between 
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three Latino groups: Mexican Americans, Puerto Ricans and Cubans. The issue was 
further confused by a changing nomenclature, for example persons of Mexican origin 
have used ethnic identities of “Mexican”, Mexican American”, Chicano”, “Latino”, and 
“Hispanic.” Ethnic groups can also alter their ethnicity by self reporting as white. The 
current trend among statistical agencies was for self identification of race and ethnicity 
and to allow multiracial identification.  
Within ethnic groups demographic patterns differ.  The Cubans migrated to the 
United States in two waves, one in the 1950’s, a higher educated  class in a forced 
permanent exile from Fidel Castro’s communist revolution, and the second the boat 
people, lower class and criminal  immigrants exiled by Castro in the 1980’s as a drain on 
the Cuban economy.   This first group is now elderly.  Cubans are an older population, 
and as an older population a greater risk for aging related chronic and disabling diseases. 
However, Cubans have higher education and socio-economic status. Mexicans and Puerto 
Ricans have the youngest populations (Saenz and Morales 2005).  
Saenz and Morales (2005) and Rogers and colleagues (2005) have noted that 
mortality within ethnic groups is affected by several variables including immigration 
effects such as the self selection of the healthy to migrate. Hummer and associates (1999) 
noted that the Mexican immigrant has a better diet, closer kinship support and is less 
likely to smoke and drink than the native born.  
Some demographers (Palloni and Morenoff 2001, Abriaido-Lanza et al. 1999, 
Franzini et al. 2001) have posited the “Salmon effect” of the sick/elderly immigrants 
returning to native lands leading to the underreporting of mortality. It should be noted 
that Puerto Ricans can be used to test the Salmon effect because unlike Mexicans, who 
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will be uncounted if they return to Mexico, Puerto Ricans have U. S. death certificates 
because Puerto Rico is a U.S. Territory.   
Others (Elo and Preston 1992 and Saenz and Rubio 2004) have discussed whether 
the noted ethnic differences were due to environmental and socioeconomic variables 
versus genetics.  Elo and Preston 1992 have argued that immigrants from less developed 
countries might experience different mortality rates due to diseases or early adult 
experiences in underdeveloped countries which predispose them to chronic diseases in 
later years. Saenz and Rubio (2004) have distinguished between Mexican Hispanics who 
entered the United States at an early age and the native born population. They found that 
the foreign born who immigrated after age 65 have the lowest disability rates. Compared 
to whites and Asians, those who immigrated at age 0-14, with a longer exposure to 
Western diet and lifestyle risk factors, had the highest disability rates.    
The CDC (2004), using 2001 Mortality Data pertaining to different leading causes 
of death, found that Hispanics compared to Non Hispanic Whites have different leading 
causes of mortality.  For non-Hispanic whites AD was the eighth leading cause of 
mortality with 49,030 or 2.5 percent of the population dying with AD as the underlying 
cause of mortality in 2001. For Hispanics AD was not ranked in the top 10 causes of 
mortality. The CDC noted that in 2001 Hispanics were more likely to die before age 75, 
which would make them less likely to die of age graded AD (CDC: 2004).  
Conversely, the website of the Alzheimer’s Association argues that Hispanics 
were at a greater risk of AD. It predicts that the number of Hispanics with AD will 
increase by 600% between 2000 and 2050. It is noted that the life expectancy of 
Hispanics is expected to continue to increase.  Since age is associated with AD risk, as 
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the Hispanic population ages so will the increase of Hispanics with AD. It predicts that 
by 2050, 16 percent of the total U. S. elderly population will be Hispanic. Hispanics also 
have higher percentages of other risk factors, related to the comorbidity of AD with other 
chronic diseases, especially vascular diseases and diabetes.  Finally, lower education 
levels place Hispanics at a greater risk of AD.  Ten percent of Hispanic elders have no 
formal education and 50 percent have ≤ 8 years of education 
(www.alz.org/Media/newsreleases/2004). 
Saenz and Morales (2005) have also described six Asian groups, namely, Asian 
Indians, Chinese, Filipinos, Japanese, Koreans and Vietnamese.   Due to migratory 
patterns the oldest Asian groups were the Japanese, with a predominance of females in 
the aged 65 and above age group, due to the war brides marriages following World War 
II. Due to low fertility one fifth of the Japanese population was elderly.  
There were also cross-cultural issues in the recognition of AD. Poston and Kim 
(1999) have noted that the incidence in North and South Korea and the United States 
were similar. Watari and Gatz (2004) compared Korean Americans with other ethnic 
groups in California and found that compared to European Americans they have  
underutilized services for AD patients. They hypothesized that the Korean cultural beliefs 
in Confucianism assign the responsibility for the care of the parents to the eldest son. 
These beliefs limit help seeking as it would be seen as a stigma. Also a greater respect for 
the elderly as well as more tolerance for cognitive decline might result in the person with 
AD remaining undiagnosed in a home care situation for a longer period. 
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Literature Concerning Morbidity and AD 
 
The literature on morbidity, the disease process of AD, was more qualitative. This 
section will briefly review literature concerning morbidity from AD as it relates to the 
variable on the death certificate as Place of death: private residence, nursing home, 
hospice and home health which are outpatient care and hospital care.  First, Mitchell and 
colleagues (2004) have noted that in nursing home settings those patients with AD have 
increased mortality, compared to other diagnoses.  Covinsky and Yaffe (2004) agree.  
They followed 521 patients of a Health Maintenance Organization and found that those 
with AD had half the life expectancy anticipated from life tables.  
Wolfson and colleagues (2001), using data from the Canadian Study of Health 
and Aging, found that the median survival from onset of symptoms was 3.3 years, with a 
range from 1 to 16+ years. They also found that the younger the age of onset the longer 
the survival.  
Freeman (1993) used the National Nursing Home survey to model the hazard of 
leaving a nursing home basedon covariants including diagnosis of AD and kin. A 
problem with the study was that she did not know about discharge disposition, whether 
they left the nursing home to return to family living or death.  She found that daughters 
and wives were more likely to provide care than sons and husbands. Women who have 
children or spouses have an average three months shorter stay in nursing homes.  She 
found that women with AD have the shortest stay of all persons with terminal conditions, 
possibly because AD was not diagnoised with certainity until the individual was in an 
advanced stage.  
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Rapp and colleagues (2005) studied the neurological functioning of 288 
participants with a mean age of 84.5 years; 192 gender and age matched community 
residents compared to 96 residents from the Jewish Home and Hospital, Bronx, NY. They 
found that functional disability was greater in nursing home residents than in community 
dwellers. They also found, controlling for gender, education level and age, that decline 
was more pronounced in nursing home residents than in community dwellers (Rapp et al. 
2005).  
Blieszner and Alley (1990) noted that results of the national Long-Term Care 
Survey found that although almost 85 percent of the 25.5 million elders in 1982 lived 
independently, about 2 million required assistance with activities of daily living (ADL), 
with the need for assistance increasing with age. Of the caregivers, 29 percent were 
daughters, 23 percent were wives, and 19 percent were husbands. Those elderly surveyed 
preferred to live independently or in their own home.  The types of services available 
include health care services funded by Medicare and Medicaid; institutional care; the 
older Americans Ace funds; Home repair; Senior Centers; Friendly visitation; Telephone 
assistance; Home Delivered Meals; Homemaker/Chore services; and Adult Day Care. 
These programs have financial eligibility limitations so if adults have family members 
who can provide these services they were often excluded from services via the Older 
Americans Act. They argued that most families caring for a family member with 
dementia need respite, day care and support groups and if this were the case, then more 
demented family members could remain in the community.  
Blieszner and Shifflett (1990) studied the relationship of married and parent-child 
pairs among caretakers of AD. They found that the relationship altered as the symptoms 
  
47 
of the disease increased with the person with AD going through stages from memory loss 
and confusion to total helplessness to death.  They found three stages in the relationships: 
an initial stage of grief and regret; a second stage of redefinition of expectations; and a 
third closure stage of accepting that even though the person was physically present he or 
she was emotionally absent.  
Harwood and colleagues (2000) studied the appraisal and psychological well 
being related to caregiving in 114 family caregivers of AD patients in Miami, Florida. 
They studied an ethnically mixed population of 56 percent non Hispanic White caregivers 
and 44 percent Hispanic caregivers. They found that ethnicity was not related to caregiver 
burden. However there were ethnic differences among the caretakers in that there was a 
higher percentage of adult daughter caregivers in the Hispanic families compared to 
spouses in the non-Hispanic white population.  
Hypotheses Suggested by Literature Review 
This chapter has reviewed literature related to AD as an age graded increasing 
cause of mortality in the elderly, and the literature related to demographic variables 
hypothesized to be risk factors for the development of AD or protective of AD. The 
following are the main hypotheses to be tested in this dissertation.  They are drawn 
primarily from the above literature review; they state the predicted relationships and the 
directions of the relationships.  
This dissertation will compare male and female decedents over age 60 with 
mortality of Alzheimer’s disease versus the other primary causes of mortality in the 
United States. Because of the issues presented in the literature review by CDC (2003) and 
Hoyert (1996) of possible under reporting of AD, three versions of AD will be used as 
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the dependent variable. The first version uses those listed with the underlying cause of 
mortality as AD; this version assumes that the NCHS criteria were followed by those who 
complete the death certificate. The second version is introduced because of the issue of 
comorbidity (CDC 2003, Hoyert (1996) Dalsania 2004, Ganguli et al 2005). This version 
focuses on those with AD as any of the 20 conditions of mortality listed on the death 
certificates compared to all decedents over 60 by age and sex.  Finally, the third version 
responds to the issue of senescence, a biological limit to life span (noted in Chapter I), 
posited by demographers (Carnes and Olshansky 1993, Olshansky 2003, Olshansky and 
Carnes 1994, Olshansky et al. 2001, Olshansky et al. 1990, Olshansky et al. 2004). This 
version uses those with AD scored as a dummy variable, compared to all decedents over 
60 with a chronic and degenerative disease.  
 Initially this study planned to use a fourth version of the dependent variable, 
those who were diagnosed with AD by autopsy. However Hoyert (1996) noted the 
improvements in diagnostics that occurred between the 1970’s through the 1990’s so that 
more than 90 percent of suspected cases were confirmed by autopsy.  The Mayo clinic 
reports that current diagnostic techniques, including magnetic resonance imaging (MRI) 
clearly reveals AD without autopsy. Since autopsy diagnosis is no longer necessary, this 
version of AD will not be used (http://www.mayoclinic.com).  
 Eight independent variables will be used: age, sex, race, ethnicity, marital status, 
education level, living in a metropolitan area and place of death. Age is measured in five-
year groups beginning with decedents age 60-64, 65-69, 70-74, 75-79, 80-84, 85-89, 90-
94,95-99, 100-104, 105-109, 110-114, 115-119, 120+. Sex is coded as male or female.  
Racial categories compiled from the death certificates were Black, White or Asian. 
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Ethnic categories provided by NCHS were Non-Hispanic White, Non-Hispanic Black 
and Hispanic. Marital status categories were obtained from NCHS as married, single-
never married, widowed and divorced. One limitation of this data is that marital status is 
reported by informants with not verification of actual status at death or how long the 
decedent was married, widowed or divorced. Education levels used were elementary 
school, middle school, high school and college. Place of death categories from the death 
certificate are outpatient, residence, dead on arrival (doa), inpatient and nursing home. 
The following series of hypotheses have been drawn from the literature review 
presented earlier.  
1.  Elderly decedents will experience age graded mortality by Alzheimer’s disease 
with a increased risk of AD up to age 90.   
2.  Elderly decedents who survive past age 90 were less likely to die of AD than 
decedents in their 70’s and 80’s. The deceleration of mortality in the oldest old 
addresses the theoretical viewpoint of longevity, the theory that life span is 
indefinite.  The AD  literature, suggests that there is a deceleration of AD 
mortality at the oldest ages; however it notes that there were limited data 
concerning the incidence of AD over age 95 other than estimates.  One advantage 
in this dissertation is that it will combine five years of death certificate data from  
approximately 10,000,000 death certificates with about 80,000-100,000 decedents 
over age 100.  With these data this study can address this gap in the literature. If 
accepted the results would question the alternative theory of demographers who 
support the rectangularization of life, with mortality due to senescence at around 
age 90 or 90.  
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3.  Elderly female decedents will be more likely to die of AD than elderly male 
decedents.  The literature questions the relationship of AD mortality by sex . The 
consensus is that females live longer so were more likely to be in the age graded 
risk period of AD, and that the greatest sex differences in AD were under age 85. 
Researchers suggest that to study the relationship between sex and AD one must 
control for both age and education level.  
4. Elderly decedents, under age 85, with higher education, high school and above 
will be less likely to die of AD than those with elementary education. Mortality 
researchers noted that mortality in general is higher among those with low levels 
of education. The Nun Priest Studies found that low educational achievement in 
early life is a risk factor related to the development of AD in later life although it 
is not know if this is due to greater cognitive or a lifetime of increased economic 
and familial support leading to greater longevity with less disability from the AD.   
5. Elderly decedents will experience the mortality crossover effect, that is, blacks 
who survive to the 80’s will achieve greater longevity than whites, applies to AD 
in that those blacks who survive past their 80’s present lower odds of dying of AD 
than whites.    
6. Hispanic populations: 
 a. There is a higher incidence of AD in stable non migrant populations of 
Hispanics using the Cuban population compared to other Hispanics. 
b. There is a lower incidence of AD in migratory Hispanic populations 
where the “Salmon effect” may be evident, that is by comparing those in 
the Southwestern states to other Hispanics and to NonHispanics.  
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 c. There were differences in mortality by AD among Hispanic 
populations: Puerto Ricans, Cubans, and Southwestern residents, those 
within 100 miles of the Mexican Border.  
7. Persons who die of AD will more likely be Nursing home residents.  The bulk 
of literature supports that AD is more expensive due to the extensive care required 
during a long morbidity, ranging from 5 to 20 years. Nursing home as place of 
death will be used as a way to address this issue. Although there is the limitation 
that nursing home as place of death does not address the length of stay in the 
nursing home prior to death.  
This chapter has reviewed the literature related to AD as an age graded increasing 
cause of mortality in the elderly, along with a review of literature related to demographic 
variables which were seen as risk factors for the development of AD or protective of AD. 
This literature review was followed by the hypotheses to be tested in this dissertation.  
The next chapter, Chapter III, will present the data and methodology. 
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CHAPTER III 
DATA AND METHODOLOGY 
Data 
This dissertation investigates dementia mortality among the elderly decedents 
(persons aged 60 and over) in the United States. The data are death certificates of those 
decedents over age 60, who died in the United States between 1998 and 2002.  The 
primary advantage of using these data is the large numbers allow for a study of the oldest 
old. 
Death Certificate Data Source 
Death certificate data are available from the National Center from Health 
Statistics (NCHS) in Hyattsville, Maryland.  The NCHS provides health information 
from vital statistics, birth and death certificates, as well as national survey data. This 
material is available to the public and health researchers. The data used in this 
dissertation are the NCHS Multiple Cause of Death Files (from 1998-2002), a 
compilation of the death certificates filed for all those who died in the U. S. in this five 
year period. There were 12,009,528 death certificates in this period and 9,643,607, for 
decedents dying after age 60. In 1998 there were 2,340,708 records; in 1999 there were 
2,394,871; in 2000 there were 2,407,193; in 2001 there were 2,419,960 and in 2002 there 
were 2,446,796. It should be noted that no period effects are noted in this five year 
period. Although there were approximately 2,600 deaths due to 9/11 most of these 
decedents were age 30 to 35 and thus did not appreciably affect mortality or the mortality 
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of the over age 60 decedents in this study. This compilation of five years of data permits 
the analysis of the oldest old, a gap noted in the literature review in Chapter II.   
Hetzel (1997) provided a historical context for the current NCHS mortality data. 
Beginning in 1790 the United States required a census every ten years to assure equal 
representation in the legislature. However, the need for vital statistics was not realized by 
the founding fathers. In the founding period there were neither universal registration laws 
nor permanent legal records covering an entire state. Vital statistics were initially under 
local control and used to document paternity and lineage for the protection of individual 
property rights. 
On the continent during this period there was a base of support for vital statistic 
data, especially death data, in order to develop a better understanding of diseases and 
mortality.  John Graunt (1620-1674), an Englishman, began this movement with his 
analysis of the Bills of Mortality.  He created a basic life table which promoted a better 
understanding of mortality caused by the plagues in London (Poston, et al 2005).    
Hetzel (1997) noted that Americans, following English trends, also began to study 
vital records to explore the relationships between diseases and mortality.  In the early 
settlements diseases, such as malaria, dysentery, smallpox and typhoid fever, could 
spread rapidly killing a local population.  In 1721 Cotton Mather used mortality statistics 
to address the smallpox epidemic in Boston. He was able to show the increased survival 
of those inoculated against smallpox by presenting data indicating that one in sixty 
inoculated died of smallpox, whereas one in six of those who were not inoculated died. 
Subsequent epidemics led to individual U. S. cities introducing health departments.  In 
1797 Massachusetts passed the first state law creating a local health department.  
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On the continent advances in European vital statistics developed in response to 
the Industrial revolution. Louis Villermé (1782-1872) showed that crowding and 
unsanitary conditions in Parisian neighborhoods were related to the spread of disease. 
There was a widespread belief that progress in public health services would be the 
primary weapon against pandemics such as the cholera epidemic that by the 1830’s had 
traveled a route following trade and immigrants from Asia through Russia, Germany, 
Britain, Canada and the United States. Shylock and Siegel (1973) noted that panic, 
caused by fear of pandemics, along with humanitarianism, helped both statisticians and 
the authorities realize the need for precise universal vital statistics. From the onset vital 
statistics were part of the scientific movement positing that an empirical approach could 
improve living conditions. In 1836 Great Britain passed a central registration law and the 
United States followed with a similar registration act in 1842 and 1844. These acts 
required the central filing of death certificates by states on standardized forms with 
specific causes of mortality (Hetzel 1997). 
 In 1846 the American Medical Association created a committee to improve the 
registration of births, marriages and deaths. Initially there was disagreement about how to 
use mortality data. One group emphasized contagion, diseases causing death entering the 
country through seaports and spread by animals or people. They believed that quarantine 
would prevent contagion.  This group promoted data for quarantine and were 
instrumental in the passing of a Congressional act in 1878 for the registration of mortality 
by contagious diseases, labeled as “notifiable diseases;” such as cholera, smallpox, 
plague, and yellow fever.  In 1879 a clause was added to the act requiring the collection 
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of data about the “notifiable diseases” from port areas to further track contagion from 
foreign ports. 
 The second group was composed of promoters of public health. Medical officers 
in the civil war noted that disease killed more people than did weapons, with troop 
movements spreading diseases such as typhoid. They posited that diseases were caused 
by sewage, garbage and polluted water as the result of overcrowding and poverty. The 
American Public Health Association, founded in 1872, used vital statistics to promote 
public health reforms, showing the decrease in mortality by contagious diseases through 
sanitation reforms. Specific notifiable disease reports began in a few cities and states 
prior to 1900, and by 1925 all states reported them regularly. The public health 
movement was advanced by medical discoveries: Koch isolated the cause of cholera, 
Gaffky discovered the cause of typhoid fever, Smith and Kilborne explored the control of 
malaria and yellow fever, and German and French bacteriologists discovered the cause of 
diphtheria. Pasteur invented the process for pasteurization of milk.  All of these 
discoveries vastly decreased infant mortality and changed the acceptance of the need for 
mortality data (Hetzel 1997). 
In 1880 the first death certificates were standardized so that enumeration could be 
mechanized, easing the accuracy of the count by the use of the Hollerith mechanical 
calculator, adapted from the textile industry for use in mortality (Hetzel 1997). The 
mechanization of the 1890 census led to standardized death certificates.  In the 1900 
census the census office, designated as Bureau of the Census in 1903, requested that each 
reporting area use a standardized death certificate, and around 1913 the Bureau of the 
Census appointed representatives in local health departments to direct the standardization 
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of death certificates. The increased mortality during WWI led to increased efforts at 
standardization; however death certificate standardization occurred on a state by state 
basis. The final state to join both birth and mortality registration was Texas in 1933. 
During the 1930’s, mortality registration shifted to the Public Health Departments; the 
emphasis was on the control of contagious diseases as public sanitation was nationally 
accepted. The onset of WWII led to a need for the reliable registration of births and 
deaths for the defense industry. In 1946 the National Office of Vital Statistics was 
established as a part of the Public Health Service. In 1942 the gathering and reporting of 
mortality statistics were assumed by the Division of Public Health Methods and in 1949 
by the National Office of Vital Statistics, where they remain today within the National 
Center for Health Statistics (NCHS) (Hetzel 1997).  
The Current U. S. Death Certificate 
 Appendix B shows the current death certificate, with completion instructions.  By 
law the funeral director compiles all data except for the cause of death, which is 
completed by the attending physician. In the case of unnatural death the coroner 
completes the cause, even if there is an attending physician. Current death certificates 
have two categories for reporting cause of death: immediate cause and underlying cause. 
Physicians and coroners receive training to increase the accuracy of distinguishing 
between an immediate cause of death, i.e. the final disease, injury or complication, versus 
the underlying cause of death, i.e. the disease, injury or complication that started the 
chain leading to death. The death certificate allows the reporting of up to twenty 
conditions so that all other significant diseases, conditions, or injuries that contributed to 
death are listed. 
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 Appendix C lists the Data File Description from 1999-2002 and from 1989-1998. 
This shows the items that are coded from the death certificates which are available for 
analysis through the NCHS Multiple cause of death files.  The data reported in 1998, via 
the Data File Description 1989-98 have slight variations, notably, that 1994 was the last 
year that reported whether or not an autopsy was performed as part of the death 
certificate file. Hoyert (2001) reported a decline in autopsies since the Joint Commission 
on the Accreditation of Hospitals eliminated autopsy requirements for hospital 
certification in 1971.  In 1961, 41 percent of hospital deaths had autopsies; this decreased 
to between 5 and 10 percent by the middle of the 1990’s. Autopsies are usually 
performed only when there is an undetermined or unnatural cause of death (Hoyert 2001). 
Therefore this variable will not be used here as a diagnostic criterion.  Data to be used in 
this study include geographic and metropolitan status information, age, education, race 
and ethnicity, marital status, sex and underlying and multiple causes of death. 
The International Classification of Diseases 
 The diagnostic naming of cause of mortality requires an explanation. Health 
statisticians recognized that a systematic diagnostic nomenclature was required for 
comparing data across times and geographic entities. In 1893 Jacques Bertilon prepared 
the first international classification of diseases, the Bertillon Classification or 
International List of Causes of Death which was accepted in the United States in 1898.  
The International Classification of diseases resulted from the Bertillion Classification and 
is considered the “gold standard” of disease nomenclature, used universally.  The ICD 
has been revised approximately every ten years with advances in medical science. 
Revisions included: ICD-1, 1900-1909; ICD-2, 1910-20; ICD-3, 1921-29; ICD-4, 
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1930-38; ICD-5,1939-48; ICD-6, 1949-57; ICD-7, 1958-67; ICDA-8, 1968-78; ICD-9, 
1979-1998 and ICD-10, 1999-current (NCHS1998). 
  This dissertation uses two versions of the ICD which demonstrate the refinements 
in diagnosis from 1979 when ICD-9 was introduced until 1994 when ICD-10 was issued. 
ICD 10 was accepted for use in the U. S. in 1999; however ICD-9 continues to be used in 
morbidity surveys. The ICD-9 is also used in the 1998 NCHS mortality files. The ICD-10 
is used in the NCHS mortality files from 1999-2002.  
 The ICD-9 is a two volume set with 4,000 disease categories whereas the ICD-10 
is a three volume set with 8,000 categories. The changes between the two were primarily 
a refinement of categories. The ICD hierarchical positions remain the same so that the 
diagnostic categories used in this dissertation will not be affected by the changes between 
ICD-9 and ICD-10. There are coding differences with the ICD-9 using numerical coding 
and the ICD-10 using an alpha numeric code 
(http://www.openclinical.org/medTermICD).  
  Appendix D lists the chapter titles in ICD-9 and ICD-10 and describes the 
nomenclature for each chapter. The chronic and degenerative diseases studied do not 
have significant nomenclature changes in the major categories of disease; most of the 
refinement is with respect to distinctions within disease category.  For example in ICD-9, 
V is Mental Disorders (290–319) which is reclassified in ICD-10 as Mental/behavioral 
disorders (F00–F99). AD is coded under VI Diseases nervous/sense organs (320–389) in 
ICD-9 as 331 and in ICD-10 in the Diseases of nervous system (G00–G99) as G20.  
Appendix E lists the 113 Cause of Mortality Recodes from the NCHS. Since ICD-
9 has 4,000 categories and ICD-10 has 8,000 categories the CDC recommends using the 
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113 Cause of Death recode used in The International Comparison of data. Appendix F is 
a compilation of the top causes of mortality for both sexes and all races for all ages in 
five year age groups from age 60-100+. Although there is minor variation in the top 
causes of mortality this dissertation will use the top 15 causes of mortality:  
1. Diseases of heart (I00-I09,I11,I13,I20-I51) 
2.  Cerebrovascular diseases (I60-I69); Atherosclerosis (I70) 
3.  Malignant neoplasms (C00-C97) 
4.  Influenza and pneumonia (J10-J18) 
5. Alzheimer's disease (G30) and  Parkinson's disease (G20-G21) 
6.  Chronic lower respiratory diseases (J40-J47) and Pneumonitis due to 
solids and liquids (J69) 
7.  Accidents (unintentional injuries) (V01-X59,Y85-Y86) 
8.  Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-
N27) 
9. Diabetes mellitus (E10-E14) 
10.  Essential (primary) hypertension and hypertensive renal disease (I10,I12) 
11.  Septicemia (A40-A41 
12.  Intentional self-harm (suicide) (*U03,X60-X84,Y87.0);  
13. All other causes (Residual). (Although the cause Assault  or homicide, 
*U01-*U02,X85-Y09,Y87.1, is one of the top causes among all ages, it is not used here 
because it is not a top cause among the elderly population.)  
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Variables 
 This dissertation addresses the possibility of undercounting AD with three 
treatments of AD as the dependent variable.  The first treatment is AD as the underlying 
cause of mortality. In the logistic regression AD is treated as a dummy variable, that is 
either a decedent dies of AD or other causes. This compares AD to all other causes of 
mortality of decedents over 60 categorized by age and sex. The second treatment is also a 
dummy variable. It uses those persons with AD listed as any of the 20 conditions of 
mortality coded on the death certificates, compared to all other causes of mortality in 
decedents over 60 by age and sex. The underlying cause of mortality uses the 113 cause 
of death recode.  The twenty conditions of mortality do not have recodes. The analysis of 
mortality by AD as one of the twenty conditions on the death certificate follows Hoyert’s 
(1996) recommendation and combines Alzheimer’s disease with the other causes of 
dementia, including the ICD-9 categories AD (ICD-9, 331.0), Senility (ICD-9, 797), 
Senile and presenile organic psychotic conditions (ICD-9, 290), and Other cerebral 
degenerations (ICD-9, 331.1-331.9). The third treatment compares AD as a dummy 
variable, scored 1, to all decedents over 60 whose cause of mortality is any of the chronic 
and degenerative diseases.  
Six independent variables are used: age, sex, race, ethnicity, marital status, 
education level and whether or not the decedent lived in a metropolitan area.  
1. Age is measured in five-year periods beginning with decedents age 60-64, 65-69, 
70-74, 75-79, 80-84, 85-89, 90-94,95-99, 100-104, 105-109, 110-114, 115-119, 
120+. 
2.  Sex is a dummy variable coded1 if male, and 0 if female.   
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3. Racial categories compiled from the death certificates are Black, White or Asian. 
Racial categories are analyzed as a dummy variable for each racial group. 
4. Ethnic categories provided by NCHS are Non-Hispanic White, Non-Hispanic 
Black and Hispanic. Ethnic categories are also analyzed as a dummy variable for 
each group. 
5. Marital status categories are obtained from NCHS are Married, Single-never 
married, Widowed and Divorced.  These are analyzed using dummy variables.   
6. Education levels used are elementary school, middle school, high school and 
college, and are also analyzed as dummy variables. 
7. Metropolitan status  categories used are either metropolitan or nonmetropolitan. 
8. Place of death categories are obtained from NCHS; outpatient, residence, 
inpatient, doa and nursing home.  
The literature review noted the research gap in mortality research pertaining to the 
oldest old, i.e. those over age 85.  As the population ages, decedents in this age group are 
increasing. By compiling five years of data there are sufficient numbers for analysis in 
the oldest age group.   An example, using data from 2001 of the 1,934,858 decedents over 
60 in 2001, 18,489 decedents were over age 100.  By combining five years of data 
approximately 80,000-100,000 decedents are over age 100.  These numbers allow for 
statistical analysis of the oldest old, those decedents in the 90’s and 100+.   These death 
certificate data will also be used to study whether the trajectory of mortality by AD 
continues to escalate with age, stabilizes or even decreases, as either an underlying cause 
of mortality or as one of the twenty conditions on the death certificate.  
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Methodology 
There will be several methodologies used in this dissertation. The first is a 
descriptive analysis of causes of mortality among the aged decedents. Descriptive 
analysis of numbers and percentages is used to show mortality differences by the 
dependent variable of cause of mortality as well as age, sex, education level, marital 
status, race and ethnicity.  Second, because the dependent variable in the death certificate 
data is dichotomous logistic regression will be used. In this case a logistic regression 
model is used to estimate the odds of dying of Alzheimer’s disease versus other causes of 
mortality. Third, because with large data there is an increased likelihood of significance, 
a Bayesian Model will be used to determine fit of model since because conventional 
statistical tests may err in the rejection of the Null hypothesis even when intuitively and 
theoretically it should be accepted. 
Logistic Regression 
Long and Freese 2003) have noted that with a binary or dichotomous dependent 
variable, the outcome of Y has two usual forms; 1 or 0. 1 is interpreted as a yes or 
“success” and 0 is interpreted as no or “failure”. The Y’s mean is the proportion of times 
it takes the value of 1. 
p  = P(Y = 1), or,  p  =  P (“success”) 
 
Thus, logistic regression allows one to estimate this probability p and determine the 
factors, i.e., independent variables the influence its value.  
Hamilton (1992) recommends the logit model because when one has a 
dichotomous dependent variable, such as one either dies of AD or of other causes. 
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Logistic regression requires some of the same assumptions as OLS: unbiasedness, 
efficiency and normality, and large sample size. The specific assumptions are:  
1. The model is specified correctly. No important variables are omitted and no 
extraneous variables are included. Also, X variables are measured without error. 
2. The cases are independent. 
3. None of the X variables are linear functions of the others. As we know perfect 
multicollinearity makes estimation impossible; strong multicollinearity makes 
estimation imprecise. 
4. Influential cases also present problems for logit regression, as they do for OLS. 
5 Sample size, should exceed 100, not only overall sample size but also on the 
number of cases with a given combination of X and Y values (Long and Freese 
2003).  
Logistic regression has other similarities to OLS regression. A goodness-of-fit test 
such as model chi-square is available in logistic regression is the “likelihood ratio chi-
square” statistic, also called LR chi-square. It’s formula is: 
LRχ2  = -2(Log likelihood at iteration of 0 - 
  Log likelihood at final iteration) 
 
Logit coefficients correspond to b coefficients in the linear regression equation 
and standardized logit coefficients correspond to beta weights. In OLS regression, which 
assumes the distribution of the errors is normal, the residual sum of squares for a fitted 
model is proportional, i.e., similar to the log likelihood at final iteration for the logistic 
model. Following these assumptions the -2 log (L0) is analogous to the total sum of 
squares in OLS (TSS), and the -2 log (L1) is analogous to the residual sum of squares in 
OLS (RSS).  
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Another similarity between OLS and Logistic regression is the goodness of fit 
function of  R2   in OLS and known as Pseudo R2, or as R2L or the “likelihood ratio 
index.” in  Logistic regression, R2L = -2 log (L0) - [-2 log (L1)] / (-2 log (L0).  The 
Pseudo R2   is used as a rough approximation of how the model fits the data, ranging 
from 0, when the predictors are completely unrelated to the dependent variable, to 1.0, 
when a model is fitted that allows perfect prediction. However, that Pseudo R2 does not 
have the "explained variance" interpretation of the R2 in OLS.  
 In logistic regression the z statistic, also called the t-test or a quasi-t-test, is used 
to indicate statistical significance and is similar to the t-statistic in OLS. The z is the 
coefficient divided by its standard error, or z = b/se. The z test statistic is considered to 
have an asymptotic t-distribution, and may be. If the z statistic is greater than 2.0, this 
means that the logit coefficient is at least twice the size of its standard error. This usually 
results in a probability value of .05 or better, indicating that the logit coefficient is 
statistically significant (Hamilton 1992).  
  Logistic regression also allows for a more understandable interpretation of a 
relationship between the dependent and independent variables. In logistic regression the 
maximum likelihood estimation can be transformed into the natural log of the odds of the 
dependent variable for easier interpretation in terms of odds ratios. The odds ratio or Ω 
may be calculated directly by taking the antilog (that is, e to the power) of the logit 
coefficient. Poston (2003) notes the odds ratio contains the same information as the 
logistic regression coefficient or the probability and provides the same ordering of the X 
variables, from strongest to weakest, as the logit coefficients. 
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Bayesian Model 
An issue of using large data sets is of an increased likelihood of significance 
based on the large numbers.  Raftery (1995) recommends the use of a Bayesian Model in 
social research involving large N’s because conventional statistical tests may err in the 
rejection of the Null hypothesis even when intuitively and theoretically it should be 
accepted. Accordingly the BIC model, recommended by Raferty for use in large data sets 
is used. Used with  logistic regression, as a rule of thumb, a BIC of 0-2 is weak, 2 - 6 is 
moderate, 6 - 10 is strong, and over 10 is very strong. (Long and Freese, 2001, 86). 
Chapter III has presented the data and methodology of this dissertation. Chapter 
IV will present the data analysis of the NCHS multiple cause of death files. Chapter V 
will present the summary, implications for policy and suggestions for future research.  
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CHAPTER IV 
RESULTS 
 This chapter presents the major results of this dissertation. It consists of an 
analysis of data from decedents aged 60 and over using the National Center for Health 
Statistics Mortality Files for the five years of 1998-2005. The analysis examines these  
likelihoods: 1. the likelihood of dying of AD as the underlying cause of mortality; 2. the 
likelihood of dying of AD as any of the twenty conditions of mortality;  and 3. the 
likelihood of dying of AD  compared to only those who die of chronic and degenerative 
diseases. The hypotheses and the proposed direction of the relationships are presented 
first.  Next is a general description of the frequencies of the variables. Then the results of 
the logistic regressions are presented and discussed.  All tables depicting results are 
placed in Appendix G, and referenced in this chapter. 
Hypotheses 
A brief listing of the hypotheses and the predicted direction of the relationships 
between the variables will be introduced before presenting the descriptive statistics and 
logistic regressions. Please refer to Chapter II for a detailed description of the variables, 
how they are measured, as well as the complete hypotheses. The projected relationships 
between the variables and the directions of each hypothesis which will be explored using 
logistic regression are:  
1.  Age and AD up to age 90 +   
2.  Past age 90 and AD - 
3.  Male and AD – 
4. Education and AD- 
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5. Blacks age 80+ and AD- 
6. Hispanic populations: 
 a. Cuban and AD + 
b. Mexican and AD- 
7. Nursing Home residence and AD+  
8. Singles and AD+ 
Descriptive Analysis 
The advantage of using a five year composite of mortality data is that there are 
sufficient numbers for analysis of the oldest old. Descriptive statistics presented here 
illustrate the epidemiological transition in the United States, with increased longevity and 
mortality due to chronic and degenerative diseases of the 12,009,528 decedents in the 
years 1998-2002. Of these decedents 9,643,607 were over age 60. There were three 
versions of AD used. The descriptive analyses use AD and AD as any cause along with a 
comparison of all causes. The descriptive analyses show similar patterns in all variables 
and all ages.  
Table G.1.A, Appendix G, describes the top causes of mortality by five year aged 
60 and above. AD is the fifth leading cause of mortality; with 313,013 dying of AD, 
though these are only 3.2 percent of the decedents aged 60 and over. This table shows the 
doubling effect, with AD increasing as the population ages.  The numbers drop 
significantly after age 80.  The only age category that was dropped from the logistic 
regressions due to small numbers of individuals in the category was the 105+ aged 
decedents, with only 492 decedents reported to be 105 or over.   
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Figure G.1, Appendix G, visually presents the mortality occurrence by age, all 
causes, AD and AD as any condition. Note that mortality by all causes, the more elevated 
curve, clearly accelerates dramatically until aged 80 to 84 when, as the cumulative effect 
of mortality peaks, begins to decline revealing a rectangularization. The two lower lines 
representing Mortality by cause of AD and AD as Any Condition follow similar paths. 
Together they demonstrate almost a Gaussian curve with the majority of deaths by AD 
and AD as any condition in the decedents in their 80’s. Both have similar patterns of 
gradual increases in the numbers of decedents beginning with decedents in their 60’s and 
peaking for decedents in their 80’s and then declining, ending over age 105.  This would 
appear to give support to Hypotheses 1 and 2.   
Table G.1.B, Appendix G, shows the frequency distribution in five year periods of 
decedents over the age of 60 grouped by ethnicity. The last row of the table illustrates the 
increased mortality by age. The mortality curve is evident: between ages 60 to 64 there 
were 675,371 decedents; between ages 65 to 69 there were 913,939 decedents; between 
ages 70 to 74 there were 1,296,730 decedents; between ages 75 to 79 there were 
1,671,023 decedents; between ages 80 to 84 there were 1,822,068 decedents. The 
frequency begins to decline to 1,667,028 in decedents aged 85 to 89; 1,085,794 decedents 
between ages 90 to 94; 420,254 decedents between ages 95 to 99; 8,158 decedents 
between ages 100 to 104 and 492 decedents ages 105+. 
Figure G.2, Appendix G, provides a picture of changes in the population by 
ethnicity as the population ages. Note that from ages 60 to 80 there is a decrease in the 
percentages of mortality among both Hispanic and NonHispanic Black decedents and a 
slight increase for NonHispanic Whites. Beginning with decedents aged 90 and over, 
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there is an increase in the percentages of NonHispanic Blacks and, to a lesser extent 
Hispanics, with a decrease in the percentage of NonHispanic Whites.  
Table G.1.B, Appendix G, provides additional data about the frequency and the 
percent of decedents by ethnicity and age, revealing racial disparity in the aging 
population. Among the younger decedents, aged 60 to 64, 76 percent were NonHispanic 
Whites and 16 percent NonHispanic Blacks; this increases to 79 percent for NonHispanic 
Whites and 14 percent for NonHispanic Blacks between ages 65 to 69. This ethnic and 
racial disparity continues until it peaks between the ages 90 to 94 with 89 percent 
NonHispanic Whites and 7 percent NonHispanic Blacks. Then, between the ages 95 to 
99, there is a slight decline with 88 percent NonHispanic Whites and 7 percent 
NonHispanic Blacks. This becomes more pronounced among the oldest ages. Between 
the ages 100 to 104 there were 78 percent were NonHispanic Whites and 18 percent were 
NonHispanic Blacks.  At ages 105+ 42 percent were NonHispanic Whites and 44 percent 
were NonHispanic Blacks.  It should be noted that death certificate data on age at death 
are provided by the decedents’ informants and, as is discussed in Chapter II, the validity 
of age reporting is an issue. However, the informant shown by age of decedent indicates 
that among the oldest old the Black/White crossover is evident.  
Table G.1.C, Appendix G, lists ethnic frequency by age of the 313,103 decedents 
with AD along with the 486,718 decedents with AD as any condition of Mortality. This 
table enables one to compare the frequency by cause of AD or AD as any condition and 
all causes by the three ethnic groups used in the logistic regressions. Consistent with the 
literature AD appears to be more prevalent among the NonHispanic white population. 
Although 85 percent of those over age 60 are NonHispanic Whites, 92 percent of the AD 
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decedents and 91 percent of the AD as any condition are NonHispanic Whites. 
Comparatively, NonHispanic Blacks make up 9 percent of the over 60 population and 
only 5 percent of AD decedents and 6 percent of those with AD as any cause. The 
Mexican decedents comprised 2 percent of the aged 60 + decedents and 1 percent of the 
AD decedents and 1 percent of those with AD as any condition. The other Hispanic 
groups had less than 1 percent of the decedents over age 60 and similar small percentages 
of mortality by AD.  Although this table presents the frequencies and percentages for 
both race and ethnicity, the low numbers in the Hispanic categories required that race and 
ethnicity be collapsed in the logistic regression, as Hispanic, NonHispanic White, and 
NonHispanic Black.   
Table G.1.D, Appendix G, presents the frequencies of mortality by sex so that one 
can compare mortality by all causes, AD, and AD as any cause by age. This table shows 
males dying in greater numbers at earlier ages. Females have increased numbers of 
mortality by AD; 302 thousand die of AD as any cause versus 184 thousand males. Not 
only do more females die aged 80-89 when there is the greatest risk of dying of AD, 
females also have an increased percentage of mortality by AD and AD as any cause at all 
ages.  
The next two tables, Tables G.1.E and G.1.F, in Appendix G, show marital status 
by age and cause. The married category is the largest, and declines with the mortality 
curve. The widowed category is interesting in that 55 percent of those who die of AD are 
widowed compared to 46 percent of those who die of other causes. Lower percentages of 
decedents with AD or AD as any condition are divorced: 5 percent of both AD and AD as 
any condition decedents compared with 9 percent of other causes.   
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Tables G.1.G and G.1.H, Appendix G, show the same trend of similar frequencies 
among the two versions of the dependent variables, AD as the underlying condition of 
mortality, and AD as any of the conditions. These tables are especially interesting in that 
the literature suggests that higher education protects against AD. However, these data 
indicate a larger percentage of decedents with high school and college education dying of 
AD and AD as any condition than of other causes. Of those AD decedents 47 percent 
have a high school or 9 to 12 years of education compared to 50 percent of decedents of 
all causes; the results for AD as any condition are similar. Those with college education, 
13 to 16 years of education, have similar percentages. It should be noted that the 
education level data may have problems because they are supplied by informants with no 
verification attempted. Education levels attained are retrospective data, with education 
levels attained possibly 40 to 60 years prior to obtaining the death certificate data. Data 
validity could be a problem.  Finally, the literature suggests that productive and mentally 
challenging activities are protective against AD. Education, usually attained in early life, 
may not be related to whether the decedent continued with productive and mentally 
challenging activities in later life. 
 Table G.1.I and G.1.J, Appendix G, differentiate the decedents by metropolitan 
residence. These data indicate that there is very little difference between those who live 
in metropolitan or nonmetropolitan areas. About 76 percent of all the groups of decedents 
are metropolitan residents. There are two possible explanations for this lack of variation. 
First, there is no difference in the incidence of AD by metropolitan residence. Second, 
there is a universal medical acceptance of AD in metropolitan and non metropolitan areas 
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and thus no difference in the diagnosis of AD between the two areas. Metropolitan status 
is included in Model 5 of the logistic regressions; however it was not significant.  
 Table G.1.K and G.1.L, Appendix G, depict the place of death by cause of AD or 
AD as any condition compared to dying of other causes. The most obvious difference is 
in the area of Nursing Home residence. Half of AD the decedents are nursing home 
residents compared to 20 percent of those with other causes. The AD as any condition 
decedents follows a similar pattern; 47 percent are nursing home residents compared to 
20 percent of those dying of other conditions. Also supporting the notion of AD being a 
chronic condition is that whereas 30 percent of decedents of other causes are hospitalized 
inpatients, only 11 percent of those decedents of AD and 14 percent of those decedents of 
AD as any condition die as hospitalized inpatients.  Finally, low percentages of those 
with AD are likely to die while living in their own home, i.e., 13 percent of those with 
AD and 12 percent of those with AD as Any of the Conditions, compared to 18 percent of 
those with other causes.  
Logistic Regressions 
This section discusses the results of the logistic regression models used and the 
extent to which they support the hypotheses.  Logistic regressions use the three versions 
of the dependent variable in five nested models with each model including an increased 
number of independent variables. Version one, Tables G.2.A to I, Appendix G, depicts 
AD as the underlying cause of mortality, a dummy variable compared to dying of all 
other causes. Version two, Tables G.3.A to I, Appendix G, depicts AD as any of the 
conditions of mortality, a dummy variable compared to dying of any other cause. Both of 
these visions were used to address questions of coding consistency and of multiple 
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conditions of mortality. In all cases the logistic regressions using versions one and two 
provided consistent results, showing that mortality by AD functions in a similar manner 
despite whether AD is the underlying cause of mortality or one of the conditions of 
mortality.  Version three, Tables G.3.A to I, Appendix G, depicts AD the as underlying 
cause compared to dying of any other chronic condition; this model allows one to look at 
AD compared to only chronic causes. Each Table is further divided into A to J subsets 
including Models 1 to 5, using only those decedents in each of the specific five year age 
groups.  Models 1 to 5 present a nested approach in that one is looking at mortality by 
AD only for those decedents in the five year group, by an increasing number of 
independent variables in the five models. Model 1: Sex; Model 2: Sex and Ethnicity; 
Model 3: Sex, Ethnicity and Marital Status; Model 4: Sex, Ethnicity, Marital Status, 
Educational level and Metropolitan residence; and finally the full model, Model 5: Sex, 
Ethnicity, Marital Status, Educational level, Metropolitan residence and location at time 
of death. The logistic regression results depict the coefficients and percent change in odds 
ratio with measures of significance and model fitness. Since the models are inclusive of 
nine age periods each table will have nine sections, one for each age period.  
The remaining tables in Appendix G include additional analyses necessary for 
hypothesis testing:  Table G.5.A (Coefficients and Percent Change in Odds Ratio AD as 
the Underlying  Condition in Decedents  Aged 60 to 105+, United States 1998-2002); 
Table G.5.B (Coefficients and Percent Change in Odds Ratio AD as Any Condition in 
Decedents Aged 60 to 105+, United States 1998-2002); Table G.5.C (Coefficients and 
Percent Change in Odds Ratio AD as Underlying  Condition in Decedents Aged 60 to 
105+, Mexican and Cuban Comparisons, United States 1998-2002) and Table G.5.D 
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(Coefficients and Percent Change in Odds RatioAD as Underlying  Condition in 
Decedents Aged 60 to 105+, by Ethnicity and Age, United States 1998-2002). 
Bayesian Measures of Model Fit 
Bayesian Measures of model fit are used for evaluating the models, BIC and BIC’ 
are used to compare the models in this analysis. Long and Freese (2006) note that BIC is 
defined as BICk = D(Mk)-dfk  Ink.  The more negative the BIC the better the fit. There is 
also BIC’ based on the LR chi-square with df’k.  BIC’ is defined as BIC’k = -G2(Mk)-df’k  
In (Long and Freese, 2006, 112). The more negative the BIC’ the better the fit. Long and 
Freese note that form selection is a matter of convenience as both give the same 
information. With both forms, when considering selection of the best fit of multiple 
models, one should compare the two, BIC1-BIC2.  When the result is <0 one should use 
the first model; when the result is >0 one should use the second model. The rule of thumb 
for the absolute difference between the models is: 0-2 denotes weak support, 2-6 positive; 
6-10 strong; >10 very strong. The full model i.e. Model 5, was used as the standard for 
model comparison. Note the next to the last row of the tables (2.A to I; 3.A to I and 4.A 
to I) provides the model comparisons using BIC.  Although models of fit, including BIC, 
do tend to accept the most complete model as the best fit, the full Model or Model 5 is 
used as the preferred model according to the BIC analysis. There are three exceptions to 
Model 5 as the best fit: the subsets addressing decedents aged 100 to 104; in Appendix G, 
Tables G.2.I and G.4.I reflect that Model 1, sex alone was preferred and Table G.3.I 
shows that Model 4 was the preferred model.  
For ease of interpretation the percent change in odds ratio will be used although 
both the coefficients and percent change in odds ratio are included in the tables in the 
  
75 
appendix. Refer to Table G.2.A for an explanation of the use of the percent change in 
odds ratio.  Male is a dummy variable, compared to females. The second column, row 1, 
shows that “Male” has a logit coefficient of -0.272.  This may be exponentiated to an 
odds ratio of 0.762. We next subtract 1.0 from this value and multiply by 100 to yield the 
percent change in the odds ratio. This value of -23.8 (shown under the logit coefficient) 
means that in Model 1 the odds of males, compared to females are 24 percent less of 
dying of AD holding all other variables constant. This result is for decedents age 60-64.  
The percent change in odds ratio is used as the preferred interpretation as it allows for a 
proportional representation which gives a clearer presentation of the change in the 
coefficients. 
The level of significance is not really an issue when one has large numbers of 
cases. Note in the last row of Tables G.2. A to I, G.3.A to I and G.4.A to I the level of 
significance is *=P<.01 and **=P<.05. Only significant findings will be noted in the 
narrative below. Unless specified the level of significance is P<.01. 
Hypotheses 
Hypothesis One and Two 
Hypothesis one predicts that age and AD, up to age 90, will have a positive 
relationship whereas hypothesis two predicts that past age 90, age and AD will have a 
negative relationship. The results support hypotheses one and two. These hypotheses 
have been addressed in the descriptive data in Figure G.1, Appendix G. Table G.5.A, 
Appendix G,  depicts the logistic regressions results comparing those decedents with AD 
with the standard of decedents aged 60 to 64. Decedents at age 65 to 69, compared to 
decedents aged 60 to 64, had 2 percent less odds of  mortality of AD, holding all 
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variables constant, whereas in all other age categories there was an increased likelihood 
of  mortality by AD. This trend continues peaking with decedents aged 90 to 94 having a 
512 higher percent odds ratio.  Then there is a slight decrease for decedents aged 95 to 
99; similar to decedents aged 85 to 89. This continues with the oldest ages. 
Table G.5.B, Appendix G, shows the logistic regression results comparing those 
decedents with AD as any condition.  They follow the trends of AD.  However, as would 
be expected, there are increasing percentages in the odds ratio of having AD as any 
condition of mortality that peak and then drop as already shown in Figure G.1, Appendix 
G. This Gaussian shaped curve is evident throughout the analyses with changes in 
mortality by AD following these same trends throughout. If one uses the path of mortality 
by AD, supported by the literature review in Chapter II, that AD is chronic and gradually 
progressive, with mortality following from five to twenty years after onset, the peak years 
of onset of AD may be from sixty to eight-five years. This would support a critical onset 
age theory, with less likelihood of the onset of AD in the oldest ages.  
Hypothesis Three 
Hypothesis three predicts that males, compared to females, will have a decreased 
likelihood of dying of AD.  The results support hypothesis three. In Table G.2.A, 
Appendix G, one first notes the relationship of sex to mortality by AD depicting the odds 
of dying of AD limited to those decedents between ages 60 to 64.   As the nested models 
increase in the number of variables the direction of the male decedents being less likely 
to die of AD remains, though there is some variation.  In Model 5, holding all variables 
constant, the odds of males dying of AD are 21 percent less than for females. Again 
holding all other variables constant, this negative relationship between male sex and AD 
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continues as a significant variable with males dying of AD decreasing by a percent 
change in odds ratio ranging from -16 percent at age 65 to 69 to -49 percent for those 
aged 100 to 104,. Tables G.3.A to I, Appendix G, show that the negative relationship 
between male sex and AD as Any Condition follows the same general trend.  Throughout 
these tables one also notes that their coefficient peaks in mortality in the 80’s owing to 
the increased longevity of females. Females were more likely to die of AD in the 
advanced ages.  
Tables G.4.A to I, Appendix G, depict the relationship between dying of AD 
versus dying of chronic and degenerative conditions. The negative relationship between 
male sex and AD follows the above trend. In the full model males dying of AD, 
compared to dying of other chronic diseases, decreases by a percent change in odds ratio 
ranging from -18 percent for decedents aged 70 to 74 to -50 percent for decedents aged 
100 to 104.  
Hypothesis Four 
Hypothesis four predicts that education will be negatively related with mortality 
by AD. Those with higher education should be less likely to die of AD. This hypothesis is 
not supported. Please refer to the possible reasons listed in the descriptive section above.  
Tables G.2.A to I, Model 5, Appendix G, depict the relationship between AD and 
both high school and college education with elementary education as the reference. Table 
2.A indicates for decedents aged 60 to 64 the high school education variable is not 
significant, and those with college education have an increased risk in the likelihood of 
mortality by AD.  Table G.2.B, Model 5, Appendix G, shows for decedents aged 65 to 69 
the odds of dying of AD are 12 percent higher for those with high school education, and 
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66 percent higher for those with college education. This relationship continues in the 
same direction, with a significant positive relationship through Tables G.2.H, Appendix 
G, ages 95 to 99. Only Table G.2.I, depicting ages 100 to 104 shows no positive 
significant relationship between dying of AD and college education and a negative 
relationship between dying of AD and high school education. Tables G.3.A to I follow 
the same pattern shown in Tables G.2 A to I, depicting the relationship between AD as 
any condition.  Table G.4.A to I, dying of AD compared to other chronic causes, show 
similar trends.  
Hypothesis Five 
  The fifth hypothesis is that NonHispanic Blacks, who survive beyond age 80, will 
have a decreased mortality by AD compared to NonHispanic Whites. As presented in 
Figure G.2, Appendix G,   this hypothesis is confirmed. Among all decedents over aged 
60, NonHispanic Blacks are less likely to die of AD than NonHispanic Whites. The 
logistic regressions also show decreased mortality by AD for NonHispanic Blacks in all 
three versions of AD as the dependent variable. Tables G.2.A to I, Appendix G, depict a 
decrease in the percent change in odds ratio of mortality by AD for NonHispanic Blacks, 
compared to NonHispanic Whites. This ranged from a decrease of 59 percent in Table 
G.2.A, Model 5, for aged 60 to 64, to a decrease of 5 percent in Table G.2.I, Model 5, 
among decedents aged 100 to 104.  Tables G.3.A to I, Appendix G, depicting AD as any 
condition of mortality, and Tables G.4.A to I, Appendix G, depicting AD compared to 
only chronic causes of mortality, show, roughly speaking, the same relationships.  
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Hypothesis Six 
It is recognized that there is no one Hispanic population. Then the relationship of 
Ethnicity and AD should involve multiple analyses. Because the Cuban population in 
Florida is an older population with positive socioeconomic support it was hypothesized 
that they would be more likely to die of AD.  The hypothesized direction between 
Mexican and AD should be negative as the Mexican population, particularly in the five 
Southwestern States, Texas, California, New Mexico, Arizona, and Nevada, is a younger 
population with fewer socioeconomic advantages. Table G.5.C, Appendix G, provides 
partial support for these hypotheses.  Mexicans, compared to other ethnic groups, have a 
lowered AD mortality, holding all other variables constant. Mexicans who live in the SW 
have a 43 percent lower AD mortality.  Cuban AD mortality is not significantly different 
from the comparison group of NonHispanic Whites. This holds for Cubans who live in 
Florida as well as for those who reside in other states.  
The issue of Hispanic ethnicity analysis is also addressed in Table G.5.D, 
Appendix G, which presents mortality by age and ethnicity, separating the Hispanic 
decedents into Mexican, Cuban, Puerto Rican and Other Hispanic categories. Of the 
Hispanic ethnic decedents only Mexicans have significantly decreased mortality by AD 
across all ages. Decreased mortality by AD among Cuban and Puerto Rican decedents 
becomes significant only at the advanced ages: Cuban decedents at age 85 to 89 and 
Puerto Rican decedents at aged 75 to 79.   It is noteworthy that in this analysis the 
Hispanic decedents have decreased mortality by AD. The only exception, not significant, 
is among decedents aged 100 to 104. 
  
80 
Due to low frequencies and the confirmation above that directions of the other 
Hispanic ethnic groups were similar, all of the Hispanic groups were combined for 
analyses using the three versions of AD and five models.  Combined, as in Table G.2 A 
to I, Appendix G, the odds of Hispanics and NonHispanic Blacks dying of AD, compared 
with other causes, also shows the predicted negative relationship. Although the direction 
is negative for all ages, in the full model, Model 5, the BIC best fit, is significant only for 
three age groups. Decedents aged 60 to 64 have a decreased odds of mortality by AD of -
19. Decedents aged 80 to 84 and 90 to 94 have a decrease of -7 percent.  
Tables G.3.A to I, Model 5, Appendix G, depicting AD as any condition, show 
similar patterns.  In Tables G.4.A to I, Model 5, Appendix G, depicting AD compared to 
other chronic causes of mortality there is a slight decrease in mortality of AD compared 
to other chronic causes.   The data show that while the relationship of Hispanics is 
negative as hypothesized, for decedents of most ages, mortality by AD does not vary 
significantly from that of NonHispanic Whites.   
Hypothesis Seven 
This hypothesis uses a proxy of the increased disability of AD and its 
accompanying financial burden predicting that AD decedents will have an increased 
likelihood of a Nursing Home being the place of death. Of all of the variables nursing 
home as place of death presents the greatest increase. Tables G.2.A to I, Appendix G, 
show that the odds of nursing home residents, aged 60 to 64, dying of AD increases by 
887 percent, holding all other variables constant. This relationship continues in all other 
aged decedents ranging from a 598 percent increase for decedents aged 65 to 69 to an 
increase of 38 percent increase for decedents aged 100 to 104.  
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Tables G.3.A to I, Appendix G, depicting AD as any condition also support this 
hypothesis. The odds of nursing home residents dying of AD as any condition range from 
702 percent among those decedents aged 60 to 64, to 40 percent increase for decedents 
aged 100 to 104.  Tables G.4.A to I, Appendix G, depicting AD compared to chronic 
causes of mortality, show the strongest support for the hypothesis that there is a positive 
relationship between nursing home as place of death and AD. The odds of nursing home 
residents aged 60 to 64, dying of AD compared to dying of other chronic causes increases 
by 909 percent, this relationship continues in all other ages. 
Hypothesis Eight 
 This hypothesis expects that singles will be more likely to die of AD compared to 
those who are not single. The results of this analysis only partially support the hypothesis.  
This may be due to the small number of singles who survive over the age of 60. If one 
compares only the married with the single then the direction of the relationship is not as 
hypothesized. Tables G.2.A to I, Model 5, Appendix G, show that among  married 
decedents, compared to singles, the odds of dying of AD, versus dying of all other 
causes, increase from 14 percent in decedents aged 60 to 64 to 82 percent in decedents 
aged 100 to 104. Results shown in Tables G.3.A to I, Model 5, Appendix G, of the odds 
of dying of AD as any condition, compared to dying of all other causes and the results in 
Tables G.4.A to I, Model 5, Appendix G, showing the odds of dying of AD, compared to 
dying of only chronic causes, are all similar. 
Conversely, the widowed, have decreased odds of dying of AD. Tables G.2.A to 
I, Model 5, show that the percent change in odds ratios ranged from -22 percent for 
decedents aged 60 to 64 to -6 percent aged 90 to 94 (in the older ages the relationships 
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are not significant). In Appendix G, Tables G.3.A to I, Model 5, AD as any condition and 
Tables G.4.A to I, Model 5, dying of AD, compared to dying of chronic causes show 
similar patterns. 
The divorced, compared with the single, follow the same trends as the widowed.  
Conclusion 
This chapter has presented the basic analyses of data for decedents aged 60 and 
over, using the National Center for Health Statistics Mortality Files from 1998-2005. 
Both descriptive statistics and logistic regressions were presented to address the 
hypotheses. Data testing eight hypotheses were presented.  The analyses supported six of 
the hypotheses, and the remaining two had partial support. 
 Age and AD had a positive relationship up to age 90.   Over age 90, age and AD 
had a negative relationship. Males were less likely to die of AD than females, a negative 
relationship as hypothesized. The relationship between education and AD was positive 
with high school and college having an increased likelihood of AD, which was not as 
hypothesized.  NonHispanic Black decedents over age 80 were less likely to die of AD. 
Data supported the hypothesis that NonHispanic Black decedents over 60 were less likely 
to die of AD than NonHispanic Whites.  Mexicans who lived in the SW as well as all 
Mexican decedents were significantly less likely to die of AD across all age categories. 
The combined Hispanic data showed that for decedents of most ages, mortality by AD 
does not vary significantly from that of NonHispanic Whites.  However, the relationship 
of Hispanics was in the negative direction as hypothesized. Nursing Home as place of 
death and AD had a strong positive relationship as was hypothesized. Of all of the 
variables, nursing home as place of death shows the greatest increase in percent change in 
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odds ratio.  Singles were hypothesized to have a positive relationship with AD. The 
results of this analysis only partially support the hypothesis.  The married were more 
likely to die of AD than the single however the widowed and divorced were less likely to 
die of AD than the single.  
 All tables depicting results are placed in Appendix G, and referenced in this 
chapter. Chapter IV will summarize the results of this dissertation, present policy 
implications and discuss the need for future research.  
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CHAPTER V 
CONCLUSIONS 
This concluding chapter has three sections. The first section is an overview of the 
findings of the dissertation including the statement of purpose, a summary of data, 
methodology, and hypotheses.  The second section presents the major implications of the 
research including implications for public policy.  The third section is a retrospective 
analysis of how this work could have been improved specifying questions that have 
surfaced from these analyses which might be addressed in future research.   
Overview and Summary 
 The purpose of this research was to explore the dynamics of mortality caused by 
Alzheimer’s disease and dementia (AD) among those over age 60 in the United States. 
The initial research questions posed were the following: what is the extent of mortality by 
AD among elderly decedents. Although AD is age related with a doubling effect cited in 
the literature (Antuono and Beyer 1999, Dalsania 2004, Gambassi et al. 1999, Hoyert 
1996, Hebert et al. 2003, Nocera et al. 2003, Pollen 2000) research on AD in the oldest 
old is limited to small numbers in those over age 90.  Researchers (Gao et al. 1998, 
Hofman et al. 1991 Ritchie and Kildea 1995) have attempted to address the small 
numbers in AD research of the oldest old through a meta analyses. General findings were 
inconclusive but suggested that incidence of AD did decrease after age 85.   
The primary significance of this dissertation is its large scale. This study was 
influenced by Carey’s (2003) suggestion that if one wants to study longevity and the 
trajectory of mortality at advanced ages one must have sufficient numbers to have 
survivors at the end of the curve. Since the literature suggested that even attempts at meta 
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analysis had limited numbers what was needed was a study with sufficient numbers to 
address the trajectory of mortality by AD in those over age 90. This dissertation 
combined five years of NCHS mortality data, with 9.5 million decedents over age 60; 
1,085,794 decedents aged 90-94; 420,254 decedents aged 95 to 99; 8,158 decedents aged 
100-104 and 492 decedents aged 105+ (refer to Table G. 1.B in Appendix G). Due to the 
years included, 1998-2002, no period effects are anticipated to affect the results. 
Although the 9/11/01 mortality is included in this period it did not impact this study as 
the focus is on the population over age 65 and NCHS data indicates the majority of those 
who died were between ages 35 to 39 beyond the scope of this study.   
As the title of this dissertation implies we are entering an era of global aging.  
Longevity researchers positing the rectangularization of mortality (Carnes and Olshansky 
1993, Olshansky and Carnes 1994, Olshansky et al. 1990, Olshansky et al. 2001, 
Olshansky 2003) posit that there is a possibility of increased life expectancy as individual 
causes of mortality are reduced. However, due to comorbidity, future life expectancies 
will not have the same dramatic increases as in the last century.  The opposing argument 
posed by other researchers (Alburg and Vaupel 1990, Horiuchi and Wilmoth 1998, 
Manton et al. 1991, and Vaupel et al 1998, Vaupel 2001)  posit  that we are altering 
senesce.  Life expectancy has been increasing for the past 160 years and life expectancy 
may reach well over 100. Alburg and Vaupel (1990) project a life expectancy of 100 
years for females  in developed countries in 2080.   Horiuchi and Wilmoth (1998) present 
three stages of mortality in those who survive past: a deceleration of mortality after age 
80, a plateau between ages 80 to 105 and an actual decline in mortality in the highest ages 
over 110.  Since AD is assumed to be age related, what is the relationship between AD 
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and age at these oldest ages?   What is the direction of the relationship between mortality 
by AD and the variables of age, sex, education level, marital status, metropolitan status 
and place of death?   
The dependent variables were three:  AD as the underlying cause of mortality, and 
AD as any condition of mortality compared to both all other causes, and to other chronic 
causes among those over sixty years.  This research focused on the extent of AD in the 
elderly population. Chapter IV presented the data analysis testing the following seven 
hypotheses, and the proposed direction of the relationships among the variables: 1.  Age 
and AD up to age 90 (+); 2. Age and AD over age 90 (-); 3.  Males and AD(-);4. 
Education and AD (-); 5. Blacks over age 80 and AD (-); 6. Hispanic populations:  a. 
Cuban and AD (+); b. Mexican and AD (-); 7. Nursing Home residence and AD (+);8. 
Singles and AD (+).   
This section will summarize the findings by hypothesis, combining one and two 
as they are both age related hypotheses. There were three versions of the dependent 
variable, as well as five models. Although three versions of AD were used, this summary 
will use only the fullest version, AD as any of the conditions of mortality, and Model 5, 
including all of the independent variables; this was shown to be the best model according 
to the Bayesian analyses. 
Age 
The first and most significant finding was the relationship between age and 
mortality by AD.  These findings answer the question raised by the title of this 
dissertation, showing that although AD is the fifth leading cause of mortality of those 
over age 60, it is not inevitable with aging.  Mortality by AD decreases in the oldest old. 
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First initially AD does increase with age, beginning at age 60. Descriptive statistics show 
that AD as any condition of mortality ranges from .7 percent of all causes for decedents 
aged 60-64 to 7.9 percent of all causes of mortality for decedents aged 90-94.  
However as is mentioned above this study was able to address the oldest old. 
Mortality researchers (Brookmeyer et al. 1998, Brookmeyer et al. 2002, Gatz et al. 2000, 
Ganguli et al. 2005, Ritchie and Kildea 1995) reviewed in Chapter II indicated a gap in 
research of the oldest old. Prior studies had either used too limited a sample size of the 
oldest old or extrapolated findings for the oldest age group from younger ages due to the 
small numbers of those surviving to the oldest old. One advantage of this dissertation was 
the large population of 12 million decedents in the years 1998 to 2002. Of these 
decedents 9.5 million were over age 60. The only age category that was dropped from the 
logistic regressions due to small numbers of individuals in the category was the 105+ 
aged decedents, with 405 dying of AD as any condition.  
Perhaps the most significant finding was that age and AD had a positive 
relationship up to age 90. The tables referenced in this section are in Appendix G. The 
descriptive statistics, shown in Table G. 1.C, show the doubling effect of mortality by AD 
that is often mentioned in the literature. Four thousand six hundred died of AD as any 
condition among decedents aged 60 to 64; 11.7 thousand, 65 to 69; 31.6 thousand, of 
those aged 70 to 74; 72.9 thousand, 75 to 79; 116 thousand, 80 to 84; 127 thousand, 85 to 
89. However, age 90 to 94 the numbers began to decline with 85 thousand dying of AD 
as any condition. This decrease continued as 31 thousand died of AD as any condition 
aged 95 to 99 decreasing to 5 thousand for age 100 to104 and .5 of a thousand for aged 
105+. These declining numbers of course were due in part to declining numbers of 
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decedents.  Furthermore, a limitation of this study, relying on informants who complete 
the death certificates,  is that those who code mortality in may not adequately code the 
comorbidity conditions.  
The logistic regressions showed this relationship. Decedents at age 65-69, 
compared to decedents aged 60-64, had a decreased mortality by AD of 2 percent, 
holding all variables constant. In all other age categories there was an increased 
likelihood of mortality by AD. Decedents aged 70-74 had an increased percent change in 
odds ratio of 80.1 percent, aged 75-79 an increase of  221.4 percent, aged 80-84 an 
increase of 376 percent, and aged 85-89 an increase of  476.7 percent. This peaks with 
decedents aged 90-94 having an increased percent change in odds ratio of 512 percent.  
Then there is a slight decrease as decedents aged 95-99 have an increased percent change 
in odds ratio of 496 percent, similar to decedents aged 85-89. This continues with the 
oldest ages; aged 100-104 an increase of 292.5 percent and aged 105+ an increase of 86.7 
percent similar to the age 70-74. 
Interestingly the morbidity literature  also shows that the length of morbidity 
varies by age, with those with early onset-in their 50’s or 60’s having the longest 
morbidity of AD, while those who have a later onset, in their 80’s having the shortest 
morbidity of AD, approximately 3 to 5 years (Brookmeyer et al. 1998). Therefore this 
research suggests that the onset of AD may be age graded with the greatest likelihood of 
onset being in the years 60 to 89.  
These findings should be considered in the light of other research that shows that 
AD mortality is different in advanced ages. Gambassi and colleagues (1999) found that 
autopsies of those who die of AD at advanced ages show fewer senile plaques and 
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neurofibrillary tangles, the key autopsy diagnostics for AD.  In the advanced ages those 
who died of AD also had less likelihood of dying in a nursing home than those dying 
earlier. This analysis indicates a different presentation of AD in the advanced ages.  In 
most cases the variables did not differ significantly for those over age 100, indicating that 
among the oldest old there may well be more similarities than differences. For example 
ethnicity, marital status and nursing home residence did not differ significantly among 
those diagnosed with AD as any Condition (Table G. 4.I). 
Sex 
The relationship between male sex and AD mortality was negative as 
hypothesized. This is the second significant finding as the literature reports conflictual 
findings about the extent of mortality by AD and whether the increase in mortality by 
females is due to the increase of females surviving to older ages or an actual increase in 
females’ incidence in AD over males. Table G. 1.C, Appendix G, showed that of the 
486,718 who died of AD as any condition of mortality 302, 414 were female and 184,304 
male. At the younger ages 60 to 69 there were more males who died of AD as any 
condition; however this must be considered in the light of greater male morbidity in the 
younger ages.  The logistic regressions in Tables G.3.A to J showed the percent change in 
odds ratio, the odds of males dying of AD as any condition, holding all other independent 
variables constant. A negative relationship between male sex and AD is significant with 
males dying of AD as any condition decreasing by a percent change in odds ratio ranging 
from -9 percent for decedents aged 65 to 69 to -44 percent for decedents aged 100 to 104.  
Throughout these tables one also notes that mortality by AD as any condition peaks in the 
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80’s.  The difference between the sexes, with increased longevity of females as well as 
their increased likelihood to die of AD as any condition, is also evident at all ages.  
Marital Status 
The mortality data shows that in the United States by time of death the majority of 
the population had been married at one time. The disadvantage of the data is that it did 
not distinguish how long a decedent had been married, divorced or widowed. Death 
certificate data also is informant data with no attempt at verification. So, to accurately 
reflect the benefits or risks of marital status, more data from a more complete source is 
needed.  Data showed 5 percent single decedents of AD or AD as any condition 
compared to about 6 percent single decedents of other causes.  Lower percentages of 
decedents with AD or AD as any condition are married; about 35 percent married 
decedents of AD or AD as any condition compared to about 39 percent married decedents 
of other causes. More widowed die of AD as any condition 55 percent, compared to 46 
percent of those decedents of other causes.  Lower percentages, approximately 5 percent 
of both AD and AD as any condition decedents, are divorced compared with 9 percent of 
other cause decedents.  The implication from marital status is that married persons live 
longer, are healthier, and have a support system to assist the person with AD remain in 
their home, receiving less expensive care. However, being married did not decrease 
mortality by AD.  
Ethnicity 
  The relationship between Hispanic ethnicity and AD indicates, as does the 
research literature, that although there is no one Hispanic ethnic population, the mortality 
of Hispanics is more similar to Non Hispanic Whites than to NonHispanic Blacks. This 
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researcher conducted four analyses to address Hispanic ethnicity. The first analysis used 
the nine categories of ethnicity listed on the death certificates and provided descriptive 
statistics.  The second analysis addressed Cuban differences; those Cubans who lived in 
Florida were distinguished from those who lived in other locations.  There were no 
significant findings. The third analysis addressed Mexicans who lived in the five 
southwestern states and those who lived in other locations. The combination of both 
Mexicans who lived in the five southwestern states and the total Mexican ethnic 
decedents did result in significant decrease in mortality by AD compared to NonHispanic 
Whites across all age categories. The fourth analyses were AD logistic regressions of 
Mexicans, Puerto Ricans, Cubans and NonHispanic Blacks compared to NonHispanic 
Whites by ethnicity and age in five year periods.  The significantly different Hispanic 
analyses focused on Mexicans. Of the other Hispanic decedents only two age groups 
were significant; Cuban decedents aged 85-94 and Puerto Rican decedents aged 75-94 
had significantly decreased mortality by AD compared to NonHispanic Whites. 
Next, the Hispanic ethnic groups’ combined data were used in logistic 
regressions. The ethnicity results showed that NonHispanic Whites, compared to 
NonHispanic Blacks and Hispanics, were most likely to die of AD. Tables G.3.A to J 
show this relationship. The relationship varies inversely with age, ranging from a 
significant -8 decreased percent change in odds ratio for NonHispanic Blacks aged 95 to 
99 to a -46 percent change in odds ratio between ages 60 to 64. For decedents of most 
ages mortality by AD does not vary significantly from that of NonHispanic Whites; 
however, the relationship of Hispanics was in the negative direction as is hypothesized.  
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My research also found changes in population by ethnicity as the population ages. 
From ages 60 to 80 there is a decrease in the percentages of both Hispanic and 
NonHispanic Black decedents and a slight increase in the percentages of decedents who 
are NonHispanic White. Beginning with decedents aged 90 and over there is an increase 
in the percentages of NonHispanic Blacks and, to a lesser extent Hispanics, with a 
decrease in the percentage of NonHispanic Whites. This would suggest support for the 
theory that minority longevity is due to their being a homogenous healthy population, 
with only the fit surviving to older ages while the NonHispanic White population is 
heterogeneous; for them due to majority advantages, the weaker, with genetic disease 
predispositions can survive longer. According to this theory the NonHispanic Whites 
would be more susceptible to the chronic and degenerative diseases than the minorities.  
Among the younger decedents aged 60 to 64, there were 76 percent NonHispanic 
Whites and 16 percent NonHispanic Blacks.  This increased to 79 percent NonHispanic 
Whites and 14 percent NonHispanic Blacks for decedents aged 65-69. Peaks occurred 
with decedents between ages 90 to 94, with 89 percent NonHispanic Whites and 7 
percent NonHispanic Blacks. Next, between ages 95 to 99, there is a slight decline; 88 
percent are NonHispanic White and 7 percent of the decedents are NonHispanic Black. In 
the oldest ages there appears to be evidence of mortality crossover. Decedents aged 100 
to 104 were 78 percent NonHispanic White and 17 percent NonHispanic Black. For 
decedents aged 105+ there were 42 percent NonHispanic White and 44 percent 
NonHispanic Black. 
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Education 
My research only found the predicted negative relationship between mortality by 
AD and higher education among decedents aged 60 to 64. In all other ages there are 
larger percentages of decedents with high school and college education dying of AD and 
AD as any condition than of other causes compared to those with elementary education. 
The descriptive data show 38 percent of those decedents due to AD as any condition have 
a high school education compared to 34 percent of those decedents of other causes; and  
26 percent of those decedents due to AD as any condition have a college education 
compared to 23 percent of  those decedents dying of other causes.   
Tables G.3.A to I, Appendix G, depict the relationship between AD as any 
condition and education. The hypothesized negative relationship was only present in one 
age group. The odds of dying of AD as any condition for decedents aged 60 to 64 
decreased by 35 percent in Model 5 for those with college education. Significant positive 
relationships between AD as any condition and high school and college education 
compared to elementary education continue through decedents aged 95 to 99. In Table 
G.3.I, it was shown that for decedents aged 100 to 104, there is a negative -34 percent 
relationship between dying of AD as any condition and high school education level, and 
no significant relationship with college education.  
Place of Death 
 Nursing Home as place of death and AD as any condition had a strong positive 
relationship as was hypothesized. Of all the variables, nursing home as place of death 
presents the greatest variation with mortality by AD and other causes. The results in 
Table G.1.M, Appendix G, indicate that 47 percent of decedents with AD as any 
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condition died in a nursing home, that is, of the 486,718 decedents of AD as any 
condition, 226,742 died listing nursing home as place of death. The logistic regression 
percent change in odds ratio ranged from an increased 702 percent change in odds ratio 
for decedents aged 60 to 64 to 40 percent change in odds ratio for those aged 100 to 104. 
Again this depicts that for decedents of AD as any condition, younger decedents, who 
according to the literature have longer morbidity, are more likely to reside in nursing 
homes and receive the more expensive type of care.  
Also supporting the notion of AD being a chronic condition is that whereas 30 
percent of decedents of other causes are hospitalized inpatients, only 11 percent of those 
decedents of AD and 14 percent of those decedents of AD as any condition die as 
hospitalized inpatients.  Finally, low percentages of those with AD are likely to die while 
living in their own home. Only12 percent of those with AD as Any Condition died in 
their own residence compared to 18 percent of those with other causes.   
Implications 
The implications section includes two subsections. The first is a description of the 
population who will be at risk for AD. Although this analysis of cause of death by AD 
showed that there may a deceleration of mortality by AD in the oldest old the greater 
impact to our systems is the increase of survivors to the critical ages for mortality by AD, 
aged 80-90.  Second are implications for policy development and services for those with 
AD in the existing Medical, Hospital and Prescriptive medication programs; Hospice and 
Home Health programs and Long Term Care programs.  
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Demographic Implications 
In 2005 life expectancy in the U. S. is now 77 and three nations have life 
expectancies over age 80: Japan’s is 82, Iceland’s is 81 and Sweden’s is 81. When the U. 
S. Social Security System was founded in the 1930’s the life expectancy was 62; thus the 
years of receiving benefits were minimal. Policy planning should be directed toward a 
baby booming population who will likely have a life expectancy closer to 85 than to the 
62 anticipated by the founders of the Social Security system in the U. S.   
Currently the U. S. system is addressing the impact of the aging of the baby 
boomers on the Social Security System and the health care system. This dissertation 
raises hope in that although we anticipate greater numbers who will experience the 
increased mortality by AD in the peak mortality years from 80 to 90, there is decreased 
mortality by AD in those who survive past 90. This goes along with longevity research 
that reveals an aging but healthier population, with fewer disabilities. If, as current media 
suggests, 70 is the new 50 then will 100 be the new 70 in 2025?  If the aging population 
is healthier then they may be able to be more productive, allowing for a different 
presentation of the dependency ratio. The wealth distribution of the aging population of 
baby boomers is also different in that they may have different resources than other 
cohorts including home ownership, stored wealth, and private retirement policies; altering 
their need for Social Security.   
Continued demographic analysis of the aging population is vital to planning for 
this new stage for baby boomers. The social and political systems of the past fifty years 
have been altered by this large cohort. The major educational, marketing and financial 
systems have responded to the population pressures as the boomers have gone through 
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life stages. The first of the cohort is now aged 60, and will soon be entering retirement, 
and also the stage of chronic and degenerative diseases. The current retirement system 
was designed with the expectation that there would be a large work force supporting a 
small retirement cohort with workers living only a few years into retirement. This aging 
of the population, owing to decreased fertility and increased life expectancy, will 
necessitate revamping our retirement system. Although the age at retirement has been 
modified, the dependency ratio will be a critical part of planning.  
The United States is twentieth in life expectancy in the world. Other nations with 
longer life expectancies will thus be dealing with the increased population over age 85 
years prior to the U. S.  Policy planners should pay close attention to the health and 
retirement systems of these more mature populations so that practical aspects can be used 
in revamping the U. S. system. 
The changing population structure indicates that with an increase in females over 
age 80, and their greater likelihood of mortality by AD, we may have a proportional 
increase in AD.  The increased life span of females projected by the U.S. Census Bureau 
from 2000-2050, for women over age 80 is significant. Table A.1, Appendix A, provides 
projections. The U. S. Census Bureau shows that in 2000, of the 9,251,968 persons over 
the age of 80, 6,158,663 were female or 4.3 percent of the female population. However, 
midrange projections for 2050 are that 33,696,359 or 8 percent of the 420,080,587 
population will be over age 80.  Females over 80 will number 20,406,847, or 9.6 percent 
of the U. S.’s 213,408,448 female population. Dalsania (2004) projected that by age 
eighty-five, 30 to 50 percent of the population will develop dementia.  This study found 
the ages 85 to 89 had the greatest likelihood of dying of AD. Therefore we will have a 
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larger portion, almost double the present number, reaching the critical age of mortality by 
AD.  
Not only will females have greater rates of AD, the literature indicates that males 
and females also have different presentations of AD. Researchers (Dodge et al. 2003, 
Ganguli et al. 2005, Hoyert 1996, Katzman and Bick 2000, Larson et al. 2004) concur 
that the age of onset and the duration of survival differ by sex.  Females are diagnosed 
earlier and live longer, up to twice as long after AD diagnosis, with increased disability in 
comparison to males. Lapane and colleagues (2001) found that females who have AD 
have more symptoms with a faster decline and are thus more likely to live in nursing 
homes and less likely to have family caretakers.  
The financial costs of AD are beyond the scope of this study.  However Hay and 
Ernst (1994) noted that total costs of Alzheimer's disease were $173,932 per case in 1991 
dollars. In the five year period of this study there were 486,718 who died with a diagnosis 
of AD as any condition.  Since that time the population at risk for AD has grown, and the 
costs of nursing home care and prescription medications have grown as well. This 
increase in cost is accompanied by a decrease in those who will pay.  The dependency 
ratio, Table A.2, Appendix A, is decreasing with the 65+ dependency ratio, comparing 
those over age 65 to those in the working years of 15-64, in the US in 2000 was 18.75, in 
2050 it is projected to be 34.57.  
Implications for Policy Development for Services 
Since AD is a chronic condition requiring years of care, ranging from 5 to 20 
years, there are two ways to manage expenses: to provide the needed care in a less 
expensive manner, and prevent or delay the onset of AD.  
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Provide Care in Less Expensive Manner 
There are four service systems that currently provide services to those with AD: 
Hospital Care, Prescriptive Medications, Hospice and Home Health, and Long term 
Care/Nursing Homes. This section will suggest that improvements in each of these 
systems will be necessary due to the large numbers who will be requiring services in 
future years in the U.S.  
The expense of AD as the fifth leading cause of mortality in those over 65 in the 
United States is related to the lengthy morbidity.  AD has morbidity from 5 to 20 years. 
Policy planning must include both development of treatments to cure or delay the onset 
of disability from AD, and work to develop less expensive ways of care and treatment 
during the years of morbidity. The research reported in this dissertation used place of 
death as a proxy for the extensiveness of services provided. The services ranging from 
least to most expensive are residence, outpatient, (dead on arrival) emergency room, 
inpatient, and nursing home. The findings were that those who died of AD had a greater 
likelihood of dying in nursing homes, the most expensive form of care, with about 47 
percent of the decedents dying in nursing homes. 
While remaining in own residence is the cheapest solution, this study showed that 
limited percentages of those with AD died while living in their own home. Twelve 
percent of those with AD as Any of the Conditions died in their own residence compared 
to 18 percent of those with other causes.  Blieszner and Shifflett (1990) found that the 
quality of life as well as the general health of the demented person was improved by 
remaining in family care. Both family members who were caretakers and the individual 
surveyed preferred to live independently or in their residence with assistance. Assistance 
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needs included: Home repair; Senior Centers; Friendly visitation; Telephone assistance; 
Home Delivered Meals; Homemaker/Chore services; and Adult Day Care. They agreed 
that in order to minimize caretaker stress, the care giving family member also needs 
respite, day care and support groups. If these services can be provided, then more 
demented family members could remain in the community with there spouses or children 
providing caretaking with significant cost saving over nursing home care.  
Hospital care, in our current system is relegated to diagnostic related groups 
(DRG’s) equating specific diseases to specific treatment courses that can respond to 
specific treatments in a specified time. DRG’s do not allow for the possibility of co-
morbidity in a chronic population. Private and Medicare insurance programs limit 
hospital care to the treatment of diseases that require nursing and physician care. The care 
of an individual with AD is, for the most part, providing daily living assistance and 
routine care that do not require a medically skilled practitioner. Because there are no 
short term treatments for long term chronic illnesses hospitals are not the treatment place 
for chronic conditions such as AD.  Thus our current system directed towards short term 
treatment of acute symptoms, the DRG costing method, does not work well with AD. 
Data reflect this as 30 percent of decedents of other causes had place of death as 
hospitalized inpatients but only 14 percent of those decedents of AD as any condition die 
as hospitalized inpatients.  
While Home Health and Hospice care were not addressed specifically they are 
part of the outpatient services that would be included on the death certificate. 
Unfortunately, as is indicated in Table G.1.L and M, Appendix G, only 1 percent of those 
who died of AD compared to 5 percent of those who died of all causes reported 
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outpatient care. Home Health services provided through Medicare provides ancillary 
services to those who are transitioning from hospital care services. Thus there are limits 
to length of service, rendering those with long term chronic conditions, with some 
exceptions, not eligible for care.  These services would need to be expanded to deal with 
a chronic population so that full range home health services, Nursing, Dietary, 
Occupational and Physical Therapy services could be offered on a chronic basis. Those 
with AD will need care until death, possibly requiring several years of service. 
 Hospice services also provide full range services for those who prefer to die in 
their residence, a family member’s home, or a hospice palliative care residence.  These 
are also time limited with eligibility restricted to the last six months of a terminal disease.  
The issue with AD is that it is difficult to determine a six months period of eligibility, one 
can live for years in a chronic debilitated condition without dying. Therefore both Home 
Health Care systems and Hospice systems will need eligibility criteria to be modified so 
that those with from 5 to 20 years morbidity will remain eligible for services enabling 
them to remain in a residence.   
The normalization and deinstitutionalization of the mentally retarded population, 
a similar chronic population, who in some cases have similar behavioral manifestations, 
can be used as a model for providing this daily living assistance for those with AD in 
community residences supported by family or friend caretakers. The mentally retarded 
programs recognize an array of in home support services which enable individuals to live 
in a family or home setting, with case managers adapting the services to the specialized 
needs of the individual. These services might include home modifications such as the 
following: bathrooms with shower chairs and shower hoses to assist in bathing, doors that 
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are wheelchair accessible, alarm systems to alert if a person wanders through a door, 
stoves that will not light without special devices, special coded locks so that an individual 
cannot wander, alerts to notify police and fire departments that a challenged person is in 
the home, and labeling all items in the home so that a person with deteriorating 
cognitions can find needed items.  
Services which are currently provided to individuals with behavioral conditions 
similar to AD can also be modified to include those with AD. For example, supportive 
day treatment services are available for the mentally challenged. These services could 
also provide a place where the individual with AD can safely stay during working hours. 
Since many with AD wander or do not sleep at night, these programs could follow the 
model of day care programs for children who assist shift workers and also offer the 
option of night care so that the caretaker can sleep. Nutritional services offered by a 
registered dietitian could help address, for example, the person with AD who goes 
through the agitated phase with the accompanying complication of weight loss. As the 
person loses eating skills an Occupational Therapist could assist in training dealing with 
how to modify food texture and assist in eating so the individual does not choke. Most 
importantly is the availability of respite care so that the caregiver can go to normal 
recreation, leisure, work and family activities, preventing caretaker burnout and stress. As 
cognitive functions decline, the person with AD needs a caretaker trained to help him or 
her eat, bathe, dress, toilet, brush teeth and remain occupied in daily leisure activities. 
Although at the latest stages, nursing home placement may be needed; there are stages 
during which care can be provided in a home or family setting with assistance from 
spouses, children or other family and friends.  
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Of the programs outlined above, the most widespread currently existing programs 
are support groups, most through the non-government voluntary system of the 
Alzheimer’s Association. These support groups provide caretakers and family members 
with emotional support and practical techniques for dealing with an individual with AD. 
These groups also serve as a network for sharing information about improvements in 
services for the AD population quickly and easily transmitting information directly to the 
caregivers.  
Finally nursing home care is usually the last choice at the end of the decision tree 
when family members and other caretakers are no longer able to manage the person with 
AD in their homes. The greatest portion of expense in nursing home care is in staff costs, 
which are anticipated to rise as the supply of workers lessens and their demand increases. 
The care for patients is labor intensive; as an individual with AD may present multiple 
symptoms and have co-morbidity.  
Prevent or Delay the Onset of AD 
The second way of managing the expenses of AD is to delay the onset of the 
dementing processes. There are two possible ways of doing this, through 
pharmacological research, and the presence of protective lifestyles. Current medications 
only work to allay symptoms temporarily, if taken in the early phases of the disease. 
Brookmeyer and colleagues (2002) have noted that the current goal of pharmacological 
research is to allay symptoms for five years, significantly reducing the morbidity by AD.  
The cost of prescriptive medications will also need to be addressed.  
Currently the U. S. has initiated the Medicare Part D program. In this system the 
consumer must make a computerized selection of private providers, from a range of 
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providers, each with a drug formulary. The person who selects the program does so for a 
year, limiting changing to another provider if newly prescribed drugs are not a part of the 
selected drug formulary.  This program will be difficult for a demented person to access 
unless he or she has an advocate making the selection. Although this program does 
appear to privatize prescriptive medications one may question what will be the long term 
costs of this program as the population ages and requires multiple medications. One could 
question whether instead of waiting for private for profit pharmaceutical companies to 
invest in drug research and then sell the drugs at high cost, there should be government or 
voluntary non-government organization sponsored research to develop drugs to delay the 
onset of AD that could be mass produced, and sold as a generic drugs more cheaply to the 
growing aging population.  
Lifestyle Issues 
Rogers and Hackenberg (1987) have suggested that the United States is in the 
hybristic stage of the Epidemiological transition with chronic and degenerative diseases 
influenced by personal choices. They noted that  diet, exercise, refraining from smoking 
and  moderate alcohol consumption are shown to increase both life span and decrease 
disability, thus lowering mortality by heart attacks, strokes, cancer, hypertension and 
diabetes.  The U.S. population is now beginning to reap the benefits of a healthier 
lifestyle with a decrease in smoking lowering the rates of cancer.  Researchers (Antuono 
and Beyer 1999, Miech and colleagues 2002, and Tschanz and colleagues 2004) have 
suggested that lifestyle choices including  such personal choices of healthy life factors as 
education, nutrition and exercise are protective of AD. The literature also suggests that 
education and engaging in mentally stimulating activities are ways of delaying the onset 
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of AD. Researchers (Gatz 2000 Scarmeas et al. 2001, Stern et al 1994) found that 
mentally challenging leisure activities appeared to decrease the risk of AD.  Since 
healthier lifestyles decrease overall mortality, AD researchers have suggested that both 
physical and mental exercise can decrease mortality or morbidity by AD. 
This dissertation did not find that higher education levels were protective against 
mortality by AD.  But discussion did address whether engaging in mentally stimulating 
activities would be protective of AD. More research is needed to determine if educational 
attainment and/or engaging in mentally or physically challenging activities protects one 
from AD. However studies, such as Bennett’s (2004) longitudinal study of Religious 
Orders showed that mentally challenging activities seem to provide a reserve that protects 
against mental decline. Therefore policies, such as tuition free classes for elders at 
community and state colleges could be developed and expanded.  Mentally challenging 
activities such as reading books, working crossword puzzles and playing math games 
along with physical exercise and senior Olympic Games should also be encouraged as 
protective of AD as well as the host of other chronic diseases. Finally the pathway from 
obesity is related to increased incidence of AD following vascular incidents, so obesity 
prevention may also be protective of AD.  
Future Research 
 In retrospect, this study could have benefited from additional analyses of the data. 
First there are four additional areas of study which could be undertaken with the NCHS 
multiple causes of death file data using Hierarchical Linear Modeling. Second, another 
area of study could combine NCHS survey data with existing mortality data. Third, 
international comparisons of incidence of AD could compare mortality by AD in 
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countries at different stages of the Epidemiological Transition. International comparisons 
could also address majority minority incidence of mortality by AD.  
Hierarchical Linear Modeling 
First, one could expand on the analysis of existing data through statistical 
analysis. This study briefly noted the differences in ethnicity between the five Southwest 
states and Florida. Additional information could be obtained from the mortality data by 
an analysis using Hierarchical Linear Modeling (HLM) showing how mortality varies not 
only individually but also by state and by region of the country. The National Center for 
Health Statistics has analyzed the likelihood of mortality by state of 18 diseases, mapping 
their incidence by state; however AD is not one of the diseases they selected.  First, states 
have different population age structures, ethnic concentrations, income rankings, and 
educational levels, as well as different portions of the population over 65.  All of these 
factors could be addressed with their relationship to the likelihood of dying of AD.  For 
example one HLM analysis could address mortality by AD, considering the age ranking 
of the population in the state.  
Second, individuals who live in states may have different health patterns.  The 
literature review noted for example that Catche County Utah has the longest lived 
persons. Rogers and colleagues (2000) note that Utah, with a largely Mormon population, 
follows a temperate lifestyle with limited alcohol and smoking, and has the longest life 
expectancy. Conversely Nevada, with a large tourism industry based on an excessive 
lifestyle, including ingestion of alcohol, has the shortest life expectancy. These two states 
have vastly different age structures as well as different life expectations due to lifestyle 
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choices.  A model could then by proxy address lifestyle issues by comparing Mortality by 
AD in these two states.  
Third, another issue which could be addressed through HLM is the ranking of 
states according to pollution indices. There is a literature that addresses the health hazards 
related to toxins. One of the areas of further research is to learn if there is an increase in 
mortality by AD in areas with high toxin levels.  
Fourth, HLM by individual and state levels could address the internal migration 
issues. The migration of retirees is increasing. The healthy and wealthy are most likely to 
move to retirement communities, created and maintained to provide services to an aging 
society. It would be interesting to use rankings of desirability as a retirement location as a 
factor in an HLM analysis.  
NCHS Survey Data 
Another limitation of this research is that mortality alone does not completely 
address the issues of morbidity of AD, length of morbidity or the extent of services 
required.  Since persons with AD live an average of between 5 and 20 years following 
diagnosis (Brookmeyer et al. 1998.), morbidity information is necessary for policy 
decisions based on projections for needed services for this increasing population. 
Brookmeyer and colleagues (2002) also found that length of survival after diagnosis 
depends on the age at onset, or original diagnosis, which would support a 
rectangularization theory. Those who have AD diagnosed in earlier ages survive with a 
morbidity of  7 to 10 years compared to the average length of survival being 3 years or 
less if diagnosed when in the 90’s. 
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 Morbidity issues could be addressed by including survey data presenting the care 
required by persons with AD compared to other chronic and degenerative diseases. There 
are three NCHS surveys which could be incorporated into an analysis of the morbidity of 
AD: the National Hospital Survey, the National Hospice and Home Health Care survey 
and the National Nursing Home Survey. These surveys provide data that address the 
duration and type of care received and the extent of mortality in AD care compared to 
those with other diagnoses. These data are necessary for financial projections about the 
future expenses in caring for an aging population with AD.  
This analysis could include a description of the incidence of AD for males and 
females in age groups. Other descriptive data are also available through these surveys 
including diagnoses, reasons for admission and discharge from care, length of care and 
status of discharge. A hazard model analyses of the likelihood of dying of AD as 
compared to other causes of mortality analyzed during the duration of stay could address 
length of stay, discharge outcome, as well as types of care necessary upon discharge. 
These data could then be used with the information about the numbers of decedents with 
AD to more completely understand the extent of care and types of services a person with 
AD requires. 
International Comparisons 
The world health organization encourages the use of the international 
classification of disease nomenclature, so international mortality due to AD comparisons 
can be based on the same coding system. International comparisons could show how the 
likelihood of cause specific mortality, including mortality by AD, is related to stages in 
the Epidemiological Transition.  AD is one of the chronic and degenerative diseases 
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which are age related. It would be especially interesting to learn of mortality differences 
between developing and mature countries.  
Another form of international analysis would be to address majority/minority 
status on an international basis. The analysis of data in this dissertation showed 
significant racial disparity in mortality by AD with Whites more likely to die of AD than 
ethnic minorities or non Hispanic Blacks. Data showed that NonHispanic blacks were 
less likely to die of AD than all other ethnic groups. One theory that supports the Black-
White Mortality Crossover is that only the healthiest and hardiest of a minority 
population survives. Therefore they would be less susceptible to chronic and degenerative 
diseases such as AD.  This raises the question of whether, using international 
comparisons, those minorities who survive to the oldest ages are hardier and therefore 
have a lower likelihood of mortality by AD. International comparisons, allowing one to 
address whether ethnicity or minority status is related to diagnosis of AD would allow for 
a more complete understanding of AD by ethnicity and majority status in the oldest old.  
Conclusion 
This dissertation has raised the question of whether mortality by AD is inevitable 
with the global aging of the population. As the population ages there will be an increased 
likelihood of mortality due to chronic and degenerative diseases such as AD.  The Center 
for Disease Control (CDC) estimates that in the United States the incidence of AD 
doubles every 5 years after age 65 with approximately 10 percent of adults ≥ 65 years, 
and 47 percent of adults ≥85 diagnosed with AD (CDC: 2003, 104). The research here 
found similar findings in the population of decedents from 1998-2002, with 4,619 dying 
of AD 116,444 aged 80 to 84; 127,113 aged 85 to 89. However, at age 90 to 94, the 
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numbers began to decline with 85,537 dying of AD as any condition. This decrease 
continued as 31,301 aged 95 to 99 decreasing to 4,923 for age 100 to104 and 405 aged 
105+. There is a different mortality pattern of AD among the oldest old. Mortality by AD 
peaks for decedents aged 85 to 89 and actually begins to decline for decedents over age 
90. With the exceptions of marital status and education the hypotheses were supported. 
Females are more likely to die of AD than males. NonHispanic Whites are more likely to 
die of AD than Hispanics and NonHispanic Blacks.  There is an increased risk of dying in 
a nursing home if one dies of AD. Future research as outlined above is needed to learn 
further about this fifth leading cause of mortality of those over age 60.  
Four systems will need to respond: the health care and hospice system, the 
hospital system, the prescriptive drug system, and the long term care system.  The current 
system of health in the United States is based on a fee for service acute care DRG model.  
Chronic and degenerative diseases require a system that is based on preventative care, 
stressing nutrition and healthy habits such as exercise and moderation. The health care 
system to meet the needs of an aging population must be able to deal with chronic 
conditions with alternatives for pain management and preventative health measures such 
as diet, exercise and avoidance of excesses. The countries of the world with the greatest 
longevity have medical care for all citizens, resulting in lower infant mortality rates and 
greater longevity. The United States does not.  
As the population ages the concern is whether with increased age one will have 
increased disability. One of the gravest disabilities is AD, due to neurological 
degeneration and a lengthy progression. The positive findings of this study are that 
although AD is the fifth leading cause of mortality for those over age 60, the total 
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mortality due to AD, the definition being AD as underlying cause only,  accounts for only 
5 percent of mortality for those over 60.  
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Table A.1: Midyear Population U. S.  2025 and 2050 by Age 60 + & Sex   
Country 
/Year 
 
Population 
both 
 
Population 
male 
 
Population 
female 
 
Percent 
total 
 
Percent 
male 
 
Percent 
female 
 
United States/2000 
 
Sex ratio 
96.4 
       
Median age 35.3 
 
60 - 64 
 
10,864,730 
 
5,165,703 
 
5,699,027 
 
3.8 
 
3.7 
 
4 
 
65 - 69 
 
9,533,955 
 
4,402,844 
 
5 ,131,111 
 
3.4 
 
3.2 
 
3.6 
 
70 - 74 
 
8,849,946 
 
3,904,321 
 
4,945,625 
 
3.1 
 
2.8 
 
3.4 
 
75 - 79 
 
7,425,378 
 
3,051,227 
 
4,374,151 
 
2.6 
 
2.2 
 
3 
 
80+ 
 
9,251,968 
 
3,093,305 
 
6,158,663 
 
3.3 
 
2.2 
 
4.3 
 
Total 
 
282,338,631 
 
138,595,702 
 
143,742,929 
 
100 
 
100 
 
100 
 
United States/2025 
 
Sex ratio 
96.7 
       
Median age 38.5 
 
60 - 64 
 
21,128,456 
 
10,184,920 
 
10,943,536 
 
6 
 
5.9 
 
6.2 
 
65 - 69 
 
19,646,750 
 
9,283,604 
 
10,363,146 
 
5.6 
 
5.4 
 
5.8 
 
70 - 74 
 
16,040,825 
 
7,346,016 
 
8,694,809 
 
4.6 
 
4.3 
 
4.9 
 
75 - 79 
 
12,267,624 
 
5,376,751 
 
6,890,873 
 
3.5 
 
3.1 
 
3.9 
 
80+ 
 
15,568,533 
 
5,793,098 
 
9,775 ,435 
 
4.5 
 
3.4 
 
5.5 
 
Total 
  
349,666,199 
 
171,918,242 
 
177,747,957 
 
100 
 
100 
 
100 
 
United States/2050 
 
Sex ratio 
96.8 
       
Median age 39.1 
 
60 - 64 
 
22,384,189 
 
10,997,678 
 
11,386,511 
 
5.3 
 
5.3 
 
5.3 
 
65 - 69 
 
20,443,823 
 
9,911,357 
 
10,532,466 
 
4.9 
 
4.8 
 
4.9 
 
70 - 74 
 
17,498,614 
 
8,27 3,629 
 
9,224,985 
 
4.2 
 
4 
 
4.3 
 
75 - 79 
 
15,066,841 
 
6,853,651 
 
8,213,190 
 
3.6 
 
3.3 
 
3.8 
 
80+ 
 
33,696,359 
 
13,289,512 
 
20,406,847 
 
8 
 
6.4 
 
9.6 
 
Total 
 
420,080,587 
 
206,672,139 
 
213,408,448 
 
100 
 
100 
 
100 
 
Source: U.S. Bureau of the Census, International Data Base. 
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Table A.2:   Projected Dependency Ratios for the U. S. 2000, 2025 and 2050  
  2000  2025  2050  
Dependency Ratio 0 - 14  32.26  32.12  32.93  
Dependency Ratio 65+  18.75  29.33  34.57  
Total Dependency Ratio  51.01  61.46  67.50  
% over 65  12.4  18.2  14.7  
Median Age  35.3  3 8.5  39.1  
Sex Ratio  96.4  96.7  96.8 
  
T able A.3 Percentages of Mortality by AD by Age in the U. S. in 2001 
 
   
 
   
         
Age  Males  F emales  
60’s  .71  .04  
70’s  2.30  2.78  
80’s  4.48  5.52  
90’s  4.61  5.86  
1 00’s  3.21  4.07  
Source :  Davis et  al. 2004  
  
Source: U.S. Bureau of the Census International Data Base 
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Figure A.1: Magnetic Resonance Imaging (MRI) of Brain Atrophy in Alzheimer’s 
Disease 
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Figure A.2:  Population Pyramid Summary for the United States 
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Figure A.3: Percentage of Mortality by Alzheimer’s Disease 2001 by Age 
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Figure A.4: Cause of Mortality among Decedents Age 60’s in the U.  S. 2001 
 
Top Ten Causes of Death Among the Elderly (60-69): U. S., 2001
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 Figure A.5: Cause of Mortality among Decedents Age 80’s in U.  S. 
Top Ten Causes of Death Among the Elderly (80-89): U. S., 2001
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APPENDIX B 
  
 
Instructions for Completing the Cause-of-Death Section of the Death Certificate  
 
Accurate cause-of-death information is important:  
• To the public health community in evaluating and improving the health of all citizens, and  
• Often to the family, now and in the future, and to the person settling the decedent's estate.  
 
The cause-of-death section consists of two parts. Part I is for reporting a chain of events leading directly to 
death, with the immediate cause of death (the final disease, injury, or complication directly causing death) 
on Line a and the underlying cause of death (the disease or injury that initiated the chain of morbid events 
that led directly and inevitably to death) on the lowest used line. Part II is for reporting all other significant 
diseases, conditions, or injuries that contributed to death but which did not result in the underlying cause of 
death given in Part I. The cause-of-death information should be YOUR best medical OPINION. A 
condition can be listed as “probable” even if it has not been definitively diagnosed.  
Examples of properly completed medical certifications  
32. PART I. Enter the chain of events—diseases, injuries, or complications—that directly 
caused the death. DO NOT enter terminal events such as cardiac arrest, respiratory arrest, 
or ventricular fibrillation without showing the etiology. DO NOT ABBREVIATE. Enter 
only one cause on a line. Add additional lines if necessary. IMMEDIATE CAUSE (Final 
disease or condition 
a._______________________________________________________________________
______________________ resulting in death) Due to (or as a consequence of): 
Sequentially list conditions, 
b.______________________________________________________________________
_______________________ if any, leading to the cause Due to (or as a consequence of): 
listed on line a. Enter the UNDERLYING CAUSE 
c._______________________________________________________________________
______________________ (disease or injury that Due to (or as a consequence of): 
initiated the events resulting in death) LAST 
d.______________________________________________________________________
_______________________ ➤ CAUSE OF DEATH (See instructions and examples) 
Rupture of myocardium Acute myocardial infarction Coronary artery thrombosis 
Atherosclerotic coronary artery disease  
Approxi
mate 
interval: 
Onset to 
death 
________
____ 
________
____ 
________
____ 
Minutes 6 
days 5 
years 7 
years  
33. WAS AN AUTOPSY 
PERFORMED? Yes No  
PART II. Enter other significant conditions contributing to death but 
not resulting in the underlying cause given in PART I. Diabetes, 
Chronic obstructive pulmonary disease, smoking  34. WERE AUTOPSY 
FINDINGS AVAILABLE 
TO COMPLETE THE 
CAUSE OF DEATH? Yes 
No  
35. DID TOBACCO USE 
CONTRIBUTE TO 
DEATH? Yes Probably No 
Unknown  
36. IF FEMALE: Not pregnant 
within past year Pregnant at time 
of death Not pregnant, but 
pregnant within 42 days of death 
Not pregnant, but pregnant 43 
days to 1 year before death 
Unknown if pregnant within the 
past year  
37. MANNER OF 
DEATHNatural Homicide 
Accident Pending Investigation 
Suicide Could not be determined  
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32. PART I. Enter the chain of events—diseases, injuries, or complications—that directly 
caused the death. DO NOT enter terminal events such as cardiac arrest, respiratory arrest, 
or ventricular fibrillation without showing the etiology. DO NOT ABBREVIATE. Enter 
only one cause on a line. Add additional lines if necessary. IMMEDIATE CAUSE (Final 
disease or condition 
a._______________________________________________________________________
______________________ resulting in death) Due to (or as a consequence of): 
Sequentially list conditions, 
b.______________________________________________________________________
_______________________ if any, leading to the cause Due to (or as a consequence of): 
listed on line a. Enter the UNDERLYING CAUSE 
c._______________________________________________________________________
______________________ (disease or injury that Due to (or as a consequence of): 
initiated the events resulting in death) LAST 
d.______________________________________________________________________
_______________________ ➤ CAUSE OF DEATH (See instructions and examples) 
Acute renal failure Hyperosmolar nonketotic coma Diabetes mellitus, noninsulin 
dependent  
Approxi
mate 
interval: 
Onset to 
death 
________
____ 
________
____ 
________
____ 5 
days 8 
weeks 15 
years  
33. WAS AN AUTOPSY 
PERFORMED? Yes No  
PART II. Enter other significant conditions contributing to death but 
not resulting in the underlying cause given in PART I.  
34. WERE AUTOPSY 
FINDINGS AVAILABLE 
TO COMPLETE THE 
CAUSE OF DEATH? Yes 
No  
35. DID TOBACCO USE 
CONTRIBUTE TO 
DEATH? Yes Probably No 
Unknown  
36. IF FEMALE: Not pregnant 
within past year Pregnant at time 
of death Not pregnant, but 
pregnant within 42 days of death 
Not pregnant, but pregnant 43 
days to 1 year before death 
Unknown if pregnant within the 
past year  
37. MANNER OF 
DEATHNatural Homicide 
Accident Pending Investigation 
Suicide Could not be determined  
 
ITEM 32 - CAUSE OF DEATH  
Take care to make the entry legible. Use a computer printer with high resolution, typewriter with good 
black ribbon and clean keys, or print legibly using permanent black ink in completing the cause-of-death 
section. Do not abbreviate conditions entered in section.  
Part I (Chain of events leading directly to death)  
• Only one cause should be entered on each line. Line a MUST ALWAYS have an entry. DO NOT leave 
blank. Additional lines may be added if necessary.  
• If the condition on Line a resulted from an underlying condition, put the underlying condition on Line b, 
and so on, until the full sequence is reported. ALWAYS enter the underlying cause of death on the lowest 
used line in Part I. 
• For each cause indicate the best estimate of the interval between the presumed onset and the date of death. 
The terms “unknown” or “approximately” may be used. General terms, such as minutes, hours, or days, are 
acceptable, if necessary. DO NOT leave blank. U.S.  
 
Source:  Department Of Health And Human Services, Centers for Disease Control and Prevention National 
Center for Health Statistics http://www.cdc.gov/nchs/data/dvs/blue_form.pdf 
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APPENDIX C 
 
Mortality Data, Multiple Cause-of-Death Public-Use Data Files 
 
Data File Description: Detail (1999-2002) 
Data year 
Residence of decedent:1 
State2 
County2,3 
City3 
Population size 
Standard metropolitan statistical area2,3 
Metropolitan and nonmetropolitan counties 
Age at death: 
Infants under 1 year (hours, days, months) 
Infants ages 1 year and over (single years) 
Day of week 
Education (single years, 0-17)2 
Hispanic origin 
Hospital (including status of decedent) and other type 
of place of death 
Industry or business3 
Injury at work  
Month of death 
Marital status 
Occupation (usual)4 
Place of birth (State and eight categories outside of the United States) 
Place of death (State,2,3 county2,3) 
Race (nine categories)5 
Sex 
State of birth 
Manner of death 
Activity code 
Place of injury 
Underlying cause of death:6 
Each cause 
Multiple condition codes: Entity axis, Record axis1 
 ______________________________________________ 
1Place of residence for decedents who were nonresidents of the United States has been 
coded to country of residence. 
2Includes FIPS codes as well as NCHS codes. 
3Includes data for areas with a population of 100,000 persons or more. 
4Applicable only for those States transmitting information to NCHS. 
5Beginning 1992, additional categories are available for some States. 
6Causes of death for 1999-2002 were coded according to the International Classification 
of Diseases, Ninth Revision. 
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Data File Description: Detail (1989-98) 
Data year 
Residence of decedent:1 
State2 
County2,3 
City3 
Population size 
Standard metropolitan statistical area2,3 
Metropolitan and nonmetropolitan counties 
Age at death: 
Infants under 1 year (hours, days, months) 
Infants ages 1 year and over (single years) 
Autopsy performed (1989-94) 
Day of week 
Education (single years, 0-17)4 
Hispanic origin4 
Hospital (including status of decedent) and other type 
of place of death 
Industry or business5 
Injury at work (beginning 1993) 
Month of death 
Marital status 
Occupation (usual)5 
Place of birth (State and eight categories outside of the United States) 
Place of death (State,2,3 county2,3) 
Race (nine categories)6 
Sex 
State of birth 
Underlying cause of death:7 
Each cause 
Multiple condition codes: Entity axis Record axis1  
1Place of residence for decedents who were nonresidents of the United States has been 
coded to country of residence. 
2Includes FIPS codes as well as NCHS codes. 
3Includes data for areas with a population of 100,000 persons or more. 
4Applicable only for those States having information on the certificate. 
5Applicable only for those States transmitting information to NCHS. 
6Beginning 1992, additional categories are available for some States. 
7Causes of death for 1989-98 were coded according to the International Classification of 
Diseases, Ninth Revision. 
 
Source: National Center for Health Statistics 
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APPENDIX D 
 
Chapter Titles for the Ninth and Tenth Revisions, 
 International Classification of Diseases 
 
Chapter ICD–91 chapter titles (code range2)        ICD–101 chapter titles (code2)                    
I Infectious and parasitic diseases (001–139)       Infectious&parasitic diseases A00–B99) 
II Neoplasms (140–239)                   Neoplasms.(C00–D48) 
III Endocrine, nutritional, metabolic diseases       Diseases of the blood and blood-  
                                                                               forming organs and certain 
                                                                              and immunity disorders (240–279) 
                                                                              disorders involving the immune 
                                                                               mechanism D50–D89) 
IV Diseases blood/ blood-forming                        Endocrine, nutritional and 
organs(280–289)                                                   metabolic diseases(E00–E90)                                                                          
V Mental disorders (290–319)                             Mental/behavioral disorders (F00–F99) 
VI Diseases nervous/sense organs(320–389)       Diseases of nervous system (G00–G99) 
VII Diseases of circulatory system 390–459)      Diseases of the eye/adnexa H00–H59) 
VIII Diseases respiratory system (460–519)        Diseases ear/mastoid process H60–H95) 
IX Diseases of digestive system (520–579)        Diseases of circulatory system.(I00–I99) 
X Diseases genitourinary system (580–629)        Diseases respiratory system (J00–J99) 
XI Complications pregnancy/birth  (630–676)    Diseases digestive system K00–K93) 
XII Diseases skin/subcutaneous (680–709)        Diseases skin/ subcutaneous (L00–L99) 
XIII Diseases/musculoskeletal tissue (710–739) Diseases musculoskeletal  (M00–M99) 
XIV Congenital anomalies (740–759)                 Diseases of the genitourinary N00–N99) 
XV Certain perinatal conditions (760–779)         Pregnancy/birth/puerperium (O00–O99) 
XVI Symptoms, ill-defined (780–799)                Certain conditions perinatal (P00–P96) 
XVII Injury and poisoning   (800–999)               Congenital/ chromosomal (Q00–Q99) 
XVIII - - - Symptoms, signs and abnormal clinical and laboratory findings, 
not elsewhere classifiedR00–R99) 
XIX - - - Injury, poisoning and certain other consequences of external 
causes S00–T98) 
XX - - - External causes of morbidity and mortality (V01–Y98) 
XXI - - - Factors influencing health status and contact with health 
services (Z00–Z99) 
- - - Supplementary classification of external causes of injury and 
poisoning (E800–E999) - - - 
- - - Supplementary classification of factors influencing health status 
and contact with health servicesV01–V82) - - - 
- - - Category not applicable. 
1ICD–9 is International Classification of Diseases, Ninth Revision, and ICD–10 is 
International Classification of Diseases, Tenth Revision. 
2The fourth digits of the upper and lower limits of the code ranges are not shown. 
 
Source: National Vital Statistics Report, Vol. 49, No. 2, May 18, 2001  
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APPENDIX E 
 
Comparable category numbers for 113 selected causes of death according to the 
Ninth and Tenth Revisions, International Classification of 
Diseases 
List 
Number Cause of death Category codes                      ICD–10                      ICD–9 
001 Salmonella infections. . . . . . . . . .  . . . . . . . . . . . A01–A02   002–003 
002 Shigellosis and amebiasis. . . . . . .  . . . . . . . . . . .A03,A06   004,006 
003 Certain other intestinal infections.  . . . . . . . . . . . A04,A07–A09           007–009 
004 Tuberculosis. . . . . . . . . . . . . . . . . . . . . . . . . . . .  A16–A19                    010–018 
005 Respiratory tuberculosis. . . . . . . . . . . . . . . . . . . A16                             010–012 
006 Other tuberculosis . . . . . . . . . . . . . . . . . . . . . . . .A17–A19                    013–018 
007 Whooping cough . . . . . . . . . . . . . . . . . . . . . . . . .A37    033 
008 Scarlet fever and erysipelas . . . . . . . . . . . . . . . . A38,A46   034.1–035 
009 Meningococcal infection . . . . . . . . . . . . . . . . . . A39   036  
010 Septicemia. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A40–A41   038 
011 Syphilis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A50–A53   090–097 
012 Acute poliomyelitis . . . . . . . . . . . . . . . . . . . . . . A80    045 
013 Arthropod–borne viral encephalitis . . . . . . . . .  A83–A84,A85.2  062–064 
014 Measles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. B05    055 
015 Viral hepatitis . . . . . . . . . . . . . . . . . . . . . . . . . . .B15–B19   070 
016 Human immunodeficiency virus (HIV) disease .B20–B24   042–044 
017 Malaria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B50–B54   084 
018 Other/infectious& parasitic diseases &sequelae A00,        001,005,020–032, 037 
A05,   A20–A36,A42–A44,A48–A49,A54–,         039–041,046–
054,056– 
A79,A81–A82,A85.0–A85.1,A85.8,                  061,065–066,071–
083, 
A86–B04,B06–B09,B25–B49,B55–B99   085–088,098–134,136,139,771.3 
019 Malignant neoplasms. . . . . . . . . . . . . . .. . . . . . C00–C97   140–208 
020 Malignant neoplasms of lip, oral cavity & pharynx C00–C14   140–149 
021 Malignant neoplasm of esophagus . . . . . . . . . . . . . C15   150 
022 Malignant neoplasm of stomach. . . . . . . . . . . . . . .. C16   151 
023 Malignant neoplasms of colon, rectum and anus . . .C18–C21               153–154 
024 Malignant neoplasms of liver & intrahepatic bile ducts C22                  155 
025 Malignant neoplasm of pancreas . . . . . . . . . . . . . . . C25                       157 
026 Malignant neoplasm of larynx . . . . . . . . . . . . . . . . . C32                        161 
027 Malignant neoplasms of trachea, bronchus and lung.C33–C34               162 
028 Malignant melanoma of skin . . . . . . . . . . . . . . . . . . C43                         172 
029 Malignant neoplasm of breast . . . . . . . . . . . . . . . . . C50                         174–175 
030 Malignant neoplasm of cervix uteri . . . . . . . . . . . . . C53                        180 
031 Malignant neoplasms of corpus uteri &uterus . . . . . C54–C55               179,182 
032 Malignant neoplasm of ovary . . . . . . . . . . . . . . . . .  C56                        183.0 
033 Malignant neoplasm of prostate . . . . . . . . . . . . . . .  C61                         185 
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034 Malignant neoplasms of kidney and renal pelvis . . .C64–C65                189.0,189.1 
035 Malignant neoplasm of bladder . . . . . . . . . . . . . . . . C67                         188 
036 Malignant neoplasms of meninges, brain CNS . . . . C70–C72     191–
192 
037 Malignant neoplasms of lymphoid, hematopoietic. . C81–C96              200–208 
038 Hodgkin’s disease. . . . . . . . . . . . . . . . . . . . . . . . . . . C81   201 
039 Non-Hodgkin’s lymphoma . . . . . . . . . . . . . . . . . . .  C82–C85   200,202 
040 Leukemia. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C91–C95   204–208 
041 Multiple myeloma & immunoproliferative neoplasmC88,C90   203 
042 Other malignant neoplasms/lymphoid/hematopoieticC96 - - - 
043 All other and unspecified malignant neoplasms . . . C17,C23–C24,       152,156 
C26–C31,C37–C41,C44–C49,                                  158–160,163–171,173,181,183.2– 
C51–C52,C57–C60,C62–C63,C66,C68–                  184,186–187,189.2–190,193–199 
C69,C73–C80,C97 
044 In situ neoplasms, benign neoplasms . . . . . . . . .    D00–D48                 210–239 
045 Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . .D50–D64                280–285 
046 Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . .  . E10–E14                250 
047 Nutritional deficiencies . . . . . . . . . . . . . . . . . . . . .  E40–E64                 260–269 
048 Malnutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E40–E46                  260–263 
049 Other nutritional deficiencies . . . . . . . . . . . . . . . . . E50–E64                 264–269 
050 Meningitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G00,G03                 320–322 
051 Parkinson’s disease . . . . . . . . . . . . . . . . . . . . . . .  . G20–G21                 332 
052 Alzheimer’s disease . . . . . . . . . . . . . . . . . . . . . . . . G30                         331.0 
053 Major cardiovascular diseases . . . . . . . . . . . . . . . . I00–I78             390–434,436–448 
054 Diseases of heart . . . . . . .  . . . . I00–I09,I11,I13,I20–I51    390–98,402,404,410–429 
055 Acute/chronic rheumatic heart diseases . . . . . . . . . I00–I09                   390–398 
056 Hypertensive heart disease . . . . . . . . . . . . . . . . . . . I11                         402 
057 Hypertensive heart and renal disease . . . . . . . . . . . I13                          404 
058 Ischemic heart diseases . . . . . . . . . . . . . . . . . . . . .  I20–I25   410–414,429.2 
059 Acute myocardial infarction . . . . . . . . . . . . . . . . . I21–I22   410 
060 Other acute ischemic heart diseases . . . . . . . . . . . I24    411 
061 Other forms of chronic ischemic heart disease . . I20,I25   412–414,429.2 
062 Atherosclerotic cardiovascular disease, so described. I25.0   429.2 
063 All other forms of chronic ischemic heart disease. I20,I25.1–I25.9  412–414 
064 Other heart diseases . . . . ……………………… I26–I51 415–429.1,429.3–429.9 
065 Acute and subacute endocarditis . . . . . . . . . . I33    421 
066 Diseases of pericardium and acute myocarditis . . I30–I31,I40  
 420,422–423 
067 Heart failure. . . . . . . . . ………………………….I50    428 
068 All other forms of heart disease .  . I26–I28,I34–I38,I42–I49,I51 415–417,424–427, 
                                                                                                      429.0–429.1,429.3–429.9 
069 Essential hypertension/hypertensive renal disease  I10,I12                     401,403 
070 Cerebrovascular diseases . . …………………...I60–I69                   430–434,436–438 
071 Atherosclerosis . . . . . . . . ………………………I70                                440 
072 Other diseases of circulatory system. . . . . . . . . . I71–I78                        441–448 
073 Aortic aneurysm and dissection . . . . . . . . . . . …I71                                441 
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074 Other diseases of arteries, arterioles and capillaries I72–I78                    442–448 
075 Other disorders of circulatory system . . . . . . . . . I80–I99                        451–459 
076 Influenza and pneumonia . . . . . . . . . . . . . . . . . . J10–J18                         480–487 
077 Influenza . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   J10–J11                         487 
078 Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . .      J12–J18                           480–486 
079 Other acute lower respirator. . . . . . . . . . . . . . y infections. . . . . . . .  J20–J22                   
466 
080 Acute bronchitis and bronchiolitis . . . . . . . . . . . . . J20–J21                 466 
081 Unspecified acute lower respiratory infection . . . . .J22 - - - 
082 Chronic lower respiratory diseases. . . . . . . . . . . . . .J40–J47               490–494,496 
083 Bronchitis, chronic and unspecified . . . . . . . . . . . . J40–J42                490–491 
084 Emphysema . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . J43           492 
085 Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J45–J46           493 
086 Other chronic lower respiratory diseases. . . . . . . . .J44,J47                494,496 
087 Pneumoconioses and chemical effects . . . . . . . . . . J60–J66,J68         500–506 
088 Pneumonitis due to solids and liquids. . . . . . . . . . . J69                        507 
089 Other diseases of respiratory system . J00–J06,J30–J39,J67,J70–J98  034.0,460– 
                                                                                                    465,470–478,495,508–519 
090 Peptic ulcer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K25–K28             531–534 
091 Diseases of appendix . . . . . . . . . . . . . . . . . . . . . . . .K35–K38             540–543 
092 Hernia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K40–K46              550–553 
093 Chronic liver disease and cirrhosis . . . . . . . . . . . . .K70,K73–K74       571 
094 Alcoholic liver disease . . . . . . . . . . . . . . . . . . . . . .K70                        571.0–571.3 
095 Other chronic liver disease and cirrhosis. . . . . . . . K73–K74                571.4–571.9 
096 Cholelithiasis and other disorders of gallbladder. . K80–K82                574–575 
097 Nephritis, nephrotic syndrome and nephrosis . . . . N00–N07,               580–589 
N17–N19,N25–N27  
098 Acute&rapidly progressive nephritic syndrome. . N00–N01,N04          580–581 
099 Chronic glomerulonephritis, nephritisNOS N02–N03,N05–N07,N26    582–583,587 
100 Renal failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N17–N19                    584–586 
101 Other disorders of kidney. . . . . . . . . . . . . . . . . . . .N25,N27     588–589 
102 Infections of kidney. . . . . . . . . . . . . . . . . . . N10–N12,N13.6,N15.1       590 
103 Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . . . . N40                          600 
104 Inflammatory diseases of female pelvic organs . . . .N70–N76     614–
616 
105 Pregnancy, childbirth and the puerperium. . . . . . . . O00–099                  630–676 
106 Pregnancy with abortive outcome . . . . . . . . . . . . . . O00–O07                630–639 
107 Other complications/pregnancy, childbirth/puerperium  O10–O99          640–676 
108 Certain conditions originating/perinatal period . . .  P00–P96     760–771.2,771.4–779 
109 Congenital malformations/chromosomal abnormalities Q00–Q99           740–759 
110 Symptoms/ abnormal clinical/laboratory NOS . . . . . R00–R99                780–799 
111 All other diseases (Residual) . . . . . . . . . . . . . . . . . Residual                      Residual 
112 Accidents (unintentional injuries) . . V01–X59,Y85–Y86 E800–E869,E880–E929 
113 Transport accidents . . . . . . . . . . . . . .V01–V99,Y85         E800–E848,E929.0,E929.1 
114 Motor vehicle accide V02–V04,V09.0,V09.2,,V12–V14,V19.0–             E810–E825 
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V19.2,V19.4–V19.6,V20–V79,V80.3–V80.5,V81.0–V81.1,V82.0–V82.1,V83–
V86,V87.0–V87.8,V88.0–V88.8,V89.0,V89.2 
115 Other land transport accidents 01,V05–V06,V09.1,              E800– E807,E826–E829 
V09.3–V09.9,V10– V11,V15–V18,V19.3,V19.8–V19.9, 
V80.0–V80.2,V80.6–V80.9,V81.2–V81.9,V82.2– 
V82.9,V87.9,V88.9,V89.1,V89.3,V89.9 
116 Water, air/space,/NOS transport accidents . . V90–V99,Y85               E830– 
E848,E929.0,E929.1 
117 Nontransport accidents . . . . . . . . . . . . . . . . . . W00–X59,Y86     E850–E869,E880– 
                                                                                                             E928,E929.2–E929.9 
118 Falls. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . W00–W19       E880–E888 
119 Accidental discharge of firearms . . . . . . . . . . . . . .W32–W34               E922 
120 Accidental drowning and submersion . . . . . . . . . . W65–W74              E910 
121 Accidental exposure to smoke, fire and flames . . . X00–X09                E890–E899 
122 Accidental poisoning/noxious substances. . . . . . .  X40–X49        E850–E869,E924.1 
123 NOS nontransport accidents and their sequelae. W20–W31,           E900–E909 
W35–W64,W75–W99,X10–,                                                                E911–E921,E923– 
X39,X50–X59,Y86           E924.0,E924.8– 
E928,E929.2–E929.9 
124 Intentional self-harm (suicide). . . . . . . . . . . . . . X60–X84,Y87.0         E950–E959 
125 Intentional self-harm (suicide) by discharge of firearms .X72–X74     E955.0–E955.4 
126 Intentional self-harm (suicide)NOS. . . . . X60–X71,X75–X84,Y87.0  E950–E954, 
           E955.5–E959 
127 Assault (homicide) . . . . . . . . . . . . . . . . . . . . . . . . X85–Y09,Y87.1       E960–E969 
128 Assault (homicide) by discharge of firearms. . . . . . X93–X95             E965.0–E965.4 
129 Assault (homicide) NOS sequelae . . . . X85–X92,X96–Y09,Y87.1    E960–E964,  
                                                                                                                      E965.5–E969 
130 Legal intervention. . . . . . . . . . . . . . . . . . . . . . . . . .Y35,Y89.0             E970–E978 
131 Events of undetermined intent . . . . .  Y10–Y34,Y87.2,Y89.9              E980–E989 
132 Discharge of firearms, undetermined intent . . . . . Y22–Y24               E985.0–E985.4 
133 Other/unspecified events and their sequelae. . . . Y10–Y21,Y25–Y34,Y87.2,Y89.9  
E980–E984,E985.5–E989 
134 Operations of war and their sequelae . . . . Y36,Y89.1            E990–E999 
135 Complications of medical and surgical care . . .. Y40–Y84,Y88         E870– E879, 
         E930–E949 
- - - No comparable category classified by ICD–9 exists. 
1ICD–10 is International Classification Diseases, Tenth Revision, and ICD–9 is 
International Classification of Diseases, Ninth Revision. 
 
Source:  National Vital Statistics Report, Vol. 49, No. 2, May 18, 2001 
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APPENDIX F 
 
Deaths, Percent Of Total Deaths, And Death Rates For The 15 Leading Causes Of 
Death In 5-Year Age Groups, Aged 60-65 All Races And Both Sexes: United States, 
2002 
 
Rates are not shown for age groups over 85 years because population figures are not 
available for these age groups. [Rates per 100,000 population in specified group. Percent 
of Cause of death (Based on the Tenth Revision, International Classification of Diseases] 
 
All races, both sexes, all ages  
...  All causes  2,443,387  100.0  847.3  
1  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
696,947  28.5  241.7  
2  Malignant neoplasms (C00-C97)  557,271  22.8  193.2  
3  Cerebrovascular diseases (I60-I69)  162,672  6.7  56.4  
4  Chronic lower respiratory diseases (J40-
J47)  
124,816  5.1  43.3  
5  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
106,742  4.4  37.0  
6  Diabetes mellitus (E10-E14)  73,249  3.0  25.4  
7  Influenza and pneumonia (J10-J18)  65,681  2.7  22.8  
8  Alzheimer's disease (G30)  58,866  2.4  20.4  
9  Nephritis, nephrotic syndrome (N00-
N07,N17-N19,N25-N27)  
40,974  1.7  14.2  
10  Septicemia (A40-A41)  33,865  1.4  11.7  
11  Intentional self-harm (suicide) 
(*U03,X60-X84,Y87.0)  
31,655  1.3  11.0  
12  Chronic liver disease and cirrhosis 
(K70,K73-K74)  
27,257  1.1  9.5  
13  Essential hypertension and hypertensive 
renal disease (I10,I12)  
20,261  0.8  7.0  
14  Assault (homicide) (*U01-*U02,X85-
Y09,Y87.1)  
17,638  0.7  6.1  
15  Pneumonitis due to solids and liquids 
(J69)  
17,593  0.7  6.1  
...  All other causes (Residual)  407,900  16.7  141.5  
All races, both sexes, 60-64 years  
...  All causes  137,901  100.0  1,187.7  
1  Malignant neoplasms (C00-C97)  51,904  37.6  447.0  
2  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
35,339  25.6  304.4  
3  Chronic lower respiratory diseases (J40-
J47)  
7,060  5.1  60.8  
4  Cerebrovascular diseases (I60-I69)  5,604  4.1  48.3  
5  Diabetes mellitus (E10-E14)  5,512  4.0  47.5  
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6  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
3,788  2.7  32.6  
7  Chronic liver disease and cirrhosis 
(K70,K73-K74)  
2,839  2.1  24.5  
8  Nephritis, nephrotic syndrome and 
nephrosis (N00-N07,N17-N19,N25-
N27)  
1,950  1.4  16.8  
9  Septicemia (A40-A41)  1,861  1.3  16.0  
10  Influenza and pneumonia (J10-J18)  1,716  1.2  14.8  
11  Intentional self-harm (suicide) 
(*U03,X60-X84,Y87.0)  
1,432  1.0  12.3  
12  Aortic aneurysm and dissection (I71)  862  0.6  7.4  
13  Essential (primary) hypertension and 
hypertensive renal disease (I10,I12)  
845  0.6  7.3  
14  In situ neoplasms, benign neoplasms and neoplasms 
of uncertain or unknown beha 632  
0.5  5.4  
15  Human immunodeficiency virus (HIV) 
disease (B20-B24)  
462  0.3  4.0  
...  All other causes (Residual)  16,095  11.7  138.6  
 
 
All races, both sexes, 65-69 years  
...  All causes  
175,59
1  100.0  
1,832.
7  
1  Malignant neoplasms (C00-C97)  63,598  36.2  663.8  
2  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
45,948  26.2  479.6  
3  Chronic lower respiratory diseases (J40-
J47)  
11,405  6.5  119.0  
4  Cerebrovascular diseases (I60-I69)  8,026  4.6  83.8  
5  Diabetes mellitus (E10-E14)  7,249  4.1  75.7  
6  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
3,672  2.1  38.3  
7  Nephritis, nephrotic syndrome and 
nephrosis (N00-N07,N17-N19,N25-N27)  
2,820  1.6  29.4  
8  Chronic liver disease and cirrhosis 
(K70,K73-K74)  
2,670  1.5  27.9  
9  Septicemia (A40-A41)  2,589  1.5  27.0  
1
0  
Influenza and pneumonia (J10-J18)  2,420  1.4  25.3  
1
1  
Aortic aneurysm and dissection (I71)  1,404  0.8  14.7  
1
2  
Intentional self-harm (suicide) 
(*U03,X60-X84,Y87.0)  
1,197  0.7  12.5  
1 Essential (primary) hypertension and 1,126  0.6  11.8  
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3  hypertensive renal disease (I10,I12)  
1
4  
Alzheimer's disease (G30)  939  0.5  9.8  
1
5  
In situ neoplasms, benign neoplasms and 
neoplasms of uncertain or unknown beha  
928  0.5  9.7  
...  All other causes (Residual)  19,600  11.2  204.6  
All races, both sexes, 70-74 years  
All causes  247,399  
100.
0  
2,845.
9  
1  Malignant neoplasms (C00-C97)  81,159  32.8  933.6  
2  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
66,599  26.9  766.1  
3  Chronic lower respiratory diseases (J40-
J47)  
18,383  7.4  211.5  
4  Cerebrovascular diseases (I60-I69)  13,966  5.6  160.7  
5  Diabetes mellitus (E10-E14)  9,460  3.8  108.8  
6  Influenza and pneumonia (J10-J18)  4,427  1.8  50.9  
7  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
4,414  1.8  50.8  
8  Nephritis, nephrotic syndrome and 
nephrosis  
(N00-N07,N17-N19,N25-N27)  
4,344  1.8  50.0  
9  Septicemia (A40-A41)  3,747  1.5  43.1  
1
0  
Chronic liver disease and cirrhosis 
(K70,K73-K74)  
2,711  1.1  31.2  
1
1  
Alzheimer's disease (G30)  2,663  1.1  30.6  
1
2  
Aortic aneurysm and dissection (I71)  2,078  0.8  23.9  
1
3  
Essential (primary) hypertension and 
 hypertensive renal disease (I10,I12)  
1,796  0.7  20.7  
1
4  
Parkinson's disease (G20-G21)  1,600  0.6  18.4  
1
5  
In situ neoplasms, benign neoplasms and 
neoplasms  
of uncertain or unknown beha  
1,420  0.6  16.3  
...  All other causes (Residual)  28,632  11.6  329.4  
All races, both sexes, 75-79 years  
...  All causes  330,140  
100.
0  
4,449.
1  
1  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
94,844  28.7  1,278.
2  
2  Malignant neoplasms (C00-C97)  89,565  27.1  1,207.
0  
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3  Chronic lower respiratory diseases (J40-
J47)  
24,495  7.4  330.1  
4  Cerebrovascular diseases (I60-I69)  22,911  6.9  308.8  
5  Diabetes mellitus (E10-E14)  11,703  3.5  157.7  
6  Influenza and pneumonia (J10-J18)  7,905  2.4  106.5  
7  Alzheimer's disease (G30)  7,078  2.1  95.4  
8  Nephritis, nephrotic syndrome and 
nephrosis (N00-N07,N17-N19,N25-N27)  
6,338  1.9  85.4  
9  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
5,938  1.8  80.0  
1
0  
Septicemia (A40-A41)  5,195  1.6  70.0  
1
1  
Parkinson's disease (G20-G21)  3,368  1.0  45.4  
1
2  
Aortic aneurysm and dissection (I71)  2,779  0.8  37.5  
1
3  
Essential (primary) hypertension and 
hypertensive renal disease (I10,I12)  
2,592  0.8  34.9  
1
4  
Chronic liver disease and cirrhosis 
(K70,K73-K74)  
2,412  0.7  32.5  
1
5  
Pneumonitis due to solids and liquids 
(J69)  
2,323  0.7  31.3  
...  All other causes (Residual)  40,694  12.3  548.4  
All races, both sexes, 80-84 years  
...  All causes  377,514  
100.
0  
7,103.
8  
1  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
118,737  31.5  2,234.
3  
2  Malignant neoplasms (C00-C97)  77,497  20.5  1,458.
3  
3  Cerebrovascular diseases (I60-I69)  31,978  8.5  601.7  
4  Chronic lower respiratory diseases (J40-
J47)  
24,746  6.6  465.7  
5  Alzheimer's disease (G30)  13,057  3.5  245.7  
6  Influenza and pneumonia (J10-J18)  12,079  3.2  227.3  
7  Diabetes mellitus (E10-E14)  11,579  3.1  217.9  
8  Nephritis, nephrotic syndrome and 
nephrosis (N00-N07,N17-N19,N25-N27)  
7,558  2.0  142.2  
9  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
6,966  1.8  131.1  
1
0  
Septicemia (A40-A41)  5,815  1.5  109.4  
1
1  
Parkinson's disease (G20-G21)  4,771  1.3  89.8  
1
2  
Pneumonitis due to solids and liquids 
(J69)  
3,577  0.9  67.3  
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1
3  
Essential (primary) hypertension and 
hypertensive renal disease (I10,I12)  
3,546  0.9  66.7  
1
4  
Aortic aneurysm and dissection (I71)  2,739  0.7  51.5  
1
5  
Atherosclerosis (I70)  2,541  0.7  47.8  
...  All other causes (Residual)  
All races, both sexes, 85-89 years  
...  All causes  
345,38
5  100.0  . . .  
1  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
119,56
5  
34.6  
. . .  
2  Malignant neoplasms (C00-C97)  50,298  14.6  . . .  
3  Cerebrovascular diseases (I60-I69)  33,197  9.6  . . .  
4  Chronic lower respiratory diseases (J40-
J47)  
17,971  5.2  
. . .  
5  Alzheimer's disease (G30)  16,267  4.7  . . .  
6  Influenza and pneumonia (J10-J18)  13,977  4.0  . . .  
7  Diabetes mellitus (E10-E14)  8,797  2.5  . . .  
8  Nephritis, nephrotic syndrome and 
nephrosis (N00-N07,N17-N19,N25-
N27)  
6,959  2.0  
. . .  
9  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
6,507  1.9  
. . .  
10  Septicemia (A40-A41)  5,026  1.5  . . .  
11  Pneumonitis due to solids and liquids 
(J69)  
4,100  1.2  
. . .  
12  Parkinson's disease (G20-G21)  3,959  1.1  . . .  
13  Essential (primary) hypertension and 
hypertensive renal disease (I10,I12)  
3,801  1.1  
. . .  
14  Atherosclerosis (I70)  3,090  0.9  . . .  
15  In situ neoplasms, benign neoplasms 
and neoplasms of uncertain or unknown 
beha  
2,052  0.6  
. . .  
...  All other causes (Residual)  49,819  14.4  . . .  
All races, both sexes, 90-94 years  
...  All causes  
228,58
7  100.0  . . .  
1  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
86,848  38.0  
. . .  
2  Cerebrovascular diseases (I60-I69)  23,110  10.1  . . .  
3  Malignant neoplasms (C00-C97)  22,323  9.8  . . .  
4  Alzheimer's disease (G30)  12,267  5.4  . . .  
5  Influenza and pneumonia (J10-J18)  11,490  5.0  . . .  
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6  Chronic lower respiratory diseases (J40-
J47)  
8,508  3.7  
. . .  
7  Nephritis, nephrotic syndrome and 
nephrosis (N00-N07,N17-N19,N25-
N27)  
4,450  1.9  
. . .  
8  Diabetes mellitus (E10-E14)  4,375  1.9  . . .  
9  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
4,255  1.9  
. . .  
10  Pneumonitis due to solids and liquids 
(J69)  
2,995  1.3  
. . .  
11  Septicemia (A40-A41)  2,988  1.3  . . .  
12  Essential (primary) hypertension and 
hypertensive renal disease (I10,I12)  
2,915  1.3  
. . .  
13  Atherosclerosis (I70)  2,802  1.2  . . .  
14  Parkinson's disease (G20-G21)  1,781  0.8  . . .  
15  In situ neoplasms, benign neoplasms 
and neoplasms of uncertain or unknown 
beha  
1,162  0.5  
. . .  
...  All other causes (Residual)  36,318  15.9  . . .  
All races, both sexes, 95-99 years  
...  All causes  88,282  100.0  . . .  
1  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
35,664  40.4  
. . .  
2  Cerebrovascular diseases (I60-I69)  8,521  9.7  . . .  
3  Malignant neoplasms (C00-C97)  5,772  6.5  . . .  
4  Influenza and pneumonia (J10-J18)  5,172  5.9  . . .  
5  Alzheimer's disease (G30)  5,140  5.8  . . .  
6  Chronic lower respiratory diseases (J40-
J47)  
2,430  2.8  
. . .  
7  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
1,595  1.8  
. . .  
8  Nephritis, nephrotic syndrome and 
nephrosis (N00-N07,N17-N19,N25-
N27)  
1,549  1.8  
. . .  
9  Atherosclerosis (I70)  1,416  1.6  . . .  
10  Diabetes mellitus (E10-E14)  1,357  1.5  . . .  
11  Essential (primary) hypertension and 
hypertensive renal disease (I10,I12)  
1,276  1.4  
. . .  
12  Pneumonitis due to solids and liquids 
(J69)  
1,219  1.4  
. . .  
13  Septicemia (A40-A41)  1,111  1.3  . . .  
14  Parkinson's disease (G20-G21)  440  0.5  . . .  
15  In situ neoplasms, benign neoplasms and 
neoplasms of uncertain or unknown beha  
366  0.4  
. . .  
...  All other causes (Residual)  15,254  17.3  . . .  
  
144 
All races, both sexes, 100 years and over  
...  All causes  18,822  100.0  . . .  
1  Diseases of heart (I00-I09,I11,I13,I20-
I51)  
8,096  43.0  
. . .  
2  Cerebrovascular diseases (I60-I69)  1,584  8.4  . . .  
3  Influenza and pneumonia (J10-J18)  1,356  7.2  . . .  
4  Alzheimer's disease (G30)  878  4.7  . . .  
5  Malignant neoplasms (C00-C97)  789  4.2  . . .  
6  Atherosclerosis (I70)  415  2.2  . . .  
7  Chronic lower respiratory diseases (J40-
J47)  
375  2.0  
. . .  
8  Nephritis, nephrotic syndrome and 
nephrosis (N00-N07,N17-N19,N25-
N27)  
298  1.6  
. . .  
9  Accidents (unintentional injuries) (V01-
X59,Y85-Y86)  
294  1.6  
. . .  
10  Essential (primary) hypertension and 
hypertensive renal disease (I10,I12)  
293  1.6  
. . .  
11  Pneumonitis due to solids and liquids 
(J69)  
229  1.2  
. . .  
12  Septicemia (A40-A41)  199  1.1  . . .  
13  Diabetes mellitus (E10-E14)  195  1.0  . . .  
14  Nutritional deficiencies (E40-E64)  93  0.5  . . .  
15  Anemias (D50-D64)  78  0.4  . . .  
...  All other causes (Residual)  3,650  19.4  . . .  
 
 
 
Source: CDC/NCHS, National Vital Statistics System 
 
 
 
Rank based on number of deaths  
* Figure does not meet standards of reliability or precision... Category not applicable --- 
Data not available  
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APPENDIX G 
 
 
Table G.1.A Frequency of Decedents Over 60 by Top Causes of Mortality United States 1998-2002 
Cardio Hyper 
Heart Cancer Vascular Pneumonia AD Diabetes Nephritis Tension Septicemia Suicide 
60-64 143,053 250,518 37,953 8,839 3,227 26,380 9,273 5,928 7,968 6,482 
65-69 195,129 325,401 58,243 13,547 7,865 35,815 14,503 7,816 11,487 5,937 
70-74 286,749 416,225 98,534 25,195 20,360 47,807 22,371 11,374 16,817 6,331 
75-79 400,165 442,506 154,664 42,975 46,243 56,811 31,684 15,935 23,108 6,235 
80-84 477,680 367,056 198,640 63,876 73,798 53,816 36,752 19,860 25,367 4,978 
85-89 482,791 239,842 203,509 74,211 80,986 40,225 34,900 20,703 23,311 2,894 
90-94 345,003 104,803 140,128 60,011 55,817 20,224 22,579 15,118 14,277 1,001 
95-99 142,570 27,286 53,632 27,056 21,098 6,209 8,309 6,399 5,262 176 
100-104 29,559 3,448 9,839 6,406 3,427 871 1,498 1,368 882 11 
105-109 3,009 229 875 738 274 67 155 120 81 0 
110-114 144 14 53 48 8 3 13 12 5 0 
115-119 12 1 2 4 0 0 0 1 0 0 
120+ 2 2 0 2 0 0 0 0 0 0 
Total 2,505,866 2,177,331 956,072 322,908 313,103 288,228 182,037 104,634 128,565 34,045 
9,643,607 26.0% 22.6% 9.9% 3.3% 3.2% 3.0% 1.9% 1.1% 1.3% 0.4% 
(Total includes more than top causes) 
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Table G.1.B: Frequency Distribution of Decedents, Over Age 60, by Age and Ethnicity, United States 1998-2002 
        Age           60-64       65-69       70-74       75-79       80-84        85-89       90-94     95-99    100-4     105+     Total
Mexican 19,367 24,458 30,632 32,225 26,626 22,028 13,859 5,790 111 15 175,111
2.87% 2.68% 2.36% 1.93% 1.46% 1.32% 1.28% 1.38% 1.36% 3.05% 1.83%
PuertoRican 5,711 6,490 6,982 7,034 6,311 5,173 2,960 1,112 40 10 41,823
0.85% 0.71% 0.54% 0.42% 0.35% 0.31% 0.27% 0.26% 0.49% 2.03% 0.44%
Cuban 3,211 4,576 6,441 7,849 8,687 8,767 6,072 2,335 31 3 47,972
0.48% 0.50% 0.50% 0.47% 0.48% 0.53% 0.56% 0.56% 0.38% 0.61% 0.50%
Central&South 3,441 4,105 4,629 4,501 4,247 3,456 2,163 802 15 2 27,361
American 0.51% 0.45% 0.36% 0.27% 0.23% 0.21% 0.20% 0.19% 0.18% 0.41% 0.29%
Other 3,662 4,795 6,209 7,058 6,961 6,182 4,375 1,824 29 3 41,098
Hispanic 0.54% 0.52% 0.48% 0.42% 0.38% 0.37% 0.40% 0.43% 0.36% 0.61% 0.43%
NonHispanic 515,457 721,412 1,065,132 1,418,252 1,593,420 1,477,606 968,511 371,078 6,323 208 8,137,399
White 76.32% 78.93% 82.14% 84.87% 87.45% 88.64% 89.20% 88.30% 77.51% 42.28% 85.11%
NonHispanic 105,175 124,668 147,365 160,356 143,864 117,126 72,035 31,131 1,426 218 903,364
Black 15.57% 13.64% 11.36% 9.60% 7.90% 7.03% 6.63% 7.41% 17.48% 44.31% 9.45%
NonHispanic 16,627 20,402 25,270 28,974 27,177 22,318 13,048 5,022 151 31 159,020
Other 2.46% 2.23% 1.95% 1.73% 1.49% 1.34% 1.20% 1.19% 1.85% 6.30% 1.66%
Hispanic 2,720 3,033 4,070 4,774 4,775 4,372 2,771 1,160 32 2 27,709
Unknown 0.40% 0.33% 0.31% 0.29% 0.26% 0.26% 0.26% 0.28% 0.39% 0.41% 0.29%
Total 675,371 913,939 1,296,730 1,671,023 1,822,068 1,667,028 1,085,794 420,254 8,158 492 9,560,857
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Table G.1.C Frequency of Decedents Aged 60 and Over by Ethnicity, Mortality by All Causes, AD and AD as Any 
Condition in the United States 1998-2002 
 
Total Causes Non Non Total AD Non Non AD as Any Non Non 
Hispanic Hispanic Hispanic Hispanic Hispanic Hispanic 
Other Hispanic White Black Total Other Hispanic White Black Total Other Hispanic White Black Total 
60-64 16,627 38,112 515,457 105,175 675,371 54 140 2,819 214 3,227 85 214 3,913 407 4,619 
65-69 20,402 47,457 721,412 124,668 913,939 123 358 6,875 509 7,865 193 544 10,044 955 11,736 
70-74 25,270 58,963 1,065,132 147,365 1,296,730 239 733 18,151 1,237 20,360 428 1,184 27,784 2,277 31,673 
75-79 28,974 63,441 1,418,252 160,356 1,671,023 419 1,401 41,859 2,564 46,243 786 2,309 65,293 4,579 72,967 
80-84 27,177 57,607 1,593,420 143,864 1,822,068 639 1,773 67,938 3,448 73,798 1,168 2,960 106,086 6,230 116,444 
85-89 22,318 49,978 1,477,606 117,126 1,667,028 673 1,909 74,697 3,707 80,986 1,198 3,201 116,319 6,395 127,113 
90-94 13,048 32,200 968,511 72,035 1,085,794 418 1,277 51,710 2,412 55,817 723 2,090 78,610 4,114 85,537 
95-99 5,022 13,023 371,078 31,131 420,254 151 500 19,299 1,148 21,098 279 816 28,378 1,828 31,301 
100-104 1,124 2,416 71,031 8,179 82,750 42 79 3,024 282 3,427 61 119 4,326 417 4,923 
105-109 151 258 6,323 1,426 8,158 5 8 222 39 274 8 12 309 62 391 
110-114 27 31 199 187 444 0 0 3 4 7 0 1 4 6 11 
115-119 3 3 9 26 41 0 0 0 1 1 0 0 1 2 3 
120+ 1 1 0 5 7 0 0 0 0 0 0 0 0 0 0 
Total 160,144 363,490 8,208,430 911,543 9,643,607 2,763 8,178 286,597 15,565 313,103 4,929 13,450 441,067 27,272 486,718 
% 1.7% 3.8% 85.1% 9.5% 0.9% 2.6% 91.5% 5.0% 1.0% 2.8% 90.6% 5.6% 
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Table G.1.D Frequency of Decedents by Age and Sex, All Causes, AD and AD as Any, 
in Decedents Over Age 60, United States 1998-2002 
All Causes AD AD as Any 
Age Male Female Total Female Male Total Female Male Total 
60-64 276,263 399,108 675,371 1,535 1,692 3,227 2,128 2,491 4,619 
65-69 388,393 525,546 913,939 3,635 4,230 7,865 5,207 6,529 11,736 
70-74 579,548 717,182 1,296,730 9,840 10,520 20,360 14,834 16,839 31,673 
75-79 809,460 861,563 1,671,023 24,208 22,035 46,243 37,156 35,811 72,967 
80-84 982,377 839,691 1,822,068 43,067 30,731 73,798 66,292 50,152 116,444 
85-89 1,026,576 640,452 1,667,028 53,768 27,218 80,986 82,363 44,750 127,113 
90-94 764,922 320,872 1,085,794 42,304 13,513 55,817 63,612 21,925 85,537 
95-99 328,264 91,990 420,254 17,745 3,353 21,098 26,041 5,260 31,301 
100-104 69,475 13,275 82,750 3,082 345 3,427 4,404 519 4,923 
105-109 7,157 1,001 8,158 256 18 274 363 28 391 
110-114 385 59 444 7 0 7 11 0 11 
115-119 31 10 41 1 0 1 3 0 3 
120+ 4 3 7 0 0 0 0 0 0 
5,232,855 4,410,752 9,643,607 199,448 113,655 313,103 302,414 184,304 486,718 
  
150
 
 
 
Table G.1.E Frequency of Decedents Over Age 60 by Marital Status Mortality All Causes and AD, 
United States 1998-2002 
Total Causes AD 
Age Single Married Divorced Widowed     Total Single Married Divorced Widowed     Total 
60-64 46,152 311,662 111,285 68,150 675,371 241 1,714 455 314 3,227 
65-69 51,332 415,800 116,278 139,767 913,939 408 4,152 874 1,047 7,865 
70-74 64,109 553,451 122,838 285,821 1,296,730 841 10,016 1,539 4,078 20,360 
75-79 73,189 636,022 113,381 505,620 1,671,023 1,657 20,109 2,505 13,077 46,243 
80-84 74,677 563,462 86,715 733,442 1,822,068 2,515 25,417 2,962 28,718 73,798 
85-89 70,676 356,877 58,442 847,532 1,667,028 2,949 18,833 2,661 41,280 80,986 
90-94 50,227 133,118 29,937 657,049 1,085,794 2,450 6,983 1,631 34,174 55,817 
95-99 20,910 24,860 9,886 280,615 420,254 1,074 1,160 544 14,508 21,098 
100-104 4,407 2,175 1,584 58,306 82,750 197 61 81 2,498 3,427 
105-109 461 100 143 5,782 8,158 15 2 6 204 274 
110-114 29 4 7 315 444 0 0 0 6 7 
115-119 2 0 1 28 41 0 0 0 1 1 
120+ 1 0 1 4 7 0 0 0 0 0 
456,172 2,997,531 650,498 3,582,431 9,643,607 12,347 88,447 13,258 139,905 313,103 
% 4.7% 31.1% 6.7% 37.1% 3.9% 28.2% 4.2% 44.7% 
(Total includes the not stated category) 
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Table G.1.F Frequency of Decedents Over Age 60 by Marital Status Mortality All Causes and AD as Any Condition, 
United States 1998-2002 
Total AD as Any Condition 
Single Married Divorced Widowed     Total Single Married Divorced Widowed     Total 
60-64 46,152 311,662 111,285 68,150 675,371 382 2,289 666 436 4,619 
65-69 51,332 415,800 116,278 139,767 913,939 646 5,806 1,277 1,573 11,736 
70-74 64,109 553,451 122,838 285,821 1,296,730 1,408 14,548 2,407 6,272 31,673 
75-79 73,189 636,022 113,381 505,620 1,671,023 2,699 29,801 3,978 20,024 72,967 
80-84 74,677 563,462 86,715 733,442 1,822,068 3,930 37,942 4,611 43,962 116,444 
85-89 70,676 356,877 58,442 847,532 1,667,028 4,581 28,345 3,995 62,026 127,113 
90-94 50,227 133,118 29,937 657,049 1,085,794 3,625 10,438 2,374 50,106 85,537 
95-99 20,910 24,860 9,886 280,615 420,254 1,509 1,694 779 20,604 31,301 
100-104 4,407 2,175 1,584 58,306 82,750 267 84 117 3,463 4,923 
105-109 461 100 143 5,782 8,158 23 3 8 286 391 
110-114 29 4 7 315 444 0 0 0 9 11 
115-119 2 0 1 28 41 0 0 0 3 3 
120+ 1 0 1 4 7 
Total 456,172 2,997,531 650,498 3,582,431 9,643,607 19,070 130,950 20,212 208,764 486,718 
% 4.7% 31.1% 6.7% 37.1% 3.9% 26.9% 4.2% 42.9% 
(Total includes the not stated category) 
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Table G.1.G Frequency of Decedents Over Aged 60, by Education , 
 Mortality by All Causes, United States 1998-2002 
Not stated Elementary High School College Total 
60-64 49,752 79,513 370,379 175,727 675,371 
65-69 65,285 132,950 490,843 224,861 913,939 
70-74 89,496 214,772 689,390 303,072 1,296,730 
75-79 112,260 297,261 876,684 384,818 1,671,023 
80-84 121,725 380,218 922,656 397,469 1,822,068 
85-89 115,266 416,518 783,015 352,229 1,667,028 
90-94 79,337 313,363 451,724 241,370 1,085,794 
95-99 33,229 138,239 158,299 90,487 420,254 
100-104 7,462 30,726 28,423 16,139 82,750 
105-109 883 3,370 2,521 1,384 8,158 
110-114 64 228 103 49 444 
115-119 11 25 4 1 41 
120+ 1 5 1 0 7 
Total 674,771 2,007,188 4,774,042 2,187,606 9,643,607 
% 7.0% 20.8% 49.5% 22.7% 
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Table G.1.H: Frequency of Decedents Over Age 60: 
 Education Level, Mortality by Cause of AD or AD as Any Condition 
Education AD Other ADANY Other 
Elementary 61,660 1,945,528 101,069 1,906,119 
19.69% 20.85% 20.77% 20.82% 
High School 146,858 3,156,525 185,835 3,095,067 
46.90% 33.83% 38.18% 33.80% 
College 84617 2,102,989 126,279 2,061,327 
27.03% 22.54% 25.95% 22.51% 
Not stated 19,968 654,803 31,549 643,222 
6.38% 7.02% 6.48% 7.02% 
Total 313,103 9,330,504 486,718 9,156,889 
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Table G.1.I Frequency of Decedents Over Aged 60,
By Metropolitan Status, Mortality by Cause of AD, 
 United States 1998-2002
AD other
Metro 238,403 7,042,146
% 76.15% 75.55%
Nonmetro 74,655 2,279,098
% 23.85% 24.45%
Total 313,058 9,321,244
 
 
 
Table G.1.J Frequency of Decedents Over Aged 60,
By Metropolitan Status, Mortality by Cause of AD as 
Any of the Conditions, United States 1998-2002
ADANY Other
Metro 367,280 6,913,269
% 75.47% 75.57%
Nonmetro 119,370 2,234,383
% 24.53% 24.43%
Total 486,650 9,147,652
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Table G.1.K Frequency of Decedents Over Age 60 by Place of Death,  
 United States 1998-2002 
Nursing 
Age Inpatient OutPat DOA Home Residence Total 
60-64 240,338 56,955 9,776 41,936 163,497 675,371 
65-69 332,573 66,830 10,860 73,017 209,732 913,939 
70-74 471,254 80,118 12,797 143,966 277,780 1,296,730 
75-79 592,291 88,406 14,041 264,688 317,474 1,671,023 
80-84 600,883 80,559 12,666 408,757 299,001 1,822,068 
85-89 491,482 59,554 9,806 493,759 229,530 1,667,028 
90-94 270,059 30,205 5,777 402,955 130,835 1,085,794 
95-99 84,919 9,103 1,988 182,582 46,834 420,254 
100-104 12,891 1,379 385 40,346 9,608 82,750 
105-109 1,119 119 29 4,042 1,012 8,158 
110-114 72 10 4 196 66 444 
115-119 10 3 0 7 9 41 
120+ 2 1 0 1 2 7 
2,857,555 416,287 68,353 2,014,316 1,521,883 8,968,236 
31.9% 4.6% 0.8% 22.5% 17.0% 
(Total includes unknown) 
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Table G.1.L Frequency of Decedents Over Age 60 by Place of Death, AD and AD as Any Conditon, 
 United States 1998-2002
AD AD as Any Condition
Nursing Nursing
Age InpatientOutPatDOA Home ResidenceTotal InpatientOutPatDOA Home ResidenceTotal
60-64 613 73 27 1,148 753 3,227 993 153 39 1,496 944 4,619
65-69 1,421 193 60 2,866 1,676 7,865 2,407 353 91 3,886 2,211 11,736
70-74 3,267 414 105 8,193 3,750 20,360 5,951 809 161 11,527 5,165 31,673
75-79 6,678 790 245 20,524 7,260 46,243 12,492 1,582 384 29,333 10,123 72,967
80-84 9,106 1,045 309 35,814 10,263 73,798 17,593 2,170 524 51,659 14,310 116,444
85-89 8,476 937 350 42,748 9,994 80,986 16,572 1,881 521 61,695 13,924 127,113
90-94 4,566 542 215 31,989 5,995 55,817 8,829 1,012 336 45,625 8,139 85,537
95-99 1,331 133 94 13,061 2,003 21,098 2,523 253 133 18,184 2,634 31,301
100-104 160 20 14 2,232 323 3,427 290 35 20 3,071 408 4,923
105-109 5 5 1 186 29 274 13 6 1 259 37 391
110-114 0 0 0 6 0 7 3 0 0 6 0 11
115+ 0 0 0 1 0 1 2 0 0 1 0 3
Total 35,623 4,152 1,420 158,768 42,046 313,103 67,668 8,254 2,210 226,742 57,895 486,718
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Figure G.1. Frequency of Mortality by Age: All Causes, AD and AD as Any 
Condition, 
Decedents Over Age 60, United States 1998-2002 
 
 
Figure G.2. Frequency of Mortality by Ethnicity in Decedents Over Aged 60 in the 
United States 1998-2002 
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Table G.2.A: Coefficients and Percent Change in Odds Ratio 
 AD as the Underlying  Condition in Decedents Aged 60-64,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.272 * -0.282 * -0.302 * -0.291 -0.231 *
(-23.8) (-24.5) (-26.1) (-25.2) (-20.7)
Hispanic -0.385 * -0.377 * -0.330 -0.204 **
(-32) (-31.4) (-28.1) (-18.5)
NonHispanicBlack -0.987 * -0.955 * -0.924 -0.885 *
(-62.7) (-61.5) * (-60.3) (-58.7)
Married 0.273 * 0.274 * 0.132 *
(31.4) (31.5) (14.1)
Widowed 0.059 0.105 -0.245 *
(6.1) (11) (-21.7)
Divorced -0.012 0.002 -0.451 *
(-1.2) (0.2) (-36.3)
High School 0.021 0.104
(2.1) (10.9)
College 0.367 * 0.467 *
(44.3) (59.5)
Nonmet -0.061 -0.035
(-5.9) (-3.4)
Inpatient -0.195 *
(-17.7)
NursingHome 2.289 *
(886.9)
Residence 0.364 *
(43.8)
Number  675371
Pseudo R2 0.0014 0.008 0.0094 0.0112 0.0766
BIC: -9025000 -9025000 -9025000 -8312000 -8314000
BIC' -45.317 -287.303 -303.801 -306.5 -2766.751
2721.43 0.00 2479.45 0.00 2462.95 0.00 2460.25
*=P<.01 **=P<.05
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Table G.2.B: Coefficients and Percent Change in Odds Ratio 
 AD as the Underlying  Condition in Decedents Aged 65-69,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.152 * -0.164 * -0.216 * -0.225 * -0.178 *
(-14.1) (-15.1) (-19.4) (-20.2) (-16.3)
Hispanic -0.226 * -0.218 * -0.117 ** 0.002
(-20.2) (-19.6) (-11.1) (0.2)
NonHispanicBlack -0.849 * -0.811 * -0.760 * -0.710 *
(-57.2) (-55.6) (-53.3) (-50.8)
Married 0.283 * 0.274 * 0.173 *
(32.8) (31.5) (18.9)
Widowed -0.038 -0.017 -0.320 *
(-3.7) (-1.7) (-27.4)
Divorced 0.008 0.014 -0.384 *
(0.8) (1.4) (-31.9)
High school 0.073 0.114 *
(7.5) (12.1)
College 0.450 * 0.508 *
(56.8) (66.2)
Nonmet -0.082 * -0.066
(-7.9) (-6.4)
Inpatient -0.405
(-33.3)
NursingHome 1.943 *
(598.2)
Residence 0.194 *
(21.4)
Number  913939
Pseudo R2 0.0005 0.0054 0.0072 0.0099 0.0732
BIC: -12450000 -12450000 -12450000 -11500000 -11510000
BIC' -30.925 -446.047 -566.455 -713.316 -6031.801
6000.876 5585.754 5465.346 5318.485
*=P<.01 **=P<.05
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Table G.2.C: Coefficients and Percent Change in Odds Ratio 
 AD as the Underlying  Condition in Decedents Aged 70-74,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.149 * -0.158 * -0.225 * -0.227 * -0.167 *
(-13.8) (-14.6) (-20.2) (-20.3) (-15.4)
Hispanic -0.310 * -0.304 * -0.194 * -0.046
(-26.7) (-26.2) (-17.7) (-4.5)
NonHispanicBlack  -0.713 * -0.676 * -0.630 * -0.530 *
(-51) (-49.2) (-46.7) (-41.1)
Married 0.253 * 0.229 * 0.299 *
(28.8) (25.7) (34.9)
Widowed -0.042 -0.031 -0.159 *
(-4.1) (-3.1) (-14.70
Divorced -0.124 * -0.141 -0.357 *
(-11.6) (-13.1) (-30)
High school 0.158 * 0.176 *
(17.1) (19.3)
College 0.480 * 0.503 *
(61.6) (65.3)
Nonmet -0.024 -0.018
(-2.4) (-1.8)
Inpatient -0.771 *
(-53.7)
NursingHome 1.456 *
(329)
Residence -1.104 *
(-66.9)
Number  1296730
Pseudo R2 0.0005 0.0042  0.00 61 0.0087 0.0754
BIC: -1.8E+07 -1.8E+07 -1.8E+07 -1.7E+07 -1.67271
BIC' -96.151 -832.497 -1200.19 -1579.6 -14629.1
14532.9 13796.6 13428.88 13049.46
*=P<.01 **=P<.05
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Table G.2.D: Coefficients and Percent Change in Odds Ratio 
 AD as the Underlying  Condition in Decedents Aged 75-79, 
United States 1998-2002 
Model 1 Model 2 Model 3 Model 4 Model 5 
Male -0.161 * -0.167 * -0.251 * -0.255 * -0.190 * 
(-14.9) (-15.4) (-22.2) (-22.5) (-17.3) 
Hispanic -0.286 * -0.279 * -0.161 * -0.001 
(-24.9) (-24.4) (-14.9) (-0.1) 
NonHB -0.623 * -0.588 * -0.536 * -0.405 * 
(-46.3) (-44.4) (-41.5) (-33.3) 
Married 0.253 * 0.225 * 0.263 * 
(28.8) (25.2) (30.1) 
Widowed -0.035 * -0.032 ** -0.153 * 
(-3.4) (-3.2) (-14.2) 
Divorced -0.139 * -0.147 * -0.336 * 
(-12.9) (-13.7) (-28.5) 
High s. 0.158 * 0.161 * 
(17.1) (17.5) 
College 0.452 * 0.455 * 
(57.2) (57.6) 
Nonmet -0.012 -0.013 
(-1.2) (-1.3) 
Inpatient -0.852 * 
(-57.3) 
NursingH 1.187 * 
(227.6) 
Resid -1.111 * 
(-67.1) 
Number  16710 
Pseudo R2 0.0007 0.0035 0.0055 0.0079 0.0708 
BIC: -2.4E+07 -2.4E+07 -2.4E+07 -2.2E+07 -2.186 
BIC' -276.404 -1431.74 -2226.24 -2989.9 -27893.9 
27617.5 26462.1 25667.63 24903.97 
*=P<.01 **=P<.05 
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Table G.2.E: Coefficients and Percent Change in Odds Ratio 
 AD as the Underlying  Condition in Decedents Aged 80-84,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.188 * -0.193 * -0.283 * -0.283 * -0.219 *
(-17.1) (-17.6) (-24.6) (-24.6) (-19.6)
Hispanic -0.330 * -0.325 * -0.240 * -0.067 *
(-28.1) (-27.7) (-21.3) (-6.5)
NonHispanicBlack -0.595 * -0.570 * -0.516 * -0.384 *
(-44.8) (-43.4) (-40.3) (-31.9)
Married  0.239 * 0.215 * 0.182 *
(27) (24) (19.9)
Widowed -0.022 ** -0.020 -0.172 *
(-2.2) (-1.9) (-15.8)
Divorced -0.109 * -0.123 * -0.317 *
(-10.3) (-11.5) (-27.2)
High school 0.119 * 0.123 *
(12.7) (13.1)
College 0.382 * 0.387 *
(46.6) (47.2)
Nonmet -0.001 -0.009
(-0.1) (-0.9)
Inpatient -0.877 *
(-58.4)
NursingHome 0.969 *
(163.6)
Residence -0.057 *
(-5.6)
Number  1700343
Pseudo R2 0.001 0.0034 0.0049 0.0068 0.0576
BIC: -25650000 -25650000 -25650000 -23820000 -23850000
BIC' -600.038 -2071.701 -2959.636 -3840.446 -33267.043
32667.005 31195.342 30307.407 29426.597
*=P<.01 **=P<.05
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Table G.2.F: Coefficients and Percent Change in Odds Ratio 
 AD as the Underlying  Condition in Decedents Aged 85-89,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.219 * -0.222 * -0.305 * -0.301 * -0.234 *
(-19.7) (-19.9) (-26.3) (-26) (-20.9)
Hispanic -0.285 * -0.282 * -0.223 * -0.045
(-24.8) (-24.6) (-20) (-4.4)
NonHispanicBlack -0.488 * -0.474 * -0.419 * -0.276 *
(-38.6) (-37.8) (-34.2) (-24.1)
Married 0.273 0.258 * 0.243 *
(31.4) (29.5) (27.5)
Widowed 0.042 * 0.049 * -0.061 *
(4.3) (5.1) (-5.9)
Divorced 0.010 0.006 -0.133 *
(1) (0.6) (-12.4)
High School 0.120 * 0.116 *
(12.7) (12.3)
College 0.306 * 0.300 *
(35.8) (35)
Nonmet -0.013 -0.022 **
(-1.3) (-2.2)
Inpatient -0.974 *
(-62.2)
NursingHome 0.715 *
(104.3)
Residence -0.033 **
(-3.3)
Number  1667028
Pseudo R2 0.0013 0.0029 0.004 0.0052 0.0458
BIC: -23240000 -23240000 -23240000 -21520000 -21540000
BIC' -832.337 -1865.73 -2515.851 -3042.108 -27559.513
26727.176 25693.783 25043.662 24517.405
*=P<.01 **=P<.05
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Table G.2.G:  AD as the Underlying  Condition  in Decedents Aged 90-94, 
Coefficients and Percent Change in Odds Ratio 
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Age 0.559 * 
(74.8) 
Male -0.286 * -0.285 * -0.349 * -0.348 * -0.281 * 
(-24.9) (-24.8) (-29.4) (-29.4) (-24.5) 
Hispanic -0.294 * -0.295 * -0.246 * -0.068 ** 
(-25.5) (-25.5) (-21.8) (-6.5) 
NonHispanic Black -0.483 * -0.479 * -0.429 * -0.268 * 
(-38.3) (-38) (-34.9) (-23.5) 
Married   0.243 * 0.238 * 0.227 * 
(27.5) (26.8) (25.5) 
Widowed 0.038 * 0.041 * -0.057 * 
(3.9) (4.2) (-5.6) 
Divorced 0.111 * 0.117 * -0.005 
(11.8) (12.4) (-0.5) 
High school 0.108 * 0.102 * 
(11.4) (10.8) 
College 0.238 * 0.231 * 
(26.8) (26) 
Non metropolitan -0.011 -0.018 
(-1.1) (-1.8) 
Inpatient -1.040 * 
(-64.7) 
Nursing Home 0.556 * 
(74.3) 
Residence -0.029 
(-2.8) 
Number  9643607 1085794 
Pseudo R2 0.0044 0.0019 0.0035 0.004 0.0048 0.0365 
BIC: -1.5E+08 -1.5E+07 -1.5E+07 -1.5E+07 -1.4E+07 -1.4E+07 
BIC' -12172.1 -822.974 -1483.08 -1675.35 -1841.42 -14754.9 
*=P<.01 **=P<.05 
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Table G.2.H: Coefficients and Percent Change in Odds Ratio 
 AD as the Underlying  Condition in Decedents Aged 95-99,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.413 * -0.408 * -0.451 * -0.450 * -0.374 *
(-33.8) (-33.5) (-36.3) (-36.2) (-31.2)
Hispanic -0.282 * -0.282 * -0.201 * -0.006
(-24.5) (-24.6) (-18.2) (-0.6)
NonHispanicBlack -0.349 * -0.348 * -0.310 * -0.129 *
(-29.4) (-29.4) (-26.6) (-12.1)
Married 0.280 * 0.279 * 0.245 *
(32.3) (32.2) (27.8)
Widowed  0.097 * 0.097 * -0.020
(10.1) (10.2) (-1.9)
Divorced 0.170 * 0.148 * 0.009
(18.5) (16) (0.9)
High school 0.121 * 0.119 *
(12.8) (12.6)
College 0.197 * 0.189 *
(21.8) (20.8)
Nonmet -0.060 * -0.067 *
(-5.8) (-6.5)
Inpatient -1.053 *
(-65.1)
NursingHome 0.491 *
(63.4)
Residence -0.049
(-4.8)
Number  420254
Pseudo R2 0.003 0.004 0.0045 0.0052 0.0302
BIC: -5275000 -5275000 -5275000 -4826000 -4829000
BIC' -488.62 -635.97 -671.608 -681.288 -4520.926
4032.306 3884.956 3849.318 3839.638
*=P<.01 **=P<.05
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Table G.2.I: Coefficients and Percent Change in Odds Ratio 
 AD as the Underlying  Condition in Decedents Aged 100-104,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.706 * -0.691 * -0.688 * -0.782 * -0.668 **
(-50.6) (-49.9) (-49.7) (-54.2) (-48.7)
Hispanic -0.093 -0.092 -0.114 0.112
(-8.9) (-8.8) (-10.8) (11.9)
NonHispanicBlack -0.229 -0.229 -0.249 -0.055
(-20.5) (-20.5) (-22) (-5.4)
Married 0.138 0.465 0.599
(14.8) (59.3) (82.1)
Widowed 0.201 0.360 ** 0.313
(22.3) (43.3) (36.8)
Divorced 0.343 0.332 0.277
(41) (39.4) (32)
High school -0.322 ** -0.325 **
(-27.5) (-27.7)
College 0.086 0.069
(9) (7.2)
Nonmet -0.386 ** -0.395 **
(-32) (-32.7)
Inpatient -1.873 *
(-84.6)
NursingHome 0.325
(38.4)
Residence -0.190
(-17.3)
Number  8158
Pseudo R2 0.0042 0.0049 0.0058 0.013 0.036
BIC: -71070.7 -71054.5 -71029.6 -62486.5 -62509.1
BIC' -1.022 15.189 40.08 52.11 29.573
-30.595 -14.384 10.507 22.537
*=P<.01 **=P<.05
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Table G.3.A: Coefficients and Percent Change in Odds Ratio 
 AD as Any Condition in Decedents Aged 60-64,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.212 * -0.219 * -0.238 * -0.228 * -0.181 *
(-19.1) (-19.7) (-21.2) (-20.4) (-16.5)
Hispanic -0.292 * -0.292 * -0.260 * -0.154 **
(-25.3) (-25.3) (-22.9) (-14.2)
NonHispanicBlack -0.673 * -0.658 * -0.636 * -0.611 *
(-49) (-48.2) (-47.1) (-45.7)
Married 0.070 ** 0.076 ** 0.001
(7.2) (7.9) (0.1)
Widowed -0.100 -0.057 -0.321 *
(-9.5) (-5.5) (-27.5)
Divorced -0.127 ** -0.119 ** -0.477 *
(-11.9) (-11.2) (-37.9)
High school -0.068 0.009
(-6.6) (0.9)
College 0.007 * 0.298 *
(22.3) (34.8)
Nonmetro 0.055 -0.046
(6.7) (-4.5)
Inpatient -0.168 *
(-15.4)
NursingHome 2.081 *
(701.6)
Residence 0.144 *
(15.5)
Number  675371
Pseudo R2 0.0009 0.0047 0.0052 0.0062 0.0625
BIC: -9010000 -9010000 -9010000 -8298000 -8301000
BIC' -37.35 -219.577 -205.213 -198.209 -3063.387
3026.037 2843.81 -205.213 2865.178
*=P<.01 **=P<.05
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Table G.3.B: Coefficients and Percent Change in Odds Ratio 
 AD as Any Condition in Decedents Aged 65-69, 
United States 1998-2002 
Model 1 Model 2 Model 3 Model 4 Model 5 
Male -0.077 * -0.086 * -0.125 * -0.136 * -0.097 * 
(-7.4) (-8.2) (-11.7) (-12.7) (-9.2) 
Hispanic -0.188 * -0.187 * -0.120 * -0.019 * 
(-17.2) (-17.1) (-11.3) (-1.8) 
NonHBlack -0.598 * -0.577 * -0.542 * -0.505 * 
(-45) (-43.8) (-41.8) (-39.6) 
Married 0.077 * 0.075 * 0.027 
-8.000 (7.7) (2.7) 
Widowed -0.150 * -0.129 * -0.362 * 
(-13.9) (-12.1) (-30.4) 
Divorced -0.154 * -0.151 * -0.472 
(-14.3) (-14) (-37.6) 
High school 0.004 0.044 * 
(0.4) (4.5) 
College 0.334 * 0.393 * 
(39.7) (48.1) 
Nonmetro -0.053 ** -0.038 
(-5.1) (-3.7) 
Inpatient -0.340 * 
(-28.8) 
NursingH 1.786 * 
(-496.7) 
Residence 0.026 
(-2.6) 
Number  913939 
Pseudo R2 0.0001 0.0031 0.0039 0.006 0.0614 
BIC: -1E+07 -1E+07 -1E+07 -1E+07 -1E+07 
BIC' -3.248 -348.27 -403.44 -575.77 -7028.8 
7025.55 6680.53 6625.35 6453.02 
*=P<.01 **=P<.05 
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Table G.3.C: Coefficients and Percent Change in Odds Ratio 
 AD as Any Condition in Decedents Aged 70-74,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.088 * -0.096 * -0.146 * -0.145 * -0.103 *
(-8.5) (-9.2) (-13.5) (-13.5) (-9.8)
Hispanic -0.260 * -0.258 * -0.170 * -0.050
(-22.9) (-22.70 (-15.7) (-4.8)
NonHispanicBlack -0.530 * -0.509 * -0.473 * -0.415 *
(-41.2) (-39.9) (-37.7) (-34)
Married 0.039 * 0.019 0.003
(3.9) (1.9) (0.3)
Widowed -0.176 * -0.164 * -0.350 *
(-16.1) (-15.1) (-29.6)
Divorced -0.260 * -0.276 * -0.543 *
(-22.9) (-24.1) (-41.9)
High school 0.081 * 0.106 *
(8.4) (11.2)
College 0.363 * 0.399 *
(43.8) (49)
Nonmetro -0.003 0.001
(-0.3) (0.1)
Inpatient -0.492 *
(-38.9)
NursingHome 1.479 *
(338.9)
Residence -0.111 *
(-10.5)
Number    1296730
Pseudo R2    0.0002 0.0026 0.0037 0.0055 0.0609
BIC: -17950000 -17950000 -17960000 -16630000 -1.7E+07
BIC': -46.015 -744.252 -1020.892 -1421.094 -16818.8
16772.758 16074.521 15797.881 -17218.98
*=P<.01 **=P<.05
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Table G.3.D: Coefficients and Percent Change in Odds Ratio 
 AD as Any Condition in Decedents Aged 75-79,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.104 * -0.109 * -0.174 * -0.177 * -0.124 *
(-9.9) (-10.3) (-16) (-16.2) (-11.7)
Hispanic -0.236 * -0.233 * -0.141 * -0.008
(-21) (-20.8) (-13.1) (-0.8)
NonHispanicBlack -0.491 * -0.469 * -0.422 * -0.337 *
(-38.8) (-37.4) (-34.4) (-28.6)
Married 0.033 * 0.009 0.010
(3.4) (0.9) (1)
Widowed -0.196 * -0.194 * -0.332
(-17.8) (-17.7) (-28.3) *
Divorced -0.280 * -0.284 * -0.486 *
(-24.4) (-24.7) (-38.5)
High school 0.098 * 0.106 *
(10.3) (11.2)
College 0.335 * 0.349 *
(39.8) (41.7)
Nonmetro 0.013 0.010
(1.3) (1)
Inpatient -0.619 *
(-46.1)
NursingHome 1.168 *
(221.7)
Residence -0.204 *
(-18.5)
Number    1671023   1,558,763
Pseudo R2    0.0003 0.0024 0.0037 0.0052   0.0576
BIC: -23340000 -23350000 -23350000 -21670000     -2.170e+07
BIC': -173.55 -1379.415 BIC: -2133.07 -2786.36   -32236.835
32063.285 30857.42 30103.765 29450.475
*=P<.01 **=P<.05
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Table G.3.E: Coefficients and Percent Change in Odds Ratio 
 AD as Any Condition in Decedents Aged 80-84, 
United States 1998-2002 
Model 1 Model 2 Model 3 Model 4 Model 5 
Male -0.130 * -0.134 * -0.201 * -0.202 * -0.145 * 
(-12.2) (-12.6) (-18.2) (-18.3) (-13.5) 
Hispanic -0.268 * -0.267 * -0.198 * -0.047 ** 
(-23.5) (-23.4) (-17.9) (-4.6) 
NonHBlack -0.453 * -0.436 * -0.391 * -0.278 * 
(-36.4) (-35.4) (-32.4) (-24.3) 
Married 0.028 * 0.007 0.028 * 
(2.9) (0.7) (2.8) 
Widowed -0.176 * -0.174 * -0.265 * 
(-16.1) (-15.9) (-23.3) 
Divorced -0.262 * -0.276 * -0.408 * 
(-23) (-24.1) (-33.5) 
High s. 0.080 * 0.084 * 
(8.4) (8.7) 
College 0.304 * 0.311 * 
(35.5) (36.5) 
Nonmetro 0.035 * 0.028 * 
(3.5) (2.8) 
Inpatient -0.726 * 
(-51.6) 
NursingH 0.859 * 
(136.1) 
Residence -0.225 * 
(-20.2) 
Number    1822068 
Pseudo R2    0.0005 0.0022 0.0034 0.0048 0.0487 
BIC: -3E+07 -3E+07 -3E+07 -2.36E+07 -2E+07 
BIC' -442.26 -1885.2 -2828.8 -3751.06 -39352 
38909.5 37466.6 36523 35600.717 
*=P<.01 **=P<.05 
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Table G.3.F: Coefficients and Percent Change in Odds Ratio 
 AD as Any Condition in Decedents Aged 85-89,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.149 * -0.152 * -0.215 * -0.212 * -0.154
(-13.9) (-14.1) (-19.4) (-19.1) (-14.3) *
Hispanic -0.215 * -0.216 * -0.169 * -0.012
(-19.4) (-19.5) (-15.5) (-1.2)
NonHispanicBlack -0.391 * -0.382 * -0.341 * -0.219
(-32.4) (-31.7) (-28.9) (-19.7) *
Married 0.052 * 0.041 * 0.074
(5.4) (4.2) (7.6) *
Widowed -0.139 * -0.134 * -0.192
(-13) (-12.5) (-17.5) *
Divorced -0.183 * -0.190 * -0.275
(-16.7) (-17.3) (-24.1) *
High school 0.075 * 0.072
(7.8) (7.5) *
College 0.235 * 0.233
(26.5) (26.3) *
Nonmetro 0.026 * 0.018
(2.7) (1.8) **
Inpatient -0.798
(-55) *
NursingHome 0.619
(85.7) *
Residence -0.187
(-17) *
Number    1667028
Pseudo R2    0.0007 0.0019 0.0027 0.0035 0.0376
BIC: -22980000 -22990000 22990000 -21280000 -2.1E+07
BIC': -592.737 -1647.531 -2341.851 -2826.53 -31403.3
30810.601 29755.807 29061.487 28576.808
*=P<.01 **=P<.05
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Table G.3.G: Coefficients and Percent Change in Odds Ratio 
 AD as Any Condition in Decedents Aged 90-94,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.212 * -0.212 * -0.261 * -0.260 * -0.203 *
(-19.1) (-9.2) (-22.9) (-22.9) (-18.3)
Hispanic -0.227 * -0.230 * -0.184 * -0.025
(-3.8) (-20.5) (-16.8) (-2.5)
NonHispanicBlack -0.374 * -0.369 * -0.322 * -0.183 *
(-8.9) (-30.9) (-27.5) (-16.7)
Married 0.039 ** 0.036 * 0.086 *
(3.9) (3.6) (9)
Widowed -0.138 * -0.136 * -0.171 *
(-12.9) (-12.7) (-15.7)
Divorced -0.077 * -0.072 -0.130 *
(-7.4) (-6.9) * (-12.2)
High school 0.074 * 0.070 *
(7.7) (7.2)
College 0.172 * 0.170 *
(18.7) (18.5)
Nonmetro 0.036 * 0.030 *
(3.7) (3.1)
Inpatient -0.866 *
(-58)
NursingHome 0.451 *
(56.9)
Residence -0.202 *
(-18.3)
Number    1085794
Pseudo R2    0.0012 0.0023 0.0029 0.0033 0.0297
BIC: -14490000 -14490000 -14490000 -13360000 -13370000
BIC': -688.916 -1313.3622 -1653.587 -1726.322 -16358.524
15669.608 15045.162 14704.937 14632.202
*=P<.01 **=P<.05
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Table G.3.H: Coefficients and Percent Change in Odds Ratio 
 AD as Any Condition in Decedents Aged 95-99, 
United States 1998-2002 
Model 1 Model 2 Model 3 Model 4 Model 5 
Age 
Male -0.351 * -0.348 * -0.382 * -0.379 * -0.315 * 
(-29.6) (-29.4) (-31.7) (-31.5) (-27) 
Hispanic -0.184 * -0.186 * -0.121 * 0.054 
(-16.8) (-17) (-11.4) (5.5) 
NonHispanicBlack -0.275 * -0.274 * -0.235 * -0.080 * 
(-24) (-24) (-20.9) (-7.6) 
Married 0.084 * 0.084 * 0.125 * 
(8.7) (8.7) (13.4) 
Widowed -0.083 * -0.086 * -0.126 * 
(-7.9) (-8.3) (-11.9) 
Divorced 0.000 -0.016 -0.077 * 
0.000 (-1.6) (-7.4) 
High school 0.085 * 0.085 * 
(8.9) (8.9) 
College 0.137 * 0.135 * 
(14.6) (14.4) 
Nonmetro -0.016 -0.023 
(-1.6) (-2.3) 
Inpatient -0.892 * 
(-59) 
NursingH 0.371 * 
(44.9) 
Residence -0.237 * 
(-21.1) 
Number    420254 
Pseudo R2    0.0024 0.0031 0.0034 0.0037 0.0244 
BIC: -5219000 -5220000 -5220000 -4775000 -4779000 
BIC': 
  -528.58 0 -654.776 -679.195 -639.997 -4863.624 
*=P<.01 **=P<.05 
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Table 3.I: Coefficients and Percent Change in Odds Ratio 
 AD as Any Condition in Decedents Aged 100-104,
United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.619 * -0.612 * -0.607 * -0.696 * -0.587 *
(-46.1) (-45.8) (-45.5) (-50.2) (-44.4)
Hispanic -0.023 -0.022 0.005 0.231
(-2.3) (-2.1) (0.5) (26)    
NonHispanicBlack -0.099 -0.099 -0.227 -0.041
(-9.5) (-9.4) (-20.3) (-4)
Married 0.045 0.378 0.502
(4.6) (46) (65.2)
Widowed 0.122 0.242 0.195
(12.9) (27.4) (21.5)
Divorced 0.223 0.251 0.188
(25) (28.5) (20.7)
High school -0.406 * -0.410 *
(-33.3) (-33.6)
College 0.052 0.042
(5.3) (4.3)
Nonmetro -0.3388 * -0.351 *
(-28.7) (-29.6)
Inpatient -1.421 *
(-75.8)
NursingHome 0.335
(39.8)
Residence -0.309
(-26.6)
Number    8158
Pseudo R2    0.0036 0.0038 0.0042 0.0121 0.0331
BIC: -70331.795 -70314.28 70288.409 -61870.42 -61901.9
BIC': -2.406 15.109 40.981 46.507 15.061
-17.467 0.048 25.92 31.446
*=P<.01 **=P<.05
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Table 4.A: Coefficients and Percent Change in Odds Ratio 
 Dying of AD Compared to Dying of Other Chronic Diseases
in Decedents Aged 60-64, United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.262 * -0.274 * -0.295 * -0.285 * -0.228 *
(-23.1) (-24) (-25.5) (-24.8) (-20.4)
Hispanic -0.320 * -0.313 * -0.273 * -0.169
(-27.4) (-26.9) (-23.9) (-15.6)
NonHispanicBlack -0.980 * -0.951 * -0.922 * -0.904 *
(-62.5) (-61.4) (-60.2) (-59.5)
Married 0.243 * 0.249 * 0.087
(27.5) (28.3) (9.1)
Widowed 0.052 0.105 -0.283 *
(5.4) (11) (-24.7)
Divorced 0.007 0.027 -0.469 *
(0.7) (2.7) (-37.4)
High school 0.006 0.072
(0.6) (7.5)
College 0.368 * 0.452 *
(44.4) (57.2)
Nonmetro -0.061 -0.032
(-5.9) (-3.1)
Inpatient -0.110
(-10.4)
NursingHome 2.312 *
(909.4)
Residence 0.318 *
(37.5)
Number  555193
Pseudo R2 0.0014 0.0079 0.009 0.0111 0.0773
BIC: -7304000 -7304000 -7304000 -6742000 -6745000
BIC' -41.378 -274.372 -277.308 -291.292 -2704.672
2663.294 2430.3 2427.364 2413.38
*=P<.01 **=P<.05
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Table 4.B: Coefficients and Percent Change in Odds Ratio 
 Dying of AD Compared to Dying of Other Chronic Diseases 
in Decedents Aged 65-69, United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.157 * -0.171 * -0.223 * -0.233 * -0.183 *
(-14.5) (-15.7) (-20) (-20.8) (-16.7)
Hispanic -0.175 * -0.169 * -0.073 * 0.038
(-16.1) (-15.5) (-7.1) (3.8)
NonHispanicBlack -0.844 * -0.808 * -0.760 * -0.731 *
(-57) (-55.4) (-53.2) (-51.8)
Married 0.265 * 0.260 * 0.140 *
(30.3) (29.7) (15)
Widowed -0.044 -0.018 -0.347 *
(-4.3) (-1.8) (-29.3)
Divorced 0.021 0.030 -0.404 *
(2.1) (3.1) (-33.2)
High school 0.063 0.104 *
(6.5) (10.9)
College 0.454 * 0.515 *
(57.4) (67.3)
Nonmetro -0.080 * -0.064 **
(-7.7) (-6.2)
Inpatient -0.322 *
(-27.5)
NursingHome 1.975 *
(620.9)
Residence 0.150 *
(16.2)
Number  770371
Pseudo R2 0.0005 0.0055 0.0071 0.0101 0.0742
BIC: -10350000 -10350000 -10350000 -9580000 -9585000
BIC' -34.02 -439.021 -539.087 -704.577 -5933.865
5899.845 5494.844 5394.778 5229.288
*=P<.01 **=P<.05
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Table 4.C: Coefficients and Percent Change in Odds Ratio 
 Dying of AD Compared to Dying of Other Chronic Diseases 
in Decedents Aged 70-74, United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.163 * -0.174 * -0.241 * -0.244 * -0.194 *
(-15.1) (-16) (-21.4) (-21.6) (-17.6)
Hispanic -0.275 * -0.270 * -0.163 * -0.036
(-24) (-23.7) (-15) (-3.6)
NonHispanicBlack -0.711 -0.675 * -0.630 * -0.577 *
(-50.9) (-49.1) (-46.7) (-43.8)
Married 0.246 * 0.225 * 0.143 *
(27.9) (25.2) (15.4)
Widowed -0.044 ** -0.030 -0.308 *
(-4.3) (-3) (-26.5)
Divorced -0.113 * -0.128 * -0.499 *
(-10.7) (-12) (-39.3)
High School 0.151 * 0.177 *
(16.4) (19.4)
College 0.487 * 0.524 *
(62.7) (69)
Nonmetro -0.021 -0.016
(-2.1) (-1.6)
Inpatient -0.521 *
(-40.6)
NursingHome 1.648 *
(419.8)
Residence -0.001
(-0.1)
Number  1098964 1024419
Pseudo R2 0.0007 0.0043 0.0062 0.009 0.0734
BIC: -15080000 -15080000 -15080000 -13990000 -14000000
BIC' -118.935 -835.834 -1176.995 -1588.75 -13802.059
13683.124 12966.225 12625.064 12213.309
*=P<.01 **=P<.05
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Table 4.D: Coefficients and Percent Change in Odds Ratio 
 Dying of AD Compared to Dying of Other Chronic Diseases 
in Decedents Aged 75-79, United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.183 * -0.190 * -0.274 * -0.279 * -0.219 *
(-16.7) (-17.) (-23.9) (-24.3) (-19.7)
Hispanic -0.273 * -0.266 * -0.149 * -0.004
(-23.9) (-23.4) (-13.8) (-0.4)
NonHispanicBlack -0.625 * -0.592 * -0.541 * -0.452 *
(-46.5) (-44.7) (-41.8) (-36.4)
Married 0.249 * 0.223 * 0.143 *
(28.3) (25) (15.4)
Widowed -0.034 * -0.029 ** -0.268 *
(-3.3) (-2.9) (-23.5)
Divorced -0.130 * -0.139 * -0.456 *
(-12.2) (-13) (-36)
High school 0.153 * 0.163 *
(16.5) (17.7)
College 0.458 * 0.475 *
(58.1) (60.8)
Nonmetro -0.009 -0.013
(-0.9) (-1.3)
Inpatient -0.643 *
(-47.4)
NursingHome 1.339 *
(281.6)
Residence -0.088 *
(-8.5)
Number  1402867
Pseudo R2 0.0009 0.0038 0.0058 0.0084 0.0692
BIC: -19450000 -19450000 -19450000 -18080000 -1.81E+07
BIC' -359.749 -1511.165 -2263.795 -3072.496 -26236.555
25876.806 24725.39 23972.76 23164.059
*=P<.01 **=P<.05
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Table 4.E: Coefficients and Percent Change in Odds Ratio 
 Dying of AD Compared to Dying of Other Chronic Diseases 
in Decedents Aged 80-84, United States 1998-2002 Model 5
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.214 * -0.220 * -0.308 * -0.309 * -0.246 *
(-19.3) (-19.7) (-26.5) (-26.6) (-21.8)
Hispanic -0.326 * -0.320 * -0.235 * -0.070 *
(-27.8) (-27.4) (-21) (-6.8)
NonHispanicBlack -0.599 * -0.575 * -0.523 * -0.405 *
(-45.1) (-43.7) (-40.7) (-33.3)
Married 0.237 * 0.215 * 0.148 *
(26.8) (23.9) (15.9)
Widowed -0.018 -0.013 -0.208 *
(-1.7) (-1.3) (-18.8)
Divorced -0.098 * -0.109 * -0.354 *
(-9.3) (-10.4) (-29.8)
High school 0.115 * 0.120 *
(12.2) (12.7)
College 0.391 * 0.401 *
(47.9) (49.4)
Nonmetro 0.002 -0.009
(0.2) (-0.9)
Inpatient -0.760 *
(-53.2)
NursingHome 1.025 *
(178.6)
Residence -0.113 *
(-10.7)
Number  1498866 1400732
Pseudo R2 0.0013 0.0039 0.0054   0.00 75 0.0586
BIC: -20730000 -20730000 -20730000 -19280000 -19300000
BIC' -774.382 -2252.27 -3089.407 -4033.774 -32213.735
31439.35 29961.47 29124.33 28179.96
*=P<.01 **=P<.05
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Table 4.F: Coefficients and Percent Change in Odds Ratio 
 Dying of AD Compared to Dying of Other Chronic Diseases 
in Decedents Aged 85-89, United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.250 * -0.253 * -0.334 * -0.330 * -0.265 *
(-22.1) -33.057 (-28.4) (-28.1) (-23.3)
Hispanic -0.295 * -0.293 * -0.231 * -0.059 **
(-25.4) (-20.7) (-5.7)
NonHispanicBlack -0.499 -0.486 * -0.431 * -0.302 *
(-38.5) (-35) (-26.1)
Married 0.269 * 0.255 * 0.201 *
(30.9) (29) (22.3)
Widowed 0.047 * 0.055 * -0.101 *
(4.8) (5.6) (-9.6)
Divorced 0.028 0.024 -0.165 *
(2.8) (2.5) (-15.2)
High school 0.120 * 0.118 *
(12.8) (12.5)
College 0.317 * 0.315 *
(37.3) (37.1)
Nonmetro -0.005 -0.018 **
(-0.5) (-1.8)
Inpatient -0.840 *
(-56.8)
NursingHome 0.768 *
(115.6)
Residence -0.096 *
(-9.2)
Number  1336410 1245886
Pseudo R2  0.00 18 0.00 36 0.0046 0.006 0.0456
BIC: -18240000 -18240000 -18240000 -16920000 -16940000
BIC' -1073.051 -2149.349 -2754.339 -3311.639 -25890.502
24817.45 23741.15 23136.16 22578.86
*=P<.01 **=P<.05
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Table 4.G: Coefficients and Percent Change in Odds Ratio 
 Dying of AD Compared to Dying of Other Chronic Diseases 
in Decedents Aged 90-94, United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.313 * -0.313 * -0.374 * -0.373 * -0.311 *
(-26.9) (-26.8) (-31.2) (-31.1) (-26.8)
Hispanic -0.321 * -0.322 * -0.271 * -0.098 *
(-27.5) (-27.6) (-23.7) (-9.3)
NonHispanicBlack -0.496 * -0.492 * -0.443 * -0.300 *
(-39.1) (-38.8) (-35.8) (-25.9)
Married 0.237 * 0.232 * 0.181 *
(26.7) (26.1) (19.9)
Widowed 0.041 * 0.045 * -0.101 *
(4.2) (4.6) (-9.6)
Divorced 0.122 * 0.128 * -0.045
(13) (13.6) (-4.4)
High school 0.111 * 0.105 *
(11.7) (11)
College 0.251 * 0.248 *
(28.6) (28.2)
Nonmetro 0.000 -0.012
(0) (-1.2)
Inpatient -0.886 *
(-58.8)
NursingHome 0.608 *
(83.7)
Residence -0.093 *
(-8.9)
Number  783533
Pseudo R2 0.0024 0.0042 0.0047 0.0057 0.0358
BIC: -11110000 -11110000 -11110000 -10250000 -10260000
BIC' -976.383 -1681.537 -1859.312 -2051.124 -13508.347
12531.96 11826.81 11649.04 11457.22
*=P<.01 **=P<.05
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Table 4.I: Coefficients and Percent Change in Odds Ratio 
 Dying of AD Compared to Dying of Other Chronic Diseases 
in Decedents Aged 100-104, United States 1998-2002
Model 1 Model 2 Model 3 Model 4 Model 5
Male -0.747 * -0.729 * -0.721 * -0.817 * -0.702 **
-52.600 (-51.8) (-51.4) (-55.8) (-50.4)
Hispanic -0.086 -0.090 -0.111 0.128
(-8.3) (-8.6) (-10.5) (13.6)
NonHispanicBlack -0.272 -0.271 -0.315 -0.131
(-23.8) (-23.8) (-27) (-12.3)
Married 0.056 0.417 0.579
(5.8) (51.8) (78.5)
Widowed 0.194 0.359 ** 0.306
(21.5) (43.1) (35.8)
Divorced 0.380 0.371 0.288
(46.2) (44.9) (33.4)
High school -0.349 ** -0.336 **
(-29.5) (-28.5)
College 0.078 0.078
(8.1) (8.1)
Nonmetro -0.319 ** -0.350 **
(-27.3) (-29.6)
Inpatient -1.725 *
(-82.2)
NursingHome 0.341
(40.7)
Residence -0.275
(-24)
Number  5158 5158
Pseudo R2 0.00 51 0.00 62 0.0072    0.01 45 0.0366
BIC: -47903.33 -47888.51 -47864.59 -42064.09 -42081.956
BIC' -2.559 12.263 36.184 48.287 30.422
-32.981 -18.159 5.762 17.865
*=P<.01 **=P<.05
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Table 5.A: Coefficients and Percent Change in Odds Ratio 
 AD as the Underlying  Condition in Decedents
 Aged 60-105+, United States 1998-2002
65-69 -0.020 (-2)
70-74 0.589 * (80.1)
75-79 1.168 * (221.4)
80-84 1.562 * (376.7)
85-89 1.752 * (476.7)
90-94 1.812 * (512)
95-99 1.787 * (496.9)
100-104 1.367 * (292.5)
105+ 0.624 (86.7)
Age 60-64 used as the standard
Number of obs   =    9643607
Pseudo R2       =     0.0317
BIC:  -1.524e+08     BIC':  -87307.777
 
 
 
 
 
Table 5.B: Coefficients and Percent Change in Odds Ratio 
AD as Any Condition in Decedents Aged 60-105+,
United States 1998-2002
65-69 0.020 (2)
70-74 0.675 * (96.4)
75-79 1.276 * (258.2)
80-84 1.678 * (435.6)
85-89 1.868 * (547.5)
90-94 1.903 * (570.8)
95-99 1.843 * (531.3)
100-104 1.373 * (294.9)
105+ 0.832 **(129.8)
Age 60-64 used as the standard
Number of obs   =    9643607
Pseudo R2       =     0.0365
BIC: -1.514e+08     BIC':  -140654.382
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Table 5.C: Coefficients and Percent Change in Odds Ratio 
AD as Underlying  Condition in Decedents Aged 60-105+,
Mexican and Cuban Comparisons,United States 1998-2002 
Mexican -0.517 * (-40.4) 176,241
Mexican in SW -0.561 * (-43) 142,283
Cuban -0.024 (-2.4) 48,244
Cuban in Florida 0.012 (1.2) 37,323
 
 
Table 5.D: Coefficients and Percent Change in Odds Ratio 
AD as Underlying  Condition in Decedents Aged 60-105+,
By Ethnicity and Age, United States 1998-2002
60-64 60-64 70-74 75-79 80-84 85-89 90-94 100-104
Mexican -0.760 * -0.342 * -0.435 * -0.351 * -0.410 * -0.376 * -0.416 * -1.385
(-53.2) (-29) (-35.3) (-29.6) (-33.6) (-31.3) (-34.1) (-75)
PuertoRican -0.060 -0.035 -0.175 -0.342 * -0.595 * -0.279 * -0.336 * 0.371
(-5.9) (-3.5) (-16.1) (-29) (-44.8) (-24.3) (-28.5) (44.9)
Cuban 0.093 0.130 -0.033 0.061 0.022 -0.214 * -0.218 * -0.086
(9.8) (13.9) (-3.3) (6.3) (2.2) (-19.2) (-19.6) (-8.2)
OtherHispanic -0.181 -0.167 -0.241 * -0.299 * -0.317 * -0.189 * -0.207 * 0.701
(-16.5) (-15.4) (-21.4) (-25.9) (-27.2) (-17.3) (-18.7) (101.5)
NonHisBlack -0.978 * -0.841 * -0.705 * -0.615 * -0.587 * -0.481 * -0.481 * -0.256
(-62.4) (-56.9) (-50.6) (-45.9) (-44.4) (-38.2) (-38.2) (-22.6)
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